
PMID- 29058718
OWN - NLM
STAT- MEDLINE
DCOM- 20171107
LR  - 20171219
IS  - 1476-4679 (Electronic)
IS  - 1465-7392 (Linking)
VI  - 19
IP  - 11
DP  - 2017 Nov
TI  - PKM2 methylation by CARM1 activates aerobic glycolysis to promote tumorigenesis.
PG  - 1358-1370
LID - 10.1038/ncb3630 [doi]
AB  - Metabolic reprogramming is a hallmark of cancer. Herein we discover that the key 
      glycolytic enzyme pyruvate kinase M2 isoform (PKM2), but not the related isoform 
      PKM1, is methylated by co-activator-associated arginine methyltransferase 1
      (CARM1). PKM2 methylation reversibly shifts the balance of metabolism from
      oxidative phosphorylation to aerobic glycolysis in breast cancer cells. Oxidative
      phosphorylation depends on mitochondrial calcium concentration, which becomes
      critical for cancer cell survival when PKM2 methylation is blocked. By
      interacting with and suppressing the expression of inositol-1,4,5-trisphosphate
      receptors (InsP3Rs), methylated PKM2 inhibits the influx of calcium from the
      endoplasmic reticulum to mitochondria. Inhibiting PKM2 methylation with a
      competitive peptide delivered by nanoparticles perturbs the metabolic energy
      balance in cancer cells, leading to a decrease in cell proliferation, migration
      and metastasis. Collectively, the CARM1-PKM2 axis serves as a metabolic
      reprogramming mechanism in tumorigenesis, and inhibiting PKM2 methylation
      generates metabolic vulnerability to InsP3R-dependent mitochondrial functions.
FAU - Liu, Fabao
AU  - Liu F
AD  - McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison,
      Wisconsin 53705, USA.
FAU - Ma, Fengfei
AU  - Ma F
AD  - School of Pharmacy, University of Wisconsin-Madison, Madison, Wisconsin 53705,
      USA.
FAU - Wang, Yuyuan
AU  - Wang Y
AD  - Department of Materials Science and Engineering and Wisconsin Institute for
      Discovery, University of Wisconsin-Madison, Madison, Wisconsin 53715, USA.
FAU - Hao, Ling
AU  - Hao L
AUID- ORCID: http://orcid.org/0000-0002-0106-5266
AD  - School of Pharmacy, University of Wisconsin-Madison, Madison, Wisconsin 53705,
      USA.
FAU - Zeng, Hao
AU  - Zeng H
AUID- ORCID: http://orcid.org/0000-0003-4967-9555
AD  - McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison,
      Wisconsin 53705, USA.
FAU - Jia, Chenxi
AU  - Jia C
AD  - School of Pharmacy, University of Wisconsin-Madison, Madison, Wisconsin 53705,
      USA.
FAU - Wang, Yidan
AU  - Wang Y
AD  - McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison,
      Wisconsin 53705, USA.
FAU - Liu, Peng
AU  - Liu P
AD  - Department of Biostatistics and Medical Informatics, University of
      Wisconsin-Madison, Madison, Wisconsin 53705, USA.
AD  - UW Carbone Cancer Center, School of Medicine and Public Health, University of
      Wisconsin-Madison, Madison, Wisconsin 53705, USA.
FAU - Ong, Irene M
AU  - Ong IM
AD  - Department of Biostatistics and Medical Informatics, University of
      Wisconsin-Madison, Madison, Wisconsin 53705, USA.
AD  - UW Carbone Cancer Center, School of Medicine and Public Health, University of
      Wisconsin-Madison, Madison, Wisconsin 53705, USA.
FAU - Li, Baobin
AU  - Li B
AD  - School of Pharmacy, University of Wisconsin-Madison, Madison, Wisconsin 53705,
      USA.
FAU - Chen, Guojun
AU  - Chen G
AD  - Department of Materials Science and Engineering and Wisconsin Institute for
      Discovery, University of Wisconsin-Madison, Madison, Wisconsin 53715, USA.
FAU - Jiang, Jiaoyang
AU  - Jiang J
AD  - School of Pharmacy, University of Wisconsin-Madison, Madison, Wisconsin 53705,
      USA.
FAU - Gong, Shaoqin
AU  - Gong S
AUID- ORCID: http://orcid.org/0000-0001-9447-2938
AD  - Department of Materials Science and Engineering and Wisconsin Institute for
      Discovery, University of Wisconsin-Madison, Madison, Wisconsin 53715, USA.
AD  - Department of Biomedical Engineering, University of Wisconsin-Madison, Madison,
      Wisconsin 53706, USA.
FAU - Li, Lingjun
AU  - Li L
AUID- ORCID: http://orcid.org/0000-0003-0056-3869
AD  - School of Pharmacy, University of Wisconsin-Madison, Madison, Wisconsin 53705,
      USA.
AD  - Department of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin
      53706, USA.
AD  - School of Life Sciences, Tianjin University, No. 92 Weijin Road, Nankai District,
      Tianjin 300072, China.
FAU - Xu, Wei
AU  - Xu W
AUID- ORCID: http://orcid.org/0000-0003-3808-0045
AD  - McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison,
      Wisconsin 53705, USA.
LA  - eng
GR  - R01 CA213293/CA/NCI NIH HHS/United States
GR  - R21 CA196653/CA/NCI NIH HHS/United States
GR  - P30 CA014520/CA/NCI NIH HHS/United States
GR  - S10 OD018039/OD/NIH HHS/United States
GR  - S10 RR029531/RR/NCRR NIH HHS/United States
GR  - P41 GM108538/GM/NIGMS NIH HHS/United States
GR  - R01 DK071801/DK/NIDDK NIH HHS/United States
PT  - Journal Article
DEP - 20171023
PL  - England
TA  - Nat Cell Biol
JT  - Nature cell biology
JID - 100890575
RN  - 0 (CARD Signaling Adaptor Proteins)
RN  - 0 (Carrier Proteins)
RN  - 0 (Inositol 1,4,5-Trisphosphate Receptors)
RN  - 0 (Membrane Proteins)
RN  - 0 (Thyroid Hormones)
RN  - 0 (thyroid hormone-binding proteins)
RN  - EC 4.6.1.2 (CARD11 protein, human)
RN  - EC 4.6.1.2 (Guanylate Cyclase)
RN  - SY7Q814VUP (Calcium)
SB  - IM
MH  - Animals
MH  - CARD Signaling Adaptor Proteins/*metabolism
MH  - Calcium/metabolism
MH  - Carcinogenesis/*metabolism/*pathology
MH  - Carrier Proteins/*metabolism
MH  - Cell Line
MH  - Cell Line, Tumor
MH  - Cell Movement/physiology
MH  - Cell Proliferation/physiology
MH  - Endoplasmic Reticulum/metabolism
MH  - Female
MH  - Glycolysis/*physiology
MH  - Guanylate Cyclase/*metabolism
MH  - HEK293 Cells
MH  - Humans
MH  - Inositol 1,4,5-Trisphosphate Receptors/metabolism
MH  - MCF-7 Cells
MH  - Membrane Proteins/*metabolism
MH  - Methylation
MH  - Mice
MH  - Mice, Inbred BALB C
MH  - Mice, Nude
MH  - Mitochondria/metabolism
MH  - Neoplasm Metastasis/pathology
MH  - Oxidative Phosphorylation
MH  - Thyroid Hormones/*metabolism
PMC - PMC5683091
MID - NIHMS907098
EDAT- 2017/10/24 06:00
MHDA- 2017/11/08 06:00
CRDT- 2017/10/24 06:00
PMCR- 2018/04/23 00:00
PHST- 2017/01/19 00:00 [received]
PHST- 2017/09/18 00:00 [accepted]
PHST- 2018/04/23 00:00 [pmc-release]
PHST- 2017/10/24 06:00 [pubmed]
PHST- 2017/11/08 06:00 [medline]
PHST- 2017/10/24 06:00 [entrez]
AID - ncb3630 [pii]
AID - 10.1038/ncb3630 [doi]
PST - ppublish
SO  - Nat Cell Biol. 2017 Nov;19(11):1358-1370. doi: 10.1038/ncb3630. Epub 2017 Oct 23.

PMID- 29129639
OWN - NLM
STAT- MEDLINE
DCOM- 20171129
LR  - 20171219
IS  - 1097-4164 (Electronic)
IS  - 1097-2765 (Linking)
VI  - 68
IP  - 4
DP  - 2017 Nov 16
TI  - Determinants of Histone H3K4 Methylation Patterns.
PG  - 773-785.e6
LID - S1097-2765(17)30788-8 [pii]
LID - 10.1016/j.molcel.2017.10.013 [doi]
AB  - Various factors differentially recognize trimethylated histone H3 lysine 4
      (H3K4me3) near promoters, H3K4me2 just downstream, and promoter-distal H3K4me1 to
      modulate gene expression. This methylation "gradient" is thought to result from
      preferential binding of the H3K4 methyltransferase Set1/complex associated with
      Set1 (COMPASS) to promoter-proximal RNA polymerase II. However, other studies
      have suggested that location-specific cues allosterically activate Set1.
      Chromatin immunoprecipitation sequencing (ChIP-seq) experiments show that H3K4
      methylation patterns on active genes are not universal or fixed and change in
      response to both transcription elongation rate and frequency as well as reduced
      COMPASS activity. Fusing Set1 to RNA polymerase II results in H3K4me2 throughout 
      transcribed regions and similarly extended H3K4me3 on highly transcribed genes.
      Tethered Set1 still requires histone H2B ubiquitylation for activity. These
      results show that higher-level methylations reflect not only Set1/COMPASS
      recruitment but also multiple rounds of transcription. This model provides a
      simple explanation for non-canonical methylation patterns at some loci or in
      certain COMPASS mutants.
CI  - Copyright (c) 2017 Elsevier Inc. All rights reserved.
FAU - Soares, Luis M
AU  - Soares LM
AD  - Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical
      School, Boston, MA 02115, USA.
FAU - He, P Cody
AU  - He PC
AD  - Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical
      School, Boston, MA 02115, USA.
FAU - Chun, Yujin
AU  - Chun Y
AD  - Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical
      School, Boston, MA 02115, USA.
FAU - Suh, Hyunsuk
AU  - Suh H
AD  - Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical
      School, Boston, MA 02115, USA.
FAU - Kim, TaeSoo
AU  - Kim T
AD  - Department of Life Science, Ewha Womans University, Seoul 03760, Korea.
FAU - Buratowski, Stephen
AU  - Buratowski S
AD  - Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical
      School, Boston, MA 02115, USA. Electronic address: steveb@hms.harvard.edu.
LA  - eng
GR  - R01 GM046498/GM/NIGMS NIH HHS/United States
GR  - R01 GM056663/GM/NIGMS NIH HHS/United States
PT  - Journal Article
DEP - 20171109
PL  - United States
TA  - Mol Cell
JT  - Molecular cell
JID - 9802571
RN  - 0 (Histones)
RN  - 0 (Schizosaccharomyces pombe Proteins)
RN  - 0 (Transcription Factors)
RN  - EC 2.1.1.43 (Histone-Lysine N-Methyltransferase)
RN  - EC 2.1.1.43 (Set1 protein, S pombe)
SB  - IM
MH  - Histone-Lysine N-Methyltransferase/genetics/metabolism
MH  - Histones/genetics/*metabolism
MH  - Methylation
MH  - *Models, Biological
MH  - Saccharomyces cerevisiae/genetics/*metabolism
MH  - Schizosaccharomyces/genetics/*metabolism
MH  - Schizosaccharomyces pombe Proteins/genetics/metabolism
MH  - Transcription Factors/genetics/metabolism
MH  - Ubiquitination/physiology
PMC - PMC5706784
MID - NIHMS919668
OTO - NOTNLM
OT  - COMPASS
OT  - RNA polymerase II
OT  - Set1
OT  - histone H3 lysine 4
OT  - histone methylation
OT  - transcription elongation
EDAT- 2017/11/14 06:00
MHDA- 2017/12/01 06:00
CRDT- 2017/11/14 06:00
PMCR- 2018/11/16 00:00
PHST- 2017/03/12 00:00 [received]
PHST- 2017/08/23 00:00 [revised]
PHST- 2017/10/12 00:00 [accepted]
PHST- 2018/11/16 00:00 [pmc-release]
PHST- 2017/11/14 06:00 [pubmed]
PHST- 2017/12/01 06:00 [medline]
PHST- 2017/11/14 06:00 [entrez]
AID - S1097-2765(17)30788-8 [pii]
AID - 10.1016/j.molcel.2017.10.013 [doi]
PST - ppublish
SO  - Mol Cell. 2017 Nov 16;68(4):773-785.e6. doi: 10.1016/j.molcel.2017.10.013. Epub
      2017 Nov 9.

PMID- 29222116
OWN - NLM
STAT- Publisher
LR  - 20171209
IS  - 1469-9001 (Electronic)
IS  - 1355-8382 (Linking)
DP  - 2017 Dec 8
TI  - Our views of dynamic N(6)-methyladenosine RNA methylation.
LID - rna.064295.117 [pii]
LID - 10.1261/rna.064295.117 [doi]
AB  - We thank Darnell et al. in their Divergent Views article for noting our
      contributions to recent progress in the field of RNA modifications. We agree with
      many of the viewpoints expressed: that a majority of messenger RNA
      N6-methyladenosine (m6A) methylation occurs co-transcriptionally, that one of the
      main functions of m6A methylation on mRNA is to mark sets of transcripts for
      expedited turnover, and that this methylation may not dramatically affect
      splicing in HeLa cells. However, although the impact of m6A methylation on
      splicing appears to be modest in many cell lines, we suggest to be cautious
      because m6A methylation is enriched in long exons and overrepresented in
      transcripts with alternative splicing variants. Two recent examples have revealed
      methylation-dependent changes in splicing: one demonstrated m6A-modulated sex
      determination in Drosophila melanogaster, and another found enhanced SAM
      synthetase expression mediated by a specific m6A site installed by METTL16 . The 
      potential effects of RNA methylation on constitutive and alternative splicing in 
      additional physiological contexts need to be further evaluated.
CI  - Published by Cold Spring Harbor Laboratory Press for the RNA Society.
FAU - Zhao, Boxuan
AU  - Zhao B
AUID- ORCID: http://orcid.org/0000-0002-3729-4511
AD  - University of Chicago.
FAU - Nachtergaele, Sigrid
AU  - Nachtergaele S
AD  - University of Chicago.
FAU - Roundtree, Ian A
AU  - Roundtree IA
AD  - University of Chicago.
FAU - He, Chuan
AU  - He C
AD  - University of Chicago chuanhe@uchicago.edu.
LA  - eng
PT  - Journal Article
DEP - 20171208
PL  - United States
TA  - RNA
JT  - RNA (New York, N.Y.)
JID - 9509184
EDAT- 2017/12/10 06:00
MHDA- 2017/12/10 06:00
CRDT- 2017/12/10 06:00
PHST- 2017/10/01 00:00 [received]
PHST- 2017/12/05 00:00 [accepted]
PHST- 2017/12/10 06:00 [entrez]
PHST- 2017/12/10 06:00 [pubmed]
PHST- 2017/12/10 06:00 [medline]
AID - rna.064295.117 [pii]
AID - 10.1261/rna.064295.117 [doi]
PST - aheadofprint
SO  - RNA. 2017 Dec 8. pii: rna.064295.117. doi: 10.1261/rna.064295.117.

PMID- 29222117
OWN - NLM
STAT- Publisher
LR  - 20171209
IS  - 1469-9001 (Electronic)
IS  - 1355-8382 (Linking)
DP  - 2017 Dec 8
TI  - pre-mRNA processing includes N6 methylation of adenosine residues that are
      retained in mRNA exons and the fallacy of "RNA epigenetics".
LID - rna.065219.117 [pii]
LID - 10.1261/rna.065219.117 [doi]
AB  - By using a cell fraction technique that separates chromatin associated nascent
      RNA, newly completed nucleoplasmic mRNA and cytoplasmic mRNA, we have shown that 
      residues in exons are methylated (m6A) in nascent pre-mRNA and remain methylated 
      in the same exonic residues in nucleoplasmic and cytoplasmic mRNA. Thus, there is
      no evidence of a substantial degree of demethylation in mRNA exons that would
      correspond to so-called "epigenetic" demethylation. The turnover rate of mRNA
      molecules is faster depending on m6A content in HeLa cell mRNA suggesting
      specification of mRNA stability may be the major role of m6A exon modification.
      In mouse embryonic stem cells (mESCs) lacking Mettl3, the major mRNA methylase,
      the cells continue to grow, making the same mRNAs with unchanged splicing
      profiles in the absence (>90%) of m6A in mRNA suggesting no common obligatory
      role of m6A in splicing. All these data argue strongly against a commonly used
      "reversible dynamic methylation/demethylation" of mRNA, calling into question the
      concept of "RNA epigenetics" that parallels the well-established role of dynamic 
      DNA epigenetics.
CI  - Published by Cold Spring Harbor Laboratory Press for the RNA Society.
FAU - Darnell, Robert B
AU  - Darnell RB
AD  - The Rockefeller University.
FAU - Ke, Shengdong
AU  - Ke S
AD  - The Rockefeller University.
FAU - Darnell, James E Jr
AU  - Darnell JE Jr
AD  - The Rockefeller University darnell@mail.rockefeller.edu.
LA  - eng
PT  - Journal Article
DEP - 20171208
PL  - United States
TA  - RNA
JT  - RNA (New York, N.Y.)
JID - 9509184
EDAT- 2017/12/10 06:00
MHDA- 2017/12/10 06:00
CRDT- 2017/12/10 06:00
PHST- 2017/12/05 00:00 [received]
PHST- 2017/12/05 00:00 [accepted]
PHST- 2017/12/10 06:00 [entrez]
PHST- 2017/12/10 06:00 [pubmed]
PHST- 2017/12/10 06:00 [medline]
AID - rna.065219.117 [pii]
AID - 10.1261/rna.065219.117 [doi]
PST - aheadofprint
SO  - RNA. 2017 Dec 8. pii: rna.065219.117. doi: 10.1261/rna.065219.117.

PMID- 29364879
OWN - NLM
STAT- Publisher
LR  - 20180124
IS  - 1476-4687 (Electronic)
IS  - 0028-0836 (Linking)
DP  - 2018 Jan 24
TI  - Mitochondrial translation requires folate-dependent tRNA methylation.
LID - 10.1038/nature25460 [doi]
AB  - Folates enable the activation and transfer of one-carbon units for the
      biosynthesis of purines, thymidine and methionine. Antifolates are important
      immunosuppressive and anticancer agents. In proliferating lymphocytes and human
      cancers, mitochondrial folate enzymes are particularly strongly upregulated. This
      in part reflects the need for mitochondria to generate one-carbon units and
      export them to the cytosol for anabolic metabolism. The full range of uses of
      folate-bound one-carbon units in the mitochondrial compartment itself, however,
      has not been thoroughly explored. Here we show that loss of the catalytic
      activity of the mitochondrial folate enzyme serine hydroxymethyltransferase 2
      (SHMT2), but not of other folate enzymes, leads to defective oxidative
      phosphorylation in human cells due to impaired mitochondrial translation. We find
      that SHMT2, presumably by generating mitochondrial
      5,10-methylenetetrahydrofolate, provides methyl donors to produce the
      taurinomethyluridine base at the wobble position of select mitochondrial tRNAs.
      Mitochondrial ribosome profiling in SHMT2-knockout human cells reveals that the
      lack of this modified base causes defective translation, with preferential
      mitochondrial ribosome stalling at certain lysine (AAG) and leucine (UUG) codons.
      This results in the impaired expression of respiratory chain enzymes. Stalling at
      these specific codons also occurs in certain inborn errors of mitochondrial
      metabolism. Disruption of whole-cell folate metabolism, by either folate
      deficiency or antifolate treatment, also impairs the respiratory chain. In
      summary, mammalian mitochondria use folate-bound one-carbon units to methylate
      tRNA, and this modification is required for mitochondrial translation and thus
      oxidative phosphorylation.
FAU - Morscher, Raphael J
AU  - Morscher RJ
AD  - Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton,
      New Jersey 08544, USA.
AD  - Department of Chemistry, Princeton University, Princeton, New Jersey 08544, USA.
FAU - Ducker, Gregory S
AU  - Ducker GS
AD  - Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton,
      New Jersey 08544, USA.
AD  - Department of Chemistry, Princeton University, Princeton, New Jersey 08544, USA.
FAU - Li, Sophia Hsin-Jung
AU  - Li SH
AD  - Department of Molecular Biology, Princeton University, Princeton, New Jersey
      08544, USA.
FAU - Mayer, Johannes A
AU  - Mayer JA
AD  - Department of Pediatrics, Salzburger Landeskliniken and Paracelsus Medical
      University, Salzburg 5020, Austria.
FAU - Gitai, Zemer
AU  - Gitai Z
AD  - Department of Molecular Biology, Princeton University, Princeton, New Jersey
      08544, USA.
FAU - Sperl, Wolfgang
AU  - Sperl W
AD  - Department of Pediatrics, Salzburger Landeskliniken and Paracelsus Medical
      University, Salzburg 5020, Austria.
FAU - Rabinowitz, Joshua D
AU  - Rabinowitz JD
AD  - Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton,
      New Jersey 08544, USA.
AD  - Department of Chemistry, Princeton University, Princeton, New Jersey 08544, USA.
LA  - eng
PT  - Journal Article
DEP - 20180124
PL  - England
TA  - Nature
JT  - Nature
JID - 0410462
EDAT- 2018/01/25 06:00
MHDA- 2018/01/25 06:00
CRDT- 2018/01/25 06:00
PHST- 2017/06/07 00:00 [received]
PHST- 2017/12/14 00:00 [accepted]
PHST- 2018/01/25 06:00 [entrez]
PHST- 2018/01/25 06:00 [pubmed]
PHST- 2018/01/25 06:00 [medline]
AID - nature25460 [pii]
AID - 10.1038/nature25460 [doi]
PST - aheadofprint
SO  - Nature. 2018 Jan 24. pii: nature25460. doi: 10.1038/nature25460.

PMID- 29203910
OWN - NLM
STAT- In-Data-Review
LR  - 20171226
IS  - 1546-1718 (Electronic)
IS  - 1061-4036 (Linking)
VI  - 50
IP  - 1
DP  - 2018 Jan
TI  - TET proteins safeguard bivalent promoters from de novo methylation in human
      embryonic stem cells.
PG  - 83-95
LID - 10.1038/s41588-017-0002-y [doi]
AB  - TET enzymes oxidize 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC),
      which can lead to DNA demethylation. However, direct connections between
      TET-mediated DNA demethylation and transcriptional output are difficult to
      establish owing to challenges in distinguishing global versus locus-specific
      effects. Here we show that TET1, TET2 and TET3 triple-knockout (TKO) human
      embryonic stem cells (hESCs) exhibit prominent bivalent promoter hypermethylation
      without an overall corresponding decrease in gene expression in the
      undifferentiated state. Focusing on the bivalent PAX6 locus, we find that
      increased DNMT3B binding is associated with promoter hypermethylation, which
      precipitates a neural differentiation defect and failure of PAX6 induction during
      differentiation. dCas9-mediated locus-specific demethylation and global
      inactivation of DNMT3B in TKO hESCs partially reverses the hypermethylation at
      the PAX6 promoter and improves differentiation to neuroectoderm. Taking these
      findings together with further genome-wide methylation and TET1 and DNMT3B
      ChIP-seq analyses, we conclude that TET proteins safeguard bivalent promoters
      from de novo methylation to ensure robust lineage-specific transcription upon
      differentiation.
FAU - Verma, Nipun
AU  - Verma N
AUID- ORCID: http://orcid.org/0000-0002-9522-6699
AD  - Developmental Biology Program, Sloan Kettering Institute, New York, NY, USA.
AD  - Weill Graduate School of Medical Sciences at Cornell University/The Rockefeller
      University/Sloan Kettering Institute Tri-Institutional MD-PhD Program, New York, 
      NY, USA.
FAU - Pan, Heng
AU  - Pan H
AD  - Department of Physiology and Biophysics, Englander Institute for Precision
      Medicine, Institute for Computational Biomedicine, Weill Cornell Medical College,
      New York, NY, USA.
AD  - Weill Cornell Graduate School of Medical Sciences, Weill Cornell Medical College,
      New York, NY, USA.
FAU - Dore, Louis C
AU  - Dore LC
AD  - Department of Chemistry, Department of Biochemistry and Molecular Biology,
      Institute for Biophysical Dynamics, Howard Hughes Medical Institute, University
      of Chicago, Chicago, IL, USA.
FAU - Shukla, Abhijit
AU  - Shukla A
AD  - Developmental Biology Program, Sloan Kettering Institute, New York, NY, USA.
FAU - Li, Qing V
AU  - Li QV
AD  - Developmental Biology Program, Sloan Kettering Institute, New York, NY, USA.
AD  - Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan
      Kettering Cancer Center, New York, NY, USA.
FAU - Pelham-Webb, Bobbie
AU  - Pelham-Webb B
AD  - Weill Graduate School of Medical Sciences at Cornell University/The Rockefeller
      University/Sloan Kettering Institute Tri-Institutional MD-PhD Program, New York, 
      NY, USA.
FAU - Teijeiro, Virginia
AU  - Teijeiro V
AD  - Developmental Biology Program, Sloan Kettering Institute, New York, NY, USA.
AD  - Weill Cornell Graduate School of Medical Sciences, Weill Cornell Medical College,
      New York, NY, USA.
FAU - Gonzalez, Federico
AU  - Gonzalez F
AD  - Developmental Biology Program, Sloan Kettering Institute, New York, NY, USA.
AD  - Institute for Bioengineering of Catalonia (IBEC), Barcelona, Spain.
FAU - Krivtsov, Andrei
AU  - Krivtsov A
AD  - Cancer Biology and Genetics Program, Sloan Kettering Institute, New York, NY,
      USA.
FAU - Chang, Chan-Jung
AU  - Chang CJ
AD  - Department of Oncological Sciences and Black Family Stem Cell Institute, Icahn
      School of Medicine at Mount Sinai, New York, NY, USA.
FAU - Papapetrou, Eirini P
AU  - Papapetrou EP
AD  - Department of Oncological Sciences and Black Family Stem Cell Institute, Icahn
      School of Medicine at Mount Sinai, New York, NY, USA.
FAU - He, Chuan
AU  - He C
AD  - Department of Chemistry, Department of Biochemistry and Molecular Biology,
      Institute for Biophysical Dynamics, Howard Hughes Medical Institute, University
      of Chicago, Chicago, IL, USA.
FAU - Elemento, Olivier
AU  - Elemento O
AD  - Department of Physiology and Biophysics, Englander Institute for Precision
      Medicine, Institute for Computational Biomedicine, Weill Cornell Medical College,
      New York, NY, USA. ole2001@med.cornell.edu.
FAU - Huangfu, Danwei
AU  - Huangfu D
AUID- ORCID: http://orcid.org/0000-0002-1145-6199
AD  - Developmental Biology Program, Sloan Kettering Institute, New York, NY, USA.
      huangfud@mskcc.org.
LA  - eng
GR  - P30 CA008748/CA/NCI NIH HHS/United States
PT  - Journal Article
DEP - 20171204
PL  - United States
TA  - Nat Genet
JT  - Nature genetics
JID - 9216904
EIN - Nat Genet. 2017 Dec 18;:. PMID: 29255265
EIN - Nat Genet. 2017 Dec 18;:. PMID: 29255266
PMC - PMC5742051
MID - NIHMS915929
EDAT- 2017/12/06 06:00
MHDA- 2017/12/06 06:00
CRDT- 2017/12/06 06:00
PMCR- 2018/06/04 00:00
PHST- 2016/10/31 00:00 [received]
PHST- 2017/10/25 00:00 [accepted]
PHST- 2018/06/04 00:00 [pmc-release]
PHST- 2017/12/06 06:00 [pubmed]
PHST- 2017/12/06 06:00 [medline]
PHST- 2017/12/06 06:00 [entrez]
AID - 10.1038/s41588-017-0002-y [doi]
AID - 10.1038/s41588-017-0002-y [pii]
PST - ppublish
SO  - Nat Genet. 2018 Jan;50(1):83-95. doi: 10.1038/s41588-017-0002-y. Epub 2017 Dec 4.

PMID- 29236683
OWN - NLM
STAT- In-Data-Review
LR  - 20180102
IS  - 1476-4687 (Electronic)
IS  - 0028-0836 (Linking)
VI  - 552
IP  - 7685
DP  - 2017 Dec 21
TI  - Effector CD8 T cells dedifferentiate into long-lived memory cells.
PG  - 404-409
LID - 10.1038/nature25144 [doi]
AB  - Memory CD8 T cells that circulate in the blood and are present in lymphoid organs
      are an essential component of long-lived T cell immunity. These memory CD8 T
      cells remain poised to rapidly elaborate effector functions upon re-exposure to
      pathogens, but also have many properties in common with naive cells, including
      pluripotency and the ability to migrate to the lymph nodes and spleen. Thus,
      memory cells embody features of both naive and effector cells, fuelling a
      long-standing debate centred on whether memory T cells develop from effector
      cells or directly from naive cells. Here we show that long-lived memory CD8 T
      cells are derived from a subset of effector T cells through a process of
      dedifferentiation. To assess the developmental origin of memory CD8 T cells, we
      investigated changes in DNA methylation programming at naive and effector
      cell-associated genes in virus-specific CD8 T cells during acute lymphocytic
      choriomeningitis virus infection in mice. Methylation profiling of terminal
      effector versus memory-precursor CD8 T cell subsets showed that, rather than
      retaining a naive epigenetic state, the subset of cells that gives rise to memory
      cells acquired de novo DNA methylation programs at naive-associated genes and
      became demethylated at the loci of classically defined effector molecules.
      Conditional deletion of the de novo methyltransferase Dnmt3a at an early stage of
      effector differentiation resulted in reduced methylation and faster re-expression
      of naive-associated genes, thereby accelerating the development of memory cells. 
      Longitudinal phenotypic and epigenetic characterization of the memory-precursor
      effector subset of virus-specific CD8 T cells transferred into antigen-free mice 
      revealed that differentiation to memory cells was coupled to erasure of de novo
      methylation programs and re-expression of naive-associated genes. Thus,
      epigenetic repression of naive-associated genes in effector CD8 T cells can be
      reversed in cells that develop into long-lived memory CD8 T cells while key
      effector genes remain demethylated, demonstrating that memory T cells arise from 
      a subset of fate-permissive effector T cells.
FAU - Youngblood, Ben
AU  - Youngblood B
AD  - Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia
      30322, USA.
AD  - Department of Microbiology and Immunology, Emory University School of Medicine,
      Atlanta, Georgia 30322, USA.
AD  - Department of Immunology, St. Jude Children's Research Hospital, Memphis,
      Tennessee 38105, USA.
FAU - Hale, J Scott
AU  - Hale JS
AD  - Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia
      30322, USA.
AD  - Department of Microbiology and Immunology, Emory University School of Medicine,
      Atlanta, Georgia 30322, USA.
FAU - Kissick, Haydn T
AU  - Kissick HT
AD  - Department of Urology, Emory University School of Medicine, Atlanta, Georgia
      30322, USA.
FAU - Ahn, Eunseon
AU  - Ahn E
AD  - Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia
      30322, USA.
AD  - Department of Microbiology and Immunology, Emory University School of Medicine,
      Atlanta, Georgia 30322, USA.
FAU - Xu, Xiaojin
AU  - Xu X
AD  - Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia
      30322, USA.
AD  - Department of Microbiology and Immunology, Emory University School of Medicine,
      Atlanta, Georgia 30322, USA.
FAU - Wieland, Andreas
AU  - Wieland A
AD  - Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia
      30322, USA.
AD  - Department of Microbiology and Immunology, Emory University School of Medicine,
      Atlanta, Georgia 30322, USA.
FAU - Araki, Koichi
AU  - Araki K
AD  - Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia
      30322, USA.
AD  - Department of Microbiology and Immunology, Emory University School of Medicine,
      Atlanta, Georgia 30322, USA.
FAU - West, Erin E
AU  - West EE
AD  - Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia
      30322, USA.
AD  - Department of Microbiology and Immunology, Emory University School of Medicine,
      Atlanta, Georgia 30322, USA.
FAU - Ghoneim, Hazem E
AU  - Ghoneim HE
AD  - Department of Immunology, St. Jude Children's Research Hospital, Memphis,
      Tennessee 38105, USA.
FAU - Fan, Yiping
AU  - Fan Y
AD  - Department of Computational Biology, St. Jude Children's Research Hospital,
      Memphis, Tennessee 38105, USA.
FAU - Dogra, Pranay
AU  - Dogra P
AD  - Department of Immunology, St. Jude Children's Research Hospital, Memphis,
      Tennessee 38105, USA.
FAU - Davis, Carl W
AU  - Davis CW
AD  - Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia
      30322, USA.
AD  - Department of Microbiology and Immunology, Emory University School of Medicine,
      Atlanta, Georgia 30322, USA.
FAU - Konieczny, Bogumila T
AU  - Konieczny BT
AD  - Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia
      30322, USA.
AD  - Department of Microbiology and Immunology, Emory University School of Medicine,
      Atlanta, Georgia 30322, USA.
FAU - Antia, Rustom
AU  - Antia R
AD  - Department of Biology, Emory University, Atlanta, Georgia 30322, USA.
FAU - Cheng, Xiaodong
AU  - Cheng X
AD  - Department of Biochemistry, Emory University School of Medicine, Atlanta, Georgia
      30322, USA.
FAU - Ahmed, Rafi
AU  - Ahmed R
AD  - Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia
      30322, USA.
AD  - Department of Microbiology and Immunology, Emory University School of Medicine,
      Atlanta, Georgia 30322, USA.
LA  - eng
PT  - Journal Article
DEP - 20171213
PL  - England
TA  - Nature
JT  - Nature
JID - 0410462
EDAT- 2017/12/14 06:00
MHDA- 2017/12/14 06:00
CRDT- 2017/12/14 06:00
PHST- 2015/11/03 00:00 [received]
PHST- 2017/11/17 00:00 [accepted]
PHST- 2017/12/14 06:00 [pubmed]
PHST- 2017/12/14 06:00 [medline]
PHST- 2017/12/14 06:00 [entrez]
AID - nature25144 [pii]
AID - 10.1038/nature25144 [doi]
PST - ppublish
SO  - Nature. 2017 Dec 21;552(7685):404-409. doi: 10.1038/nature25144. Epub 2017 Dec
      13.

PMID- 29056337
OWN - NLM
STAT- MEDLINE
DCOM- 20171215
LR  - 20171219
IS  - 1097-4172 (Electronic)
IS  - 0092-8674 (Linking)
VI  - 171
IP  - 5
DP  - 2017 Nov 16
TI  - Early-Life Gene Expression in Neurons Modulates Lasting Epigenetic States.
PG  - 1151-1164.e16
LID - S0092-8674(17)31141-8 [pii]
LID - 10.1016/j.cell.2017.09.047 [doi]
AB  - In mammals, the environment plays a critical role in promoting the final steps in
      neuronal development during the early postnatal period. While epigenetic factors 
      are thought to contribute to this process, the underlying molecular mechanisms
      remain poorly understood. Here, we show that in the brain during early life, the 
      DNA methyltransferase DNMT3A transiently binds across transcribed regions of
      lowly expressed genes, and its binding specifies the pattern of DNA methylation
      at CA sequences (mCA) within these genes. We find that DNMT3A occupancy and mCA
      deposition within the transcribed regions of genes is negatively regulated by
      gene transcription and may be modified by early-life experience. Once deposited, 
      mCA is bound by the methyl-DNA-binding protein MECP2 and functions in a
      rheostat-like manner to fine-tune the cell-type-specific transcription of genes
      that are critical for brain function.
CI  - Copyright (c) 2017 Elsevier Inc. All rights reserved.
FAU - Stroud, Hume
AU  - Stroud H
AD  - Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA.
FAU - Su, Susan C
AU  - Su SC
AD  - Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA.
FAU - Hrvatin, Sinisa
AU  - Hrvatin S
AD  - Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA.
FAU - Greben, Alexander W
AU  - Greben AW
AD  - Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA.
FAU - Renthal, William
AU  - Renthal W
AD  - Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA.
FAU - Boxer, Lisa D
AU  - Boxer LD
AD  - Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA.
FAU - Nagy, M Aurel
AU  - Nagy MA
AD  - Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA.
FAU - Hochbaum, Daniel R
AU  - Hochbaum DR
AD  - Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA.
FAU - Kinde, Benyam
AU  - Kinde B
AD  - Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA.
FAU - Gabel, Harrison W
AU  - Gabel HW
AD  - Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA.
FAU - Greenberg, Michael E
AU  - Greenberg ME
AD  - Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA.
      Electronic address: michael_greenberg@hms.harvard.edu.
LA  - eng
GR  - F32 NS089186/NS/NINDS NIH HHS/United States
GR  - R01 NS048276/NS/NINDS NIH HHS/United States
GR  - T32 GM007753/GM/NIGMS NIH HHS/United States
GR  - T32 NS007484/NS/NINDS NIH HHS/United States
PT  - Journal Article
DEP - 20171019
PL  - United States
TA  - Cell
JT  - Cell
JID - 0413066
RN  - 0 (MECP2 protein, human)
RN  - 0 (Methyl-CpG-Binding Protein 2)
RN  - EC 2.1.1.37 (DNA (Cytosine-5-)-Methyltransferases)
RN  - EC 2.1.1.37 (DNA methyltransferase 3A)
SB  - IM
MH  - Animals
MH  - Brain/cytology/metabolism
MH  - DNA (Cytosine-5-)-Methyltransferases/*genetics/*metabolism
MH  - *DNA Methylation
MH  - *Epigenesis, Genetic
MH  - Gene Expression Regulation, Developmental
MH  - Humans
MH  - Methyl-CpG-Binding Protein 2
MH  - Mice
MH  - Neurons/*metabolism
MH  - Transcription, Genetic
MH  - Transcriptional Activation
PMC - PMC5693680
MID - NIHMS909707
EDAT- 2017/10/24 06:00
MHDA- 2017/12/16 06:00
CRDT- 2017/10/24 06:00
PMCR- 2018/11/16 00:00
PHST- 2017/02/21 00:00 [received]
PHST- 2017/07/17 00:00 [revised]
PHST- 2017/09/25 00:00 [accepted]
PHST- 2018/11/16 00:00 [pmc-release]
PHST- 2017/10/24 06:00 [pubmed]
PHST- 2017/12/16 06:00 [medline]
PHST- 2017/10/24 06:00 [entrez]
AID - S0092-8674(17)31141-8 [pii]
AID - 10.1016/j.cell.2017.09.047 [doi]
PST - ppublish
SO  - Cell. 2017 Nov 16;171(5):1151-1164.e16. doi: 10.1016/j.cell.2017.09.047. Epub
      2017 Oct 19.

PMID- 29255258
OWN - NLM
STAT- In-Data-Review
LR  - 20171223
IS  - 1546-1718 (Electronic)
IS  - 1061-4036 (Linking)
VI  - 50
IP  - 1
DP  - 2018 Jan
TI  - Single-cell DNA methylome sequencing of human preimplantation embryos.
PG  - 12-19
LID - 10.1038/s41588-017-0007-6 [doi]
AB  - DNA methylation is a crucial layer of epigenetic regulation during mammalian
      embryonic development (1-3) . Although the DNA methylome of early human embryos
      has been analyzed (4-6) , some of the key features have not been addressed thus
      far. Here we performed single-cell DNA methylome sequencing for human
      preimplantation embryos and found that tens of thousands of genomic loci
      exhibited de novo DNA methylation. This finding indicates that genome-wide DNA
      methylation reprogramming during preimplantation development is a dynamic balance
      between strong global demethylation and drastic focused remethylation.
      Furthermore, demethylation of the paternal genome is much faster and thorough
      than that of the maternal genome. From the two-cell to the postimplantation
      stage, methylation of the paternal genome is consistently lower than that of the 
      maternal genome. We also show that the genetic lineage of early blastomeres can
      be traced by DNA methylation analysis. Our work paves the way for deciphering the
      secrets of DNA methylation reprogramming in early human embryos.
FAU - Zhu, Ping
AU  - Zhu P
AUID- ORCID: http://orcid.org/0000-0002-4521-7524
AD  - Beijing Advanced Innovation Center for Genomics, College of Life Sciences,
      Department of Obstetrics and Gynecology, Third Hospital, Peking University,
      Beijing, China.
AD  - Biomedical Institute for Pioneering Investigation via Convergence and Center for 
      Reproductive Medicine, College of Life Sciences, Department of Obstetrics and
      Gynecology, Third Hospital, Peking University, Beijing, China.
AD  - Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, China.
AD  - State Key Laboratory of Experimental Hematology, Institute of Hematology and
      Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union
      Medical College, Tianjin, China.
FAU - Guo, Hongshan
AU  - Guo H
AD  - Beijing Advanced Innovation Center for Genomics, College of Life Sciences,
      Department of Obstetrics and Gynecology, Third Hospital, Peking University,
      Beijing, China.
AD  - Biomedical Institute for Pioneering Investigation via Convergence and Center for 
      Reproductive Medicine, College of Life Sciences, Department of Obstetrics and
      Gynecology, Third Hospital, Peking University, Beijing, China.
AD  - Massachusetts General Hospital Cancer Center, Harvard Medical School,
      Charlestown, MA, USA.
FAU - Ren, Yixin
AU  - Ren Y
AD  - Beijing Advanced Innovation Center for Genomics, College of Life Sciences,
      Department of Obstetrics and Gynecology, Third Hospital, Peking University,
      Beijing, China.
AD  - Key Laboratory of Assisted Reproduction and Key Laboratory of Cell Proliferation 
      and Differentiation, Ministry of Education, Beijing, China.
FAU - Hou, Yu
AU  - Hou Y
AUID- ORCID: http://orcid.org/0000-0001-7875-7087
AD  - Beijing Advanced Innovation Center for Genomics, College of Life Sciences,
      Department of Obstetrics and Gynecology, Third Hospital, Peking University,
      Beijing, China.
AD  - Biomedical Institute for Pioneering Investigation via Convergence and Center for 
      Reproductive Medicine, College of Life Sciences, Department of Obstetrics and
      Gynecology, Third Hospital, Peking University, Beijing, China.
FAU - Dong, Ji
AU  - Dong J
AD  - Beijing Advanced Innovation Center for Genomics, College of Life Sciences,
      Department of Obstetrics and Gynecology, Third Hospital, Peking University,
      Beijing, China.
AD  - Biomedical Institute for Pioneering Investigation via Convergence and Center for 
      Reproductive Medicine, College of Life Sciences, Department of Obstetrics and
      Gynecology, Third Hospital, Peking University, Beijing, China.
FAU - Li, Rong
AU  - Li R
AD  - Beijing Advanced Innovation Center for Genomics, College of Life Sciences,
      Department of Obstetrics and Gynecology, Third Hospital, Peking University,
      Beijing, China.
AD  - Key Laboratory of Assisted Reproduction and Key Laboratory of Cell Proliferation 
      and Differentiation, Ministry of Education, Beijing, China.
FAU - Lian, Ying
AU  - Lian Y
AD  - Beijing Advanced Innovation Center for Genomics, College of Life Sciences,
      Department of Obstetrics and Gynecology, Third Hospital, Peking University,
      Beijing, China.
AD  - Key Laboratory of Assisted Reproduction and Key Laboratory of Cell Proliferation 
      and Differentiation, Ministry of Education, Beijing, China.
FAU - Fan, Xiaoying
AU  - Fan X
AD  - Beijing Advanced Innovation Center for Genomics, College of Life Sciences,
      Department of Obstetrics and Gynecology, Third Hospital, Peking University,
      Beijing, China.
AD  - Biomedical Institute for Pioneering Investigation via Convergence and Center for 
      Reproductive Medicine, College of Life Sciences, Department of Obstetrics and
      Gynecology, Third Hospital, Peking University, Beijing, China.
FAU - Hu, Boqiang
AU  - Hu B
AD  - Beijing Advanced Innovation Center for Genomics, College of Life Sciences,
      Department of Obstetrics and Gynecology, Third Hospital, Peking University,
      Beijing, China.
AD  - Biomedical Institute for Pioneering Investigation via Convergence and Center for 
      Reproductive Medicine, College of Life Sciences, Department of Obstetrics and
      Gynecology, Third Hospital, Peking University, Beijing, China.
FAU - Gao, Yun
AU  - Gao Y
AD  - Beijing Advanced Innovation Center for Genomics, College of Life Sciences,
      Department of Obstetrics and Gynecology, Third Hospital, Peking University,
      Beijing, China.
AD  - Biomedical Institute for Pioneering Investigation via Convergence and Center for 
      Reproductive Medicine, College of Life Sciences, Department of Obstetrics and
      Gynecology, Third Hospital, Peking University, Beijing, China.
FAU - Wang, Xiaoye
AU  - Wang X
AD  - Beijing Advanced Innovation Center for Genomics, College of Life Sciences,
      Department of Obstetrics and Gynecology, Third Hospital, Peking University,
      Beijing, China.
AD  - Key Laboratory of Assisted Reproduction and Key Laboratory of Cell Proliferation 
      and Differentiation, Ministry of Education, Beijing, China.
FAU - Wei, Yuan
AU  - Wei Y
AD  - Beijing Advanced Innovation Center for Genomics, College of Life Sciences,
      Department of Obstetrics and Gynecology, Third Hospital, Peking University,
      Beijing, China.
AD  - Key Laboratory of Assisted Reproduction and Key Laboratory of Cell Proliferation 
      and Differentiation, Ministry of Education, Beijing, China.
FAU - Liu, Ping
AU  - Liu P
AD  - Beijing Advanced Innovation Center for Genomics, College of Life Sciences,
      Department of Obstetrics and Gynecology, Third Hospital, Peking University,
      Beijing, China.
AD  - Key Laboratory of Assisted Reproduction and Key Laboratory of Cell Proliferation 
      and Differentiation, Ministry of Education, Beijing, China.
FAU - Yan, Jie
AU  - Yan J
AD  - Beijing Advanced Innovation Center for Genomics, College of Life Sciences,
      Department of Obstetrics and Gynecology, Third Hospital, Peking University,
      Beijing, China.
AD  - Key Laboratory of Assisted Reproduction and Key Laboratory of Cell Proliferation 
      and Differentiation, Ministry of Education, Beijing, China.
FAU - Ren, Xiulian
AU  - Ren X
AD  - Beijing Advanced Innovation Center for Genomics, College of Life Sciences,
      Department of Obstetrics and Gynecology, Third Hospital, Peking University,
      Beijing, China.
AD  - Key Laboratory of Assisted Reproduction and Key Laboratory of Cell Proliferation 
      and Differentiation, Ministry of Education, Beijing, China.
FAU - Yuan, Peng
AU  - Yuan P
AD  - Beijing Advanced Innovation Center for Genomics, College of Life Sciences,
      Department of Obstetrics and Gynecology, Third Hospital, Peking University,
      Beijing, China.
AD  - Key Laboratory of Assisted Reproduction and Key Laboratory of Cell Proliferation 
      and Differentiation, Ministry of Education, Beijing, China.
FAU - Yuan, Yifeng
AU  - Yuan Y
AD  - Beijing Advanced Innovation Center for Genomics, College of Life Sciences,
      Department of Obstetrics and Gynecology, Third Hospital, Peking University,
      Beijing, China.
AD  - Key Laboratory of Assisted Reproduction and Key Laboratory of Cell Proliferation 
      and Differentiation, Ministry of Education, Beijing, China.
FAU - Yan, Zhiqiang
AU  - Yan Z
AD  - Beijing Advanced Innovation Center for Genomics, College of Life Sciences,
      Department of Obstetrics and Gynecology, Third Hospital, Peking University,
      Beijing, China.
AD  - Key Laboratory of Assisted Reproduction and Key Laboratory of Cell Proliferation 
      and Differentiation, Ministry of Education, Beijing, China.
FAU - Wen, Lu
AU  - Wen L
AD  - Beijing Advanced Innovation Center for Genomics, College of Life Sciences,
      Department of Obstetrics and Gynecology, Third Hospital, Peking University,
      Beijing, China.
AD  - Biomedical Institute for Pioneering Investigation via Convergence and Center for 
      Reproductive Medicine, College of Life Sciences, Department of Obstetrics and
      Gynecology, Third Hospital, Peking University, Beijing, China.
FAU - Yan, Liying
AU  - Yan L
AUID- ORCID: http://orcid.org/0000-0001-9572-9440
AD  - Beijing Advanced Innovation Center for Genomics, College of Life Sciences,
      Department of Obstetrics and Gynecology, Third Hospital, Peking University,
      Beijing, China. yanliyingkind@aliyun.com.
AD  - Biomedical Institute for Pioneering Investigation via Convergence and Center for 
      Reproductive Medicine, College of Life Sciences, Department of Obstetrics and
      Gynecology, Third Hospital, Peking University, Beijing, China.
      yanliyingkind@aliyun.com.
AD  - Key Laboratory of Assisted Reproduction and Key Laboratory of Cell Proliferation 
      and Differentiation, Ministry of Education, Beijing, China.
      yanliyingkind@aliyun.com.
AD  - Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive
      Technology, Beijing, China. yanliyingkind@aliyun.com.
FAU - Qiao, Jie
AU  - Qiao J
AUID- ORCID: http://orcid.org/0000-0003-2126-1376
AD  - Beijing Advanced Innovation Center for Genomics, College of Life Sciences,
      Department of Obstetrics and Gynecology, Third Hospital, Peking University,
      Beijing, China. jie.qiao@263.net.
AD  - Biomedical Institute for Pioneering Investigation via Convergence and Center for 
      Reproductive Medicine, College of Life Sciences, Department of Obstetrics and
      Gynecology, Third Hospital, Peking University, Beijing, China. jie.qiao@263.net.
AD  - Key Laboratory of Assisted Reproduction and Key Laboratory of Cell Proliferation 
      and Differentiation, Ministry of Education, Beijing, China. jie.qiao@263.net.
AD  - Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive
      Technology, Beijing, China. jie.qiao@263.net.
AD  - Academy for Advanced Interdisciplinary Studies, Peking University, Beijing,
      China. jie.qiao@263.net.
AD  - Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, China.
      jie.qiao@263.net.
FAU - Tang, Fuchou
AU  - Tang F
AUID- ORCID: http://orcid.org/0000-0002-8625-7717
AD  - Beijing Advanced Innovation Center for Genomics, College of Life Sciences,
      Department of Obstetrics and Gynecology, Third Hospital, Peking University,
      Beijing, China. tangfuchou@pku.edu.cn.
AD  - Biomedical Institute for Pioneering Investigation via Convergence and Center for 
      Reproductive Medicine, College of Life Sciences, Department of Obstetrics and
      Gynecology, Third Hospital, Peking University, Beijing, China.
      tangfuchou@pku.edu.cn.
AD  - Key Laboratory of Assisted Reproduction and Key Laboratory of Cell Proliferation 
      and Differentiation, Ministry of Education, Beijing, China.
      tangfuchou@pku.edu.cn.
AD  - Academy for Advanced Interdisciplinary Studies, Peking University, Beijing,
      China. tangfuchou@pku.edu.cn.
AD  - Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, China.
      tangfuchou@pku.edu.cn.
LA  - eng
PT  - Journal Article
DEP - 20171218
PL  - United States
TA  - Nat Genet
JT  - Nature genetics
JID - 9216904
EDAT- 2017/12/20 06:00
MHDA- 2017/12/20 06:00
CRDT- 2017/12/20 06:00
PHST- 2016/10/23 00:00 [received]
PHST- 2017/11/01 00:00 [accepted]
PHST- 2017/12/20 06:00 [pubmed]
PHST- 2017/12/20 06:00 [medline]
PHST- 2017/12/20 06:00 [entrez]
AID - 10.1038/s41588-017-0007-6 [doi]
AID - 10.1038/s41588-017-0007-6 [pii]
PST - ppublish
SO  - Nat Genet. 2018 Jan;50(1):12-19. doi: 10.1038/s41588-017-0007-6. Epub 2017 Dec
      18.

PMID- 29058709
OWN - NLM
STAT- MEDLINE
DCOM- 20171229
LR  - 20180119
IS  - 1545-9985 (Electronic)
IS  - 1545-9985 (Linking)
VI  - 24
IP  - 12
DP  - 2017 Dec
TI  - Molecular analysis of PRC2 recruitment to DNA in chromatin and its inhibition by 
      RNA.
PG  - 1028-1038
LID - 10.1038/nsmb.3487 [doi]
AB  - Many studies have revealed pathways of epigenetic gene silencing by Polycomb
      repressive complex 2 (PRC2) in vivo, but understanding the underlying molecular
      mechanisms requires biochemistry. Here we analyze interactions of reconstituted
      human PRC2 with nucleosome complexes. Histone modifications, the H3K27M cancer
      mutation, and inclusion of JARID2 or EZH1 in the PRC2 complex have unexpectedly
      minor effects on PRC2-nucleosome binding. Instead, protein-free linker DNA
      dominates the PRC2-nucleosome interaction. Specificity for CG-rich sequences is
      consistent with PRC2 occupying CG-rich DNA in vivo. PRC2 preferentially binds
      methylated DNA regulated by its AEBP2 subunit, suggesting how DNA and histone
      methylation collaborate to repress chromatin. We find that RNA, known to inhibit 
      PRC2 activity, is not a methyltransferase inhibitor per se. Instead, RNA
      sequesters PRC2 from nucleosome substrates, because PRC2 binding requires linker 
      DNA, and RNA and DNA binding are mutually exclusive. Together, we provide a model
      for PRC2 recruitment and an explanation for how actively transcribed genomic
      regions bind PRC2 but escape silencing.
FAU - Wang, Xueyin
AU  - Wang X
AD  - Department of Chemistry & Biochemistry, BioFrontiers Institute, University of
      Colorado Boulder, Boulder, Colorado, USA.
AD  - Howard Hughes Medical Institute, University of Colorado Boulder, Boulder,
      Colorado, USA.
FAU - Paucek, Richard D
AU  - Paucek RD
AUID- ORCID: http://orcid.org/0000-0002-4105-2443
AD  - Department of Chemistry & Biochemistry, BioFrontiers Institute, University of
      Colorado Boulder, Boulder, Colorado, USA.
AD  - Howard Hughes Medical Institute, University of Colorado Boulder, Boulder,
      Colorado, USA.
FAU - Gooding, Anne R
AU  - Gooding AR
AD  - Department of Chemistry & Biochemistry, BioFrontiers Institute, University of
      Colorado Boulder, Boulder, Colorado, USA.
AD  - Howard Hughes Medical Institute, University of Colorado Boulder, Boulder,
      Colorado, USA.
FAU - Brown, Zachary Z
AU  - Brown ZZ
AD  - Department of Chemistry, Princeton University, Princeton, New Jersey, USA.
FAU - Ge, Eva J
AU  - Ge EJ
AD  - Department of Chemistry, Princeton University, Princeton, New Jersey, USA.
FAU - Muir, Tom W
AU  - Muir TW
AD  - Department of Chemistry, Princeton University, Princeton, New Jersey, USA.
FAU - Cech, Thomas R
AU  - Cech TR
AUID- ORCID: http://orcid.org/0000-0001-7338-3389
AD  - Department of Chemistry & Biochemistry, BioFrontiers Institute, University of
      Colorado Boulder, Boulder, Colorado, USA.
AD  - Howard Hughes Medical Institute, University of Colorado Boulder, Boulder,
      Colorado, USA.
LA  - eng
GR  - Howard Hughes Medical Institute/United States
GR  - P01 CA196539/CA/NCI NIH HHS/United States
GR  - R01 GM086868/GM/NIGMS NIH HHS/United States
GR  - R37 GM086868/GM/NIGMS NIH HHS/United States
PT  - Journal Article
DEP - 20171023
PL  - United States
TA  - Nat Struct Mol Biol
JT  - Nature structural & molecular biology
JID - 101186374
RN  - 0 (AEBP2 protein, human)
RN  - 0 (Chromatin)
RN  - 0 (DNA-Binding Proteins)
RN  - 0 (Histones)
RN  - 0 (JARID2 protein, human)
RN  - 0 (MTF2 protein, human)
RN  - 0 (Nucleosomes)
RN  - 0 (Repressor Proteins)
RN  - 63231-63-0 (RNA)
RN  - 9007-49-2 (DNA)
RN  - EC 2.1.1.43 (EZH1 protein, human)
RN  - EC 2.1.1.43 (Polycomb Repressive Complex 2)
SB  - IM
MH  - Base Composition/genetics
MH  - Cell Line
MH  - Chromatin/*genetics
MH  - DNA/metabolism
MH  - DNA Methylation/genetics
MH  - DNA-Binding Proteins/*genetics
MH  - Epigenesis, Genetic/genetics
MH  - Gene Silencing/*physiology
MH  - Histones/genetics/metabolism
MH  - Humans
MH  - Nucleosomes/metabolism
MH  - Polycomb Repressive Complex 2/*genetics
MH  - Protein Binding/genetics
MH  - RNA/*metabolism
MH  - Repressor Proteins/metabolism
PMC - PMC5771497
MID - NIHMS928189
EDAT- 2017/10/24 06:00
MHDA- 2017/12/30 06:00
CRDT- 2017/10/24 06:00
PMCR- 2018/04/23 00:00
PHST- 2017/06/14 00:00 [received]
PHST- 2017/09/20 00:00 [accepted]
PHST- 2018/04/23 00:00 [pmc-release]
PHST- 2017/10/24 06:00 [pubmed]
PHST- 2017/12/30 06:00 [medline]
PHST- 2017/10/24 06:00 [entrez]
AID - nsmb.3487 [pii]
AID - 10.1038/nsmb.3487 [doi]
PST - ppublish
SO  - Nat Struct Mol Biol. 2017 Dec;24(12):1028-1038. doi: 10.1038/nsmb.3487. Epub 2017
      Oct 23.

PMID- 29198561
OWN - NLM
STAT- MEDLINE
DCOM- 20171226
LR  - 20171226
IS  - 1097-4164 (Electronic)
IS  - 1097-2765 (Linking)
VI  - 68
IP  - 5
DP  - 2017 Dec 7
TI  - Transcriptome-wide Analysis of Roles for tRNA Modifications in Translational
      Regulation.
PG  - 978-992.e4
LID - S1097-2765(17)30837-7 [pii]
LID - 10.1016/j.molcel.2017.11.002 [doi]
AB  - Covalent nucleotide modifications in noncoding RNAs affect a plethora of
      biological processes, and new functions continue to be discovered even for
      well-known modifying enzymes. To systematically compare the functions of a large 
      set of noncoding RNA modifications in gene regulation, we carried out ribosome
      profiling in budding yeast to characterize 57 nonessential genes involved in tRNA
      modification. Deletion mutants exhibited a range of translational phenotypes,
      with enzymes known to modify anticodons, or non-tRNA substrates such as rRNA,
      exhibiting the most dramatic translational perturbations. Our data build on prior
      reports documenting translational upregulation of the nutrient-responsive
      transcription factor Gcn4 in response to numerous tRNA perturbations, and
      identify many additional translationally regulated mRNAs throughout the yeast
      genome. Our data also uncover unexpected roles for tRNA-modifying enzymes in
      regulation of TY retroelements, and in rRNA 2'-O-methylation. This dataset should
      provide a rich resource for discovery of additional links between tRNA
      modifications and gene regulation.
CI  - Copyright (c) 2017 Elsevier Inc. All rights reserved.
FAU - Chou, Hsin-Jung
AU  - Chou HJ
AD  - Department of Biochemistry and Molecular Pharmacology, University of
      Massachusetts Medical School, Worcester, MA 01605, USA.
FAU - Donnard, Elisa
AU  - Donnard E
AD  - Program in Bioinformatics and Integrative Biology, University of Massachusetts
      Medical School, Worcester, MA 01605, USA.
FAU - Gustafsson, H Tobias
AU  - Gustafsson HT
AD  - Department of Biochemistry and Molecular Pharmacology, University of
      Massachusetts Medical School, Worcester, MA 01605, USA.
FAU - Garber, Manuel
AU  - Garber M
AD  - Program in Bioinformatics and Integrative Biology, University of Massachusetts
      Medical School, Worcester, MA 01605, USA; Program in Molecular Medicine,
      University of Massachusetts Medical School, Worcester, MA 01605, USA.
FAU - Rando, Oliver J
AU  - Rando OJ
AD  - Department of Biochemistry and Molecular Pharmacology, University of
      Massachusetts Medical School, Worcester, MA 01605, USA. Electronic address:
      oliver.rando@umassmed.edu.
LA  - eng
GR  - R01 GM079205/GM/NIGMS NIH HHS/United States
GR  - R01 HD080224/HD/NICHD NIH HHS/United States
PT  - Journal Article
DEP - 20171130
PL  - United States
TA  - Mol Cell
JT  - Molecular cell
JID - 9802571
RN  - 0 (Basic-Leucine Zipper Transcription Factors)
RN  - 0 (GCN4 protein, S cerevisiae)
RN  - 0 (RNA, Fungal)
RN  - 0 (RNA, Messenger)
RN  - 0 (RNA, Ribosomal)
RN  - 0 (RNA, Untranslated)
RN  - 0 (Retroelements)
RN  - 0 (Saccharomyces cerevisiae Proteins)
RN  - 9014-25-9 (RNA, Transfer)
RN  - EC 2.1.1.- (Trm7 protein, S cerevisiae)
RN  - EC 2.1.1.- (tRNA Methyltransferases)
SB  - IM
MH  - Basic-Leucine Zipper Transcription Factors/biosynthesis/genetics
MH  - Gene Expression Profiling/methods
MH  - Gene Expression Regulation, Fungal
MH  - Genotype
MH  - Methylation
MH  - Mutation
MH  - Phenotype
MH  - RNA, Fungal/genetics/*metabolism
MH  - RNA, Messenger/genetics/metabolism
MH  - RNA, Ribosomal/genetics/metabolism
MH  - RNA, Transfer/genetics/*metabolism
MH  - RNA, Untranslated/genetics/metabolism
MH  - Retroelements
MH  - Ribosomes/*enzymology/genetics
MH  - Saccharomyces cerevisiae/*enzymology/genetics
MH  - Saccharomyces cerevisiae Proteins/biosynthesis/genetics/*metabolism
MH  - Terminal Repeat Sequences
MH  - *Transcriptome
MH  - tRNA Methyltransferases/genetics/*metabolism
PMC - PMC5728682
MID - NIHMS918249
OTO - NOTNLM
OT  - RNA modifications
OT  - noncoding RNA
OT  - protein translation
OT  - ribosome profiling
OT  - tRNA
EDAT- 2017/12/05 06:00
MHDA- 2017/12/27 06:00
CRDT- 2017/12/05 06:00
PMCR- 2018/12/07 00:00
PHST- 2017/06/29 00:00 [received]
PHST- 2017/09/19 00:00 [revised]
PHST- 2017/10/31 00:00 [accepted]
PHST- 2018/12/07 00:00 [pmc-release]
PHST- 2017/12/05 06:00 [pubmed]
PHST- 2017/12/27 06:00 [medline]
PHST- 2017/12/05 06:00 [entrez]
AID - S1097-2765(17)30837-7 [pii]
AID - 10.1016/j.molcel.2017.11.002 [doi]
PST - ppublish
SO  - Mol Cell. 2017 Dec 7;68(5):978-992.e4. doi: 10.1016/j.molcel.2017.11.002. Epub
      2017 Nov 30.

PMID- 29171881
OWN - NLM
STAT- Publisher
LR  - 20171124
IS  - 1527-3350 (Electronic)
IS  - 0270-9139 (Linking)
DP  - 2017 Nov 24
TI  - RNA N6-methyladenosine methyltransferase METTL3 promotes liver cancer progression
      through YTHDF2 dependent post-transcriptional silencing of SOCS2.
LID - 10.1002/hep.29683 [doi]
AB  - Epigenetic alterations immensely contributed to human carcinogenesis.
      Conventional epigenetic studies predominantly focused on DNA methylation, histone
      modifications, and chromatin remodeling. Recently, diverse and reversible
      chemical modifications on RNAs emerge as a new layer of epigenetic regulation.
      N6-methyladenosine (m6A) is the most abundant chemical modification on eukaryotic
      mRNA and is important to the regulation of mRNA stability, splicing, and
      translation. Using transcriptome sequencing, we discovered that METTL3
      (methyltransferase like 3), a major RNA N6-adenosine methyltransferase, was
      significantly up-regulated in human hepatocellular carcinoma (HCC) and multiple
      solid tumors. Clinically, overexpression of METTL3 was associated with poor
      prognosis of HCC patients. Functionally, we proved that knockdown of METTL3
      drastically reduced HCC cell proliferation, migration and colony formation in
      vitro. Knockout of METTL3 remarkably suppressed HCC tumorigenicity and lung
      metastasis in vivo. On the other hand, using CRISPR/dCas9-VP64 activation system,
      we demonstrated that overexpression of METTL3 significantly promoted HCC growth
      both in vitro and in vivo. Through transcriptome sequencing, m6A-Seq and m6A
      MeRIP qRT-PCR, we identified SOCS2 (suppressor of cytokine signaling 2) as a
      target of METTL3-mediated m6A modification. Knockdown of METTL3 substantially
      abolished SOCS2 mRNA m6A modification and augmented SOCS2 mRNA expression. We
      also showed that m6A-mediated SOCS2 mRNA degradation relied on m6A "reader"
      protein YTHDF2 dependent pathway. In conclusion, we demonstrated that METTL3 was 
      frequently up-regulated in human HCC and contributed to HCC progression. METTL3
      repressed SOCS2 expression in HCC via the m6A-YTHDF2 dependent mechanism. Thus,
      our findings suggested a new dimension of epigenetic alteration in liver
      carcinogenesis. This article is protected by copyright. All rights reserved.
CI  - (c) 2017 by the American Association for the Study of Liver Diseases.
FAU - Chen, Mengnuo
AU  - Chen M
AD  - State Key Laboratory for Liver Research and Department of Pathology, Li Ka Shing 
      Faculty of Medicine, the University of Hong Kong.
FAU - Wei, Lai
AU  - Wei L
AD  - State Key Laboratory for Liver Research and Department of Pathology, Li Ka Shing 
      Faculty of Medicine, the University of Hong Kong.
FAU - Law, Cheuk-Ting
AU  - Law CT
AD  - State Key Laboratory for Liver Research and Department of Pathology, Li Ka Shing 
      Faculty of Medicine, the University of Hong Kong.
FAU - Tsang, Felice Ho-Ching
AU  - Tsang FH
AD  - State Key Laboratory for Liver Research and Department of Pathology, Li Ka Shing 
      Faculty of Medicine, the University of Hong Kong.
FAU - Shen, Jialing
AU  - Shen J
AD  - State Key Laboratory for Liver Research and Department of Pathology, Li Ka Shing 
      Faculty of Medicine, the University of Hong Kong.
FAU - Cheng, Carol Lai-Hung
AU  - Cheng CL
AD  - State Key Laboratory for Liver Research and Department of Pathology, Li Ka Shing 
      Faculty of Medicine, the University of Hong Kong.
FAU - Tsang, Long-Hin
AU  - Tsang LH
AD  - State Key Laboratory for Liver Research and Department of Pathology, Li Ka Shing 
      Faculty of Medicine, the University of Hong Kong.
FAU - Ho, Daniel Wai-Hung
AU  - Ho DW
AD  - State Key Laboratory for Liver Research and Department of Pathology, Li Ka Shing 
      Faculty of Medicine, the University of Hong Kong.
FAU - Chiu, David Kung-Chun
AU  - Chiu DK
AD  - State Key Laboratory for Liver Research and Department of Pathology, Li Ka Shing 
      Faculty of Medicine, the University of Hong Kong.
FAU - Lee, Joyce Man-Fong
AU  - Lee JM
AD  - State Key Laboratory for Liver Research and Department of Pathology, Li Ka Shing 
      Faculty of Medicine, the University of Hong Kong.
FAU - Wong, Carmen Chak-Lui
AU  - Wong CC
AD  - State Key Laboratory for Liver Research and Department of Pathology, Li Ka Shing 
      Faculty of Medicine, the University of Hong Kong.
FAU - Ng, Irene Oi-Lin
AU  - Ng IO
AD  - State Key Laboratory for Liver Research and Department of Pathology, Li Ka Shing 
      Faculty of Medicine, the University of Hong Kong.
FAU - Wong, Chun-Ming
AU  - Wong CM
AUID- ORCID: http://orcid.org/0000-0002-2497-7858
AD  - State Key Laboratory for Liver Research and Department of Pathology, Li Ka Shing 
      Faculty of Medicine, the University of Hong Kong.
LA  - eng
PT  - Journal Article
DEP - 20171124
PL  - United States
TA  - Hepatology
JT  - Hepatology (Baltimore, Md.)
JID - 8302946
OTO - NOTNLM
OT  - Epigenetics
OT  - Hepatocellular carcinoma
OT  - METTL3
OT  - N6-methyladenosine
OT  - SOCS2
OT  - YTHDF2
EDAT- 2017/11/25 06:00
MHDA- 2017/11/25 06:00
CRDT- 2017/11/25 06:00
PHST- 2017/02/09 00:00 [received]
PHST- 2017/11/08 00:00 [revised]
PHST- 2017/11/21 00:00 [accepted]
PHST- 2017/11/25 06:00 [entrez]
PHST- 2017/11/25 06:00 [pubmed]
PHST- 2017/11/25 06:00 [medline]
AID - 10.1002/hep.29683 [doi]
PST - aheadofprint
SO  - Hepatology. 2017 Nov 24. doi: 10.1002/hep.29683.

PMID- 29227476
OWN - NLM
STAT- In-Data-Review
LR  - 20180111
IS  - 1546-170X (Electronic)
IS  - 1078-8956 (Linking)
VI  - 24
IP  - 1
DP  - 2018 Jan
TI  - The molecular landscape of pediatric acute myeloid leukemia reveals recurrent
      structural alterations and age-specific mutational interactions.
PG  - 103-112
LID - 10.1038/nm.4439 [doi]
AB  - We present the molecular landscape of pediatric acute myeloid leukemia (AML) and 
      characterize nearly 1,000 participants in Children's Oncology Group (COG) AML
      trials. The COG-National Cancer Institute (NCI) TARGET AML initiative assessed
      cases by whole-genome, targeted DNA, mRNA and microRNA sequencing and CpG
      methylation profiling. Validated DNA variants corresponded to diverse, infrequent
      mutations, with fewer than 40 genes mutated in >2% of cases. In contrast, somatic
      structural variants, including new gene fusions and focal deletions of MBNL1,
      ZEB2 and ELF1, were disproportionately prevalent in young individuals as compared
      to adults. Conversely, mutations in DNMT3A and TP53, which were common in adults,
      were conspicuously absent from virtually all pediatric cases. New mutations in
      GATA2, FLT3 and CBL and recurrent mutations in MYC-ITD, NRAS, KRAS and WT1 were
      frequent in pediatric AML. Deletions, mutations and promoter DNA hypermethylation
      convergently impacted Wnt signaling, Polycomb repression, innate immune cell
      interactions and a cluster of zinc finger-encoding genes associated with KMT2A
      rearrangements. These results highlight the need for and facilitate the
      development of age-tailored targeted therapies for the treatment of pediatric
      AML.
FAU - Bolouri, Hamid
AU  - Bolouri H
AD  - Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle,
      Washington, USA.
FAU - Farrar, Jason E
AU  - Farrar JE
AUID- ORCID: http://orcid.org/0000-0003-2148-5839
AD  - Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical
      Sciences and Arkansas Children's Research Institute, Little Rock, Arkansas, USA.
FAU - Triche, Timothy Jr
AU  - Triche T Jr
AD  - Jane Anne Nohl Division of Hematology, University of Southern California Norris
      Comprehensive Cancer Center, Los Angeles, California, USA.
FAU - Ries, Rhonda E
AU  - Ries RE
AD  - Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle,
      Washington, USA.
FAU - Lim, Emilia L
AU  - Lim EL
AD  - Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency,
      Vancouver, British Columbia, Canada.
FAU - Alonzo, Todd A
AU  - Alonzo TA
AD  - Keck School of Medicine, University of Southern California, Los Angeles,
      California, USA.
AD  - Children's Oncology Group, Monrovia, California, USA.
FAU - Ma, Yussanne
AU  - Ma Y
AD  - Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency,
      Vancouver, British Columbia, Canada.
FAU - Moore, Richard
AU  - Moore R
AD  - Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency,
      Vancouver, British Columbia, Canada.
FAU - Mungall, Andrew J
AU  - Mungall AJ
AUID- ORCID: http://orcid.org/0000-0002-0905-2742
AD  - Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency,
      Vancouver, British Columbia, Canada.
FAU - Marra, Marco A
AU  - Marra MA
AD  - Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency,
      Vancouver, British Columbia, Canada.
FAU - Zhang, Jinghui
AU  - Zhang J
AD  - Division of Computational Biology, St. Jude Children's Research Hospital,
      Memphis, Tennessee, USA.
FAU - Ma, Xiaotu
AU  - Ma X
AD  - Division of Computational Biology, St. Jude Children's Research Hospital,
      Memphis, Tennessee, USA.
FAU - Liu, Yu
AU  - Liu Y
AD  - Division of Computational Biology, St. Jude Children's Research Hospital,
      Memphis, Tennessee, USA.
FAU - Liu, Yanling
AU  - Liu Y
AD  - Division of Computational Biology, St. Jude Children's Research Hospital,
      Memphis, Tennessee, USA.
FAU - Auvil, Jaime M Guidry
AU  - Auvil JMG
AD  - Office of Cancer Genomics, National Cancer Institute, Bethesda, Maryland, USA.
FAU - Davidsen, Tanja M
AU  - Davidsen TM
AD  - Office of Cancer Genomics, National Cancer Institute, Bethesda, Maryland, USA.
FAU - Gesuwan, Patee
AU  - Gesuwan P
AD  - Office of Cancer Genomics, National Cancer Institute, Bethesda, Maryland, USA.
FAU - Hermida, Leandro C
AU  - Hermida LC
AD  - Office of Cancer Genomics, National Cancer Institute, Bethesda, Maryland, USA.
FAU - Salhia, Bodour
AU  - Salhia B
AD  - Department of Translational Genomics, Keck School of Medicine, University of
      Southern California, Los Angeles, California, USA.
FAU - Capone, Stephen
AU  - Capone S
AD  - Jane Anne Nohl Division of Hematology, University of Southern California Norris
      Comprehensive Cancer Center, Los Angeles, California, USA.
FAU - Ramsingh, Giridharan
AU  - Ramsingh G
AD  - Jane Anne Nohl Division of Hematology, University of Southern California Norris
      Comprehensive Cancer Center, Los Angeles, California, USA.
FAU - Zwaan, Christian Michel
AU  - Zwaan CM
AD  - Department of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital,
      Rotterdam, the Netherlands.
FAU - Noort, Sanne
AU  - Noort S
AD  - Department of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital,
      Rotterdam, the Netherlands.
FAU - Piccolo, Stephen R
AU  - Piccolo SR
AUID- ORCID: http://orcid.org/0000-0003-2001-5640
AD  - Department of Biology, Brigham Young University, Provo, Utah, USA.
AD  - Department of Biomedical Informatics, University of Utah, Salt Lake City, Utah,
      USA.
FAU - Kolb, E Anders
AU  - Kolb EA
AD  - Nemours Center for Cancer and Blood Disorders, Alfred I. DuPont Hospital for
      Children, Wilmington, Delaware, USA.
FAU - Gamis, Alan S
AU  - Gamis AS
AD  - Division of Hematology, Oncology and Bone Marrow Transplantation, Children's
      Mercy Hospitals and Clinics, Kansas City, Missouri, USA.
FAU - Smith, Malcolm A
AU  - Smith MA
AD  - Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland,
      USA.
FAU - Gerhard, Daniela S
AU  - Gerhard DS
AD  - Office of Cancer Genomics, National Cancer Institute, Bethesda, Maryland, USA.
FAU - Meshinchi, Soheil
AU  - Meshinchi S
AD  - Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle,
      Washington, USA.
LA  - eng
PT  - Journal Article
DEP - 20171211
PL  - United States
TA  - Nat Med
JT  - Nature medicine
JID - 9502015
EDAT- 2017/12/12 06:00
MHDA- 2017/12/12 06:00
CRDT- 2017/12/12 06:00
PHST- 2017/02/06 00:00 [received]
PHST- 2017/10/12 00:00 [accepted]
PHST- 2017/12/12 06:00 [pubmed]
PHST- 2017/12/12 06:00 [medline]
PHST- 2017/12/12 06:00 [entrez]
AID - nm.4439 [pii]
AID - 10.1038/nm.4439 [doi]
PST - ppublish
SO  - Nat Med. 2018 Jan;24(1):103-112. doi: 10.1038/nm.4439. Epub 2017 Dec 11.

PMID- 29083406
OWN - NLM
STAT- MEDLINE
DCOM- 20171211
LR  - 20171219
IS  - 1546-1718 (Electronic)
IS  - 1061-4036 (Linking)
VI  - 49
IP  - 12
DP  - 2017 Dec
TI  - Shared genetic origin of asthma, hay fever and eczema elucidates allergic disease
      biology.
PG  - 1752-1757
LID - 10.1038/ng.3985 [doi]
AB  - Asthma, hay fever (or allergic rhinitis) and eczema (or atopic dermatitis) often 
      coexist in the same individuals, partly because of a shared genetic origin. To
      identify shared risk variants, we performed a genome-wide association study
      (GWAS; n = 360,838) of a broad allergic disease phenotype that considers the
      presence of any one of these three diseases. We identified 136 independent risk
      variants (P < 3 x 10(-8)), including 73 not previously reported, which implicate 
      132 nearby genes in allergic disease pathophysiology. Disease-specific effects
      were detected for only six variants, confirming that most represent shared risk
      factors. Tissue-specific heritability and biological process enrichment analyses 
      suggest that shared risk variants influence lymphocyte-mediated immunity. Six
      target genes provide an opportunity for drug repositioning, while for 36 genes
      CpG methylation was found to influence transcription independently of genetic
      effects. Asthma, hay fever and eczema partly coexist because they share many
      genetic risk variants that dysregulate the expression of immune-related genes.
FAU - Ferreira, Manuel A
AU  - Ferreira MA
AUID- ORCID: http://orcid.org/0000-0001-9059-1825
AD  - Genetics and Computational Biology, QIMR Berghofer Medical Research Institute,
      Brisbane, Queensland, Australia.
FAU - Vonk, Judith M
AU  - Vonk JM
AD  - Epidemiology, University of Groningen, University Medical Center Groningen,
      Groningen Research Institute for Asthma and COPD, Groningen, the Netherlands.
FAU - Baurecht, Hansjorg
AU  - Baurecht H
AD  - Department of Dermatology, Allergology and Venereology, University Hospital
      Schleswig-Holstein, Campus Kiel, Kiel, Germany.
FAU - Marenholz, Ingo
AU  - Marenholz I
AD  - Max Delbruck Center (MDC) for Molecular Medicine, Berlin, Germany.
AD  - Clinic for Pediatric Allergy, Experimental and Clinical Research Center of
      Charite Universitatsmedizin Berlin and Max Delbruck Center, Berlin, Germany.
FAU - Tian, Chao
AU  - Tian C
AD  - Research, 23andMe, Mountain View, California, USA.
FAU - Hoffman, Joshua D
AU  - Hoffman JD
AD  - Department of Epidemiology and Biostatistics, University of California, San
      Francisco, San Francisco, California, USA.
FAU - Helmer, Quinta
AU  - Helmer Q
AD  - Department of Biological Psychology, Netherlands Twin Register, Vrije University,
      Amsterdam, the Netherlands.
FAU - Tillander, Annika
AU  - Tillander A
AD  - Department of Medical Epidemiology and Biostatistics, Karolinska Institutet,
      Stockholm, Sweden.
FAU - Ullemar, Vilhelmina
AU  - Ullemar V
AD  - Department of Medical Epidemiology and Biostatistics, Karolinska Institutet,
      Stockholm, Sweden.
FAU - van Dongen, Jenny
AU  - van Dongen J
AD  - Department of Biological Psychology, Netherlands Twin Register, Vrije University,
      Amsterdam, the Netherlands.
FAU - Lu, Yi
AU  - Lu Y
AD  - Department of Medical Epidemiology and Biostatistics, Karolinska Institutet,
      Stockholm, Sweden.
FAU - Ruschendorf, Franz
AU  - Ruschendorf F
AUID- ORCID: http://orcid.org/0000-0001-5640-810X
AD  - Max Delbruck Center (MDC) for Molecular Medicine, Berlin, Germany.
FAU - Esparza-Gordillo, Jorge
AU  - Esparza-Gordillo J
AD  - Max Delbruck Center (MDC) for Molecular Medicine, Berlin, Germany.
AD  - Clinic for Pediatric Allergy, Experimental and Clinical Research Center of
      Charite Universitatsmedizin Berlin and Max Delbruck Center, Berlin, Germany.
FAU - Medway, Chris W
AU  - Medway CW
AD  - MRC Integrative Epidemiology Unit, School of Social and Community Medicine,
      University of Bristol, Bristol, UK.
FAU - Mountjoy, Edward
AU  - Mountjoy E
AUID- ORCID: http://orcid.org/0000-0002-0626-1821
AD  - MRC Integrative Epidemiology Unit, School of Social and Community Medicine,
      University of Bristol, Bristol, UK.
FAU - Burrows, Kimberley
AU  - Burrows K
AD  - MRC Integrative Epidemiology Unit, School of Social and Community Medicine,
      University of Bristol, Bristol, UK.
FAU - Hummel, Oliver
AU  - Hummel O
AD  - Max Delbruck Center (MDC) for Molecular Medicine, Berlin, Germany.
FAU - Grosche, Sarah
AU  - Grosche S
AD  - Max Delbruck Center (MDC) for Molecular Medicine, Berlin, Germany.
AD  - Clinic for Pediatric Allergy, Experimental and Clinical Research Center of
      Charite Universitatsmedizin Berlin and Max Delbruck Center, Berlin, Germany.
FAU - Brumpton, Ben M
AU  - Brumpton BM
AD  - MRC Integrative Epidemiology Unit, School of Social and Community Medicine,
      University of Bristol, Bristol, UK.
AD  - K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and
      Nursing, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.
AD  - Department of Thoracic Medicine, St. Olavs Hospital, Trondheim University
      Hospital, Trondheim, Norway.
FAU - Witte, John S
AU  - Witte JS
AD  - Epidemiology and Biostatistics, University of California, San Francisco, San
      Francisco, California, USA.
FAU - Hottenga, Jouke-Jan
AU  - Hottenga JJ
AD  - Department of Biological Psychology, Netherlands Twin Register, Vrije University,
      Amsterdam, the Netherlands.
FAU - Willemsen, Gonneke
AU  - Willemsen G
AD  - Department of Biological Psychology, Netherlands Twin Register, Vrije University,
      Amsterdam, the Netherlands.
FAU - Zheng, Jie
AU  - Zheng J
AD  - MRC Integrative Epidemiology Unit, School of Social and Community Medicine,
      University of Bristol, Bristol, UK.
FAU - Rodriguez, Elke
AU  - Rodriguez E
AD  - Department of Dermatology, Allergology and Venereology, University Hospital
      Schleswig-Holstein, Campus Kiel, Kiel, Germany.
FAU - Hotze, Melanie
AU  - Hotze M
AD  - Department of Dermatology, Allergology and Venereology, University Hospital
      Schleswig-Holstein, Campus Kiel, Kiel, Germany.
FAU - Franke, Andre
AU  - Franke A
AUID- ORCID: http://orcid.org/0000-0003-1530-5811
AD  - Institute of Clinical Molecular Biology, Christian Albrechts University of Kiel, 
      Kiel, Germany.
FAU - Revez, Joana A
AU  - Revez JA
AD  - Genetics and Computational Biology, QIMR Berghofer Medical Research Institute,
      Brisbane, Queensland, Australia.
FAU - Beesley, Jonathan
AU  - Beesley J
AD  - Genetics and Computational Biology, QIMR Berghofer Medical Research Institute,
      Brisbane, Queensland, Australia.
FAU - Matheson, Melanie C
AU  - Matheson MC
AD  - Melbourne School of Population and Global Health, University of Melbourne,
      Melbourne, Victoria, Australia.
FAU - Dharmage, Shyamali C
AU  - Dharmage SC
AD  - Melbourne School of Population and Global Health, University of Melbourne,
      Melbourne, Victoria, Australia.
FAU - Bain, Lisa M
AU  - Bain LM
AD  - Genetics and Computational Biology, QIMR Berghofer Medical Research Institute,
      Brisbane, Queensland, Australia.
FAU - Fritsche, Lars G
AU  - Fritsche LG
AD  - K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and
      Nursing, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.
FAU - Gabrielsen, Maiken E
AU  - Gabrielsen ME
AD  - K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and
      Nursing, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.
FAU - Balliu, Brunilda
AU  - Balliu B
AD  - Department of Pathology, Stanford University School of Medicine, Stanford,
      California, USA.
CN  - 23andMe Research Team
CN  - AAGC collaborators
CN  - BIOS consortium
CN  - LifeLines Cohort Study
FAU - Nielsen, Jonas B
AU  - Nielsen JB
AUID- ORCID: http://orcid.org/0000-0002-6654-2852
AD  - Department of Human Genetics, University of Michigan, Ann Arbor, Michigan, USA.
AD  - Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan,
      USA.
FAU - Zhou, Wei
AU  - Zhou W
AD  - Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan,
      USA.
FAU - Hveem, Kristian
AU  - Hveem K
AD  - K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and
      Nursing, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.
AD  - HUNT Research Centre, Department of Public Health and Nursing, NTNU, Norwegian
      University of Science and Technology, Trondheim, Norway.
FAU - Langhammer, Arnulf
AU  - Langhammer A
AD  - HUNT Research Centre, Department of Public Health and Nursing, NTNU, Norwegian
      University of Science and Technology, Trondheim, Norway.
FAU - Holmen, Oddgeir L
AU  - Holmen OL
AD  - K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and
      Nursing, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.
FAU - Loset, Mari
AU  - Loset M
AD  - K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and
      Nursing, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.
AD  - Department of Dermatology, St. Olavs Hospital, Trondheim University Hospital,
      Trondheim, Norway.
FAU - Abecasis, Goncalo R
AU  - Abecasis GR
AD  - K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and
      Nursing, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.
AD  - Center for Statistical Genetics, University of Michigan, Ann Arbor, Michigan,
      USA.
FAU - Willer, Cristen J
AU  - Willer CJ
AUID- ORCID: http://orcid.org/0000-0001-5645-4966
AD  - K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and
      Nursing, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.
AD  - Department of Human Genetics, University of Michigan, Ann Arbor, Michigan, USA.
AD  - Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan,
      USA.
AD  - Center for Statistical Genetics, University of Michigan, Ann Arbor, Michigan,
      USA.
FAU - Arnold, Andreas
AU  - Arnold A
AD  - Clinic and Polyclinic of Dermatology, University Medicine Greifswald, Greifswald,
      Germany.
FAU - Homuth, Georg
AU  - Homuth G
AD  - Department of Functional Genomics, Interfaculty Institute for Genetics and
      Functional Genomics, University Medicine and Ernst-Moritz-Arndt University
      Greifswald, Greifswald, Germany.
FAU - Schmidt, Carsten O
AU  - Schmidt CO
AD  - Institute for Community Medicine, Study of Health in Pomerania/KEF, University
      Medicine Greifswald, Greifswald, Germany.
FAU - Thompson, Philip J
AU  - Thompson PJ
AD  - Institute for Respiratory Health, Harry Perkins Institute of Medical Research,
      University of Western Australia, Nedlands, Western Australia, Australia.
FAU - Martin, Nicholas G
AU  - Martin NG
AD  - Genetics and Computational Biology, QIMR Berghofer Medical Research Institute,
      Brisbane, Queensland, Australia.
FAU - Duffy, David L
AU  - Duffy DL
AD  - Genetics and Computational Biology, QIMR Berghofer Medical Research Institute,
      Brisbane, Queensland, Australia.
FAU - Novak, Natalija
AU  - Novak N
AD  - Department of Dermatology and Allergology, University Hospital Bonn, Bonn,
      Germany.
FAU - Schulz, Holger
AU  - Schulz H
AD  - Institute of Epidemiology I, Helmholtz Zentrum Munchen-German Research Center for
      Environmental Health, Neuherberg, Germany.
AD  - Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for
      Lung Research, Munich, Germany.
FAU - Karrasch, Stefan
AU  - Karrasch S
AD  - Institute of Epidemiology I, Helmholtz Zentrum Munchen-German Research Center for
      Environmental Health, Neuherberg, Germany.
AD  - Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for
      Lung Research, Munich, Germany.
AD  - Institute and Outpatient Clinic for Occupational, Social and Environmental
      Medicine, Ludwig-Maximilians-Universitat, Munich, Germany.
FAU - Gieger, Christian
AU  - Gieger C
AD  - Research Unit of Molecular Epidemiology and Institute of Epidemiology II,
      Helmholtz Zentrum Munchen-German Research Center for Environmental Health,
      Neuherberg, Germany.
FAU - Strauch, Konstantin
AU  - Strauch K
AD  - Institute of Genetic Epidemiology, Helmholtz Zentrum Munchen-German Research
      Center for Environmental Health, Neuherberg, Germany.
FAU - Melles, Ronald B
AU  - Melles RB
AD  - Division of Research, Kaiser Permanente Northern California, Oakland, California,
      USA.
FAU - Hinds, David A
AU  - Hinds DA
AD  - Research, 23andMe, Mountain View, California, USA.
FAU - Hubner, Norbert
AU  - Hubner N
AD  - Max Delbruck Center (MDC) for Molecular Medicine, Berlin, Germany.
FAU - Weidinger, Stephan
AU  - Weidinger S
AD  - Department of Dermatology, Allergology and Venereology, University Hospital
      Schleswig-Holstein, Campus Kiel, Kiel, Germany.
FAU - Magnusson, Patrik K E
AU  - Magnusson PKE
AD  - Department of Medical Epidemiology and Biostatistics, Karolinska Institutet,
      Stockholm, Sweden.
FAU - Jansen, Rick
AU  - Jansen R
AUID- ORCID: http://orcid.org/0000-0002-3333-6737
AD  - Department of Psychiatry, VU University Medical Center, Amsterdam, the
      Netherlands.
FAU - Jorgenson, Eric
AU  - Jorgenson E
AUID- ORCID: http://orcid.org/0000-0002-5829-8191
AD  - Division of Research, Kaiser Permanente Northern California, Oakland, California,
      USA.
FAU - Lee, Young-Ae
AU  - Lee YA
AD  - Max Delbruck Center (MDC) for Molecular Medicine, Berlin, Germany.
AD  - Clinic for Pediatric Allergy, Experimental and Clinical Research Center of
      Charite Universitatsmedizin Berlin and Max Delbruck Center, Berlin, Germany.
FAU - Boomsma, Dorret I
AU  - Boomsma DI
AD  - Department of Biological Psychology, Netherlands Twin Register, Vrije University,
      Amsterdam, the Netherlands.
FAU - Almqvist, Catarina
AU  - Almqvist C
AUID- ORCID: http://orcid.org/0000-0002-1045-1898
AD  - Department of Medical Epidemiology and Biostatistics, Karolinska Institutet,
      Stockholm, Sweden.
AD  - Pediatric Allergy and Pulmonology Unit at Astrid Lindgren Children's Hospital,
      Karolinska University Hospital, Stockholm, Sweden.
FAU - Karlsson, Robert
AU  - Karlsson R
AUID- ORCID: http://orcid.org/0000-0002-8949-2587
AD  - Department of Medical Epidemiology and Biostatistics, Karolinska Institutet,
      Stockholm, Sweden.
FAU - Koppelman, Gerard H
AU  - Koppelman GH
AD  - University of Groningen, University Medical Center Groningen, Beatrix Children's 
      Hospital, Pediatric Pulmonology and Pediatric Allergology, and University of
      Groningen, University Medical Center Groningen, Groningen Research Institute for 
      Asthma and COPD, Groningen, the Netherlands.
FAU - Paternoster, Lavinia
AU  - Paternoster L
AD  - MRC Integrative Epidemiology Unit, School of Social and Community Medicine,
      University of Bristol, Bristol, UK.
LA  - eng
PT  - Journal Article
PT  - Meta-Analysis
DEP - 20171030
PL  - United States
TA  - Nat Genet
JT  - Nature genetics
JID - 9216904
SB  - IM
MH  - Asthma/*genetics
MH  - Eczema/*genetics
MH  - Genetic Predisposition to Disease/*genetics
MH  - Genome-Wide Association Study/methods
MH  - Humans
MH  - Hypersensitivity/*genetics
MH  - Phenotype
MH  - Polymorphism, Single Nucleotide
MH  - Rhinitis, Allergic, Seasonal/*genetics
MH  - Risk Factors
EDAT- 2017/10/31 06:00
MHDA- 2017/12/12 06:00
CRDT- 2017/10/31 06:00
PHST- 2017/06/13 00:00 [received]
PHST- 2017/10/06 00:00 [accepted]
PHST- 2017/10/31 06:00 [pubmed]
PHST- 2017/12/12 06:00 [medline]
PHST- 2017/10/31 06:00 [entrez]
AID - ng.3985 [pii]
AID - 10.1038/ng.3985 [doi]
PST - ppublish
SO  - Nat Genet. 2017 Dec;49(12):1752-1757. doi: 10.1038/ng.3985. Epub 2017 Oct 30.

PMID- 29228327
OWN - NLM
STAT- Publisher
LR  - 20171211
IS  - 1537-1719 (Electronic)
IS  - 0737-4038 (Linking)
DP  - 2017 Dec 8
TI  - Most m6A RNA modifications in protein-coding regions are evolutionarily
      unconserved and likely nonfunctional.
LID - 10.1093/molbev/msx320 [doi]
AB  - Methylation of the adenosine base at the nitrogen-6 position (m6A) is the most
      prevalent internal posttranscriptional modification of mRNAs in many eukaryotes. 
      Despite the rapid progress in the transcriptome-wide mapping of m6As,
      identification of proteins responsible for writing, reading, and erasing m6As,
      and elucidation of m6A functions in splicing, RNA stability, translation, and
      other processes, it is unknown whether most observed m6A modifications are
      functional. To address this question, we respectively analyze the evolutionary
      conservation of yeast and human m6As in protein-coding regions. Relative to
      comparable unmethylated As, m6As are overall no more conserved in yeasts and only
      slightly more conserved in mammals. Furthermore, yeast m6As and comparable
      unmethylated As have no significant difference in single nucleotide polymorphism 
      (SNP) density or SNP site frequency spectrum. The same is true in human. The
      methylation status of a gene, not necessarily the specific sites methylated in
      the gene, is subject to purifying selection for no more than approximately 20% of
      m6A-modified genes. These observations suggest that most m6A modifications in
      protein-coding regions are nonfunctional and nonadaptive, probably resulting from
      off-target activities of m6A methyltransferases. In addition, our reanalysis
      invalidates the recent claim of positive selection for newly acquired m6A
      modifications in human evolution. Regarding the small number of evolutionarily
      conserved m6As, evidence suggests that a large proportion of them are likely
      functional; they should be prioritized in future functional characterizations of 
      m6As. Together, these findings have important implications for understanding the 
      biological significance of m6A and other posttranscriptional modifications.
CI  - (c) The Author 2017. Published by Oxford University Press on behalf of the
      Society for Molecular Biology and Evolution. All rights reserved. For
      permissions, please e-mail: journals.permissions@oup.com.
FAU - Liu, Zhen
AU  - Liu Z
AD  - State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of
      Zoology, Chinese Academy of Sciences, Kunming, China.
AD  - Department of Ecology and Evolutionary Biology, University of Michigan, Ann
      Arbor, MI, USA.
FAU - Zhang, Jianzhi
AU  - Zhang J
AD  - Department of Ecology and Evolutionary Biology, University of Michigan, Ann
      Arbor, MI, USA.
LA  - eng
PT  - Journal Article
DEP - 20171208
PL  - United States
TA  - Mol Biol Evol
JT  - Molecular biology and evolution
JID - 8501455
OTO - NOTNLM
OT  - Evolution
OT  - RNA methylation
OT  - human
OT  - posttranscriptional modification
OT  - yeast
EDAT- 2017/12/12 06:00
MHDA- 2017/12/12 06:00
CRDT- 2017/12/12 06:00
PHST- 2017/09/30 00:00 [received]
PHST- 2017/12/02 00:00 [accepted]
PHST- 2017/12/12 06:00 [entrez]
PHST- 2017/12/12 06:00 [pubmed]
PHST- 2017/12/12 06:00 [medline]
AID - 4711175 [pii]
AID - 10.1093/molbev/msx320 [doi]
PST - aheadofprint
SO  - Mol Biol Evol. 2017 Dec 8. pii: 4711175. doi: 10.1093/molbev/msx320.

PMID- 29100075
OWN - NLM
STAT- MEDLINE
DCOM- 20171121
LR  - 20171219
IS  - 1097-4172 (Electronic)
IS  - 0092-8674 (Linking)
VI  - 171
IP  - 4
DP  - 2017 Nov 2
TI  - Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue
      Sarcomas.
PG  - 950-965.e28
LID - S0092-8674(17)31203-5 [pii]
LID - 10.1016/j.cell.2017.10.014 [doi]
AB  - Sarcomas are a broad family of mesenchymal malignancies exhibiting remarkable
      histologic diversity. We describe the multi-platform molecular landscape of 206
      adult soft tissue sarcomas representing 6 major types. Along with novel insights 
      into the biology of individual sarcoma types, we report three overarching
      findings: (1) unlike most epithelial malignancies, these sarcomas (excepting
      synovial sarcoma) are characterized predominantly by copy-number changes, with
      low mutational loads and only a few genes (TP53, ATRX, RB1) highly recurrently
      mutated across sarcoma types; (2) within sarcoma types, genomic and regulomic
      diversity of driver pathways defines molecular subtypes associated with patient
      outcome; and (3) the immune microenvironment, inferred from DNA methylation and
      mRNA profiles, associates with outcome and may inform clinical trials of immune
      checkpoint inhibitors. Overall, this large-scale analysis reveals previously
      unappreciated sarcoma-type-specific changes in copy number, methylation, RNA, and
      protein, providing insights into refining sarcoma therapy and relationships to
      other cancer types.
CI  - Copyright (c) 2017 The Authors. Published by Elsevier Inc. All rights reserved.
CN  - Cancer Genome Atlas Research Network. Electronic address:
      elizabeth.demicco@sinaihealthsystem.ca
AD  - Cancer Genome Atlas Program Office, National Cancer Institute at NIH, 31 Center
      Drive, Bldg. 31, Suite 3A20, Bethesda, MD 20892, USA.
CN  - Cancer Genome Atlas Research Network
LA  - eng
GR  - P30 CA016672/CA/NCI NIH HHS/United States
GR  - U24 CA143882/CA/NCI NIH HHS/United States
GR  - U54 HG003067/HG/NHGRI NIH HHS/United States
GR  - U24 CA143835/CA/NCI NIH HHS/United States
GR  - U24 CA143866/CA/NCI NIH HHS/United States
GR  - U24 CA143845/CA/NCI NIH HHS/United States
GR  - U24 CA143799/CA/NCI NIH HHS/United States
GR  - U54 HG003273/HG/NHGRI NIH HHS/United States
GR  - U24 CA144025/CA/NCI NIH HHS/United States
GR  - U24 CA143840/CA/NCI NIH HHS/United States
GR  - U24 CA143843/CA/NCI NIH HHS/United States
GR  - U24 CA143858/CA/NCI NIH HHS/United States
GR  - U24 CA143848/CA/NCI NIH HHS/United States
GR  - U24 CA126543/CA/NCI NIH HHS/United States
GR  - U54 HG003079/HG/NHGRI NIH HHS/United States
GR  - U24 CA143883/CA/NCI NIH HHS/United States
GR  - U24 CA143867/CA/NCI NIH HHS/United States
PT  - Journal Article
PL  - United States
TA  - Cell
JT  - Cell
JID - 0413066
SB  - IM
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Cluster Analysis
MH  - DNA Copy Number Variations
MH  - Epigenomics
MH  - Genome, Human
MH  - Genome-Wide Association Study
MH  - Humans
MH  - Middle Aged
MH  - Mutation
MH  - Sarcoma/diagnosis/*genetics/pathology
MH  - Young Adult
PMC - PMC5693358
MID - NIHMS912614
OTO - NOTNLM
OT  - DNA methylation
OT  - The Cancer Genome Atlas
OT  - dedifferentiated liposarcoma
OT  - genomics
OT  - immune infiltration
OT  - leiomyosarcoma
OT  - molecular subtype
OT  - myxofibrosarcoma
OT  - pleomorphism
OT  - undifferentiated pleomorphic sarcoma
IR  - Abeshouse A
FIR - Abeshouse, Adam
IR  - Adebamowo C
FIR - Adebamowo, Clement
IR  - Adebamowo SN
FIR - Adebamowo, Sally N
IR  - Akbani R
FIR - Akbani, Rehan
IR  - Akeredolu T
FIR - Akeredolu, Teniola
IR  - Ally A
FIR - Ally, Adrian
IR  - Anderson ML
FIR - Anderson, Matthew L
IR  - Anur P
FIR - Anur, Pavana
IR  - Appelbaum EL
FIR - Appelbaum, Elizabeth L
IR  - Armenia J
FIR - Armenia, Joshua
IR  - Auman JT
FIR - Auman, J Todd
IR  - Bailey MH
FIR - Bailey, Matthew H
IR  - Baker L
FIR - Baker, Laurence
IR  - Balasundaram M
FIR - Balasundaram, Miruna
IR  - Balu S
FIR - Balu, Saianand
IR  - Barthel FP
FIR - Barthel, Floris P
IR  - Bartlett J
FIR - Bartlett, John
IR  - Baylin SB
FIR - Baylin, Stephen B
IR  - Behera M
FIR - Behera, Madhusmita
IR  - Belyaev D
FIR - Belyaev, Dmitry
IR  - Bennett J
FIR - Bennett, Joesph
IR  - Benz C
FIR - Benz, Christopher
IR  - Beroukhim R
FIR - Beroukhim, Rameen
IR  - Birrer M
FIR - Birrer, Michael
IR  - Bocklage T
FIR - Bocklage, Therese
IR  - Bodenheimer T
FIR - Bodenheimer, Tom
IR  - Boice L
FIR - Boice, Lori
IR  - Bootwalla MS
FIR - Bootwalla, Moiz S
IR  - Bowen J
FIR - Bowen, Jay
IR  - Bowlby R
FIR - Bowlby, Reanne
IR  - Boyd J
FIR - Boyd, Jeff
IR  - Brohl AS
FIR - Brohl, Andrew S
IR  - Brooks D
FIR - Brooks, Denise
IR  - Byers L
FIR - Byers, Lauren
IR  - Carlsen R
FIR - Carlsen, Rebecca
IR  - Castro P
FIR - Castro, Patricia
IR  - Chen HW
FIR - Chen, Hsiao-Wei
IR  - Cherniack AD
FIR - Cherniack, Andrew D
IR  - Chibon F
FIR - Chibon, Frederic
IR  - Chin L
FIR - Chin, Lynda
IR  - Cho J
FIR - Cho, Juok
IR  - Chuah E
FIR - Chuah, Eric
IR  - Chudamani S
FIR - Chudamani, Sudha
IR  - Cibulskis C
FIR - Cibulskis, Carrie
IR  - Cooper LAD
FIR - Cooper, Lee A D
IR  - Cope L
FIR - Cope, Leslie
IR  - Cordes MG
FIR - Cordes, Matthew G
IR  - Crain D
FIR - Crain, Daniel
IR  - Curley E
FIR - Curley, Erin
IR  - Danilova L
FIR - Danilova, Ludmila
IR  - Dao F
FIR - Dao, Fanny
IR  - Davis IJ
FIR - Davis, Ian J
IR  - Davis LE
FIR - Davis, Lara E
IR  - Defreitas T
FIR - Defreitas, Timothy
IR  - Delman K
FIR - Delman, Keith
IR  - Demchok JA
FIR - Demchok, John A
IR  - Demetri GD
FIR - Demetri, George D
IR  - Demicco EG
FIR - Demicco, Elizabeth G
IR  - Dhalla N
FIR - Dhalla, Noreen
IR  - Diao L
FIR - Diao, Lixia
IR  - Ding L
FIR - Ding, Li
IR  - DiSaia P
FIR - DiSaia, Phil
IR  - Dottino P
FIR - Dottino, Peter
IR  - Doyle LA
FIR - Doyle, Leona A
IR  - Drill E
FIR - Drill, Esther
IR  - Dubina M
FIR - Dubina, Michael
IR  - Eschbacher J
FIR - Eschbacher, Jennifer
IR  - Fedosenko K
FIR - Fedosenko, Konstantin
IR  - Felau I
FIR - Felau, Ina
IR  - Ferguson ML
FIR - Ferguson, Martin L
IR  - Frazer S
FIR - Frazer, Scott
IR  - Fronick CC
FIR - Fronick, Catrina C
IR  - Fulidou V
FIR - Fulidou, Victoria
IR  - Fulton LA
FIR - Fulton, Lucinda A
IR  - Fulton RS
FIR - Fulton, Robert S
IR  - Gabriel SB
FIR - Gabriel, Stacey B
IR  - Gao J
FIR - Gao, Jianjiong
IR  - Gao Q
FIR - Gao, Qingsong
IR  - Gardner J
FIR - Gardner, Johanna
IR  - Gastier-Foster JM
FIR - Gastier-Foster, Julie M
IR  - Gay CM
FIR - Gay, Carl M
IR  - Gehlenborg N
FIR - Gehlenborg, Nils
IR  - Gerken M
FIR - Gerken, Mark
IR  - Getz G
FIR - Getz, Gad
IR  - Godwin AK
FIR - Godwin, Andrew K
IR  - Godwin EM
FIR - Godwin, Eryn M
IR  - Gordienko E
FIR - Gordienko, Elena
IR  - Grilley-Olson JE
FIR - Grilley-Olson, Juneko E
IR  - Gutman DA
FIR - Gutman, David A
IR  - Gutmann DH
FIR - Gutmann, David H
IR  - Hayes DN
FIR - Hayes, D Neil
IR  - Hegde AM
FIR - Hegde, Apurva M
IR  - Heiman DI
FIR - Heiman, David I
IR  - Heins Z
FIR - Heins, Zachary
IR  - Helsel C
FIR - Helsel, Carmen
IR  - Hepperla AJ
FIR - Hepperla, Austin J
IR  - Higgins K
FIR - Higgins, Kelly
IR  - Hoadley KA
FIR - Hoadley, Katherine A
IR  - Hobensack S
FIR - Hobensack, Shital
IR  - Holt RA
FIR - Holt, Robert A
IR  - Hoon DB
FIR - Hoon, Dave B
IR  - Hornick JL
FIR - Hornick, Jason L
IR  - Hoyle AP
FIR - Hoyle, Alan P
IR  - Hu X
FIR - Hu, Xin
IR  - Huang M
FIR - Huang, Mei
IR  - Hutter CM
FIR - Hutter, Carolyn M
IR  - Iacocca M
FIR - Iacocca, Mary
IR  - Ingram DR
FIR - Ingram, Davis R
IR  - Ittmann M
FIR - Ittmann, Michael
IR  - Iype L
FIR - Iype, Lisa
IR  - Jefferys SR
FIR - Jefferys, Stuart R
IR  - Jones KB
FIR - Jones, Kevin B
IR  - Jones CD
FIR - Jones, Corbin D
IR  - Jones SJM
FIR - Jones, Steven J M
IR  - Kalir T
FIR - Kalir, Tamara
IR  - Karlan BY
FIR - Karlan, Beth Y
IR  - Karseladze A
FIR - Karseladze, Apollon
IR  - Kasaian K
FIR - Kasaian, Katayoon
IR  - Kim J
FIR - Kim, Jaegil
IR  - Kundra R
FIR - Kundra, Ritika
IR  - Kuo H
FIR - Kuo, Hanluen
IR  - Ladanyi M
FIR - Ladanyi, Marc
IR  - Lai PH
FIR - Lai, Phillip H
IR  - Laird PW
FIR - Laird, Peter W
IR  - Larsson E
FIR - Larsson, Erik
IR  - Lawrence MS
FIR - Lawrence, Michael S
IR  - Lazar AJ
FIR - Lazar, Alexander J
IR  - Lee S
FIR - Lee, Sanghoon
IR  - Lee D
FIR - Lee, Darlene
IR  - Lehmann KV
FIR - Lehmann, Kjong-Van
IR  - Leraas KM
FIR - Leraas, Kristen M
IR  - Lester J
FIR - Lester, Jenny
IR  - Levine DA
FIR - Levine, Douglas A
IR  - Li I
FIR - Li, Irene
IR  - Lichtenberg TM
FIR - Lichtenberg, Tara M
IR  - Lin P
FIR - Lin, Pei
IR  - Liu J
FIR - Liu, Jia
IR  - Liu W
FIR - Liu, Wenbin
IR  - Liu EM
FIR - Liu, Eric Minwei
IR  - Lolla L
FIR - Lolla, Laxmi
IR  - Lu Y
FIR - Lu, Yiling
IR  - Ma Y
FIR - Ma, Yussanne
IR  - Madan R
FIR - Madan, Rashna
IR  - Maglinte DT
FIR - Maglinte, Dennis T
IR  - Magliocco A
FIR - Magliocco, Anthony
IR  - Maki RG
FIR - Maki, Robert G
IR  - Mallery D
FIR - Mallery, David
IR  - Manikhas G
FIR - Manikhas, Georgy
IR  - Mardis ER
FIR - Mardis, Elaine R
IR  - Mariamidze A
FIR - Mariamidze, Armaz
IR  - Marra MA
FIR - Marra, Marco A
IR  - Martignetti JA
FIR - Martignetti, John A
IR  - Martinez C
FIR - Martinez, Cathleen
IR  - Mayo M
FIR - Mayo, Michael
IR  - McLellan MD
FIR - McLellan, Michael D
IR  - Meier S
FIR - Meier, Sam
IR  - Meng S
FIR - Meng, Shaowu
IR  - Meyerson M
FIR - Meyerson, Matthew
IR  - Mieczkowski PA
FIR - Mieczkowski, Piotr A
IR  - Miller CA
FIR - Miller, Christopher A
IR  - Mills GB
FIR - Mills, Gordon B
IR  - Moore RA
FIR - Moore, Richard A
IR  - Morris S
FIR - Morris, Scott
IR  - Mose LE
FIR - Mose, Lisle E
IR  - Mozgovoy E
FIR - Mozgovoy, Evgeny
IR  - Mungall AJ
FIR - Mungall, Andrew J
IR  - Mungall K
FIR - Mungall, Karen
IR  - Nalisnik M
FIR - Nalisnik, Michael
IR  - Naresh R
FIR - Naresh, Rashi
IR  - Newton Y
FIR - Newton, Yulia
IR  - Noble MS
FIR - Noble, Michael S
IR  - Novak JE
FIR - Novak, Janet E
IR  - Ochoa A
FIR - Ochoa, Angelica
IR  - Olvera N
FIR - Olvera, Narciso
IR  - Owonikoko TK
FIR - Owonikoko, Taofeek K
IR  - Paklina O
FIR - Paklina, Oxana
IR  - Parfitt J
FIR - Parfitt, Jeremy
IR  - Parker JS
FIR - Parker, Joel S
IR  - Pastore A
FIR - Pastore, Alessandro
IR  - Paulauskis J
FIR - Paulauskis, Joseph
IR  - Penny R
FIR - Penny, Robert
IR  - Pereira E
FIR - Pereira, Elena
IR  - Perou CM
FIR - Perou, Charles M
IR  - Perou AH
FIR - Perou, Amy H
IR  - Pihl T
FIR - Pihl, Todd
IR  - Pollock RE
FIR - Pollock, Raphael E
IR  - Potapova O
FIR - Potapova, Olga
IR  - Radenbaugh AJ
FIR - Radenbaugh, Amie J
IR  - Ramalingam SS
FIR - Ramalingam, Suresh S
IR  - Ramirez NC
FIR - Ramirez, Nilsa C
IR  - Rathmell WK
FIR - Rathmell, W Kimryn
IR  - Raut CP
FIR - Raut, Chandrajit P
IR  - Riedel RF
FIR - Riedel, Richard F
IR  - Reilly C
FIR - Reilly, Colleen
IR  - Reynolds SM
FIR - Reynolds, Sheila M
IR  - Roach J
FIR - Roach, Jeffrey
IR  - Robertson AG
FIR - Robertson, A Gordon
IR  - Roszik J
FIR - Roszik, Jason
IR  - Rubin BP
FIR - Rubin, Brian P
IR  - Sadeghi S
FIR - Sadeghi, Sara
IR  - Saksena G
FIR - Saksena, Gordon
IR  - Salner A
FIR - Salner, Andrew
IR  - Sanchez-Vega F
FIR - Sanchez-Vega, Francisco
IR  - Sander C
FIR - Sander, Chris
IR  - Schein JE
FIR - Schein, Jacqueline E
IR  - Schmidt HK
FIR - Schmidt, Heather K
IR  - Schultz N
FIR - Schultz, Nikolaus
IR  - Schumacher SE
FIR - Schumacher, Steven E
IR  - Sekhon H
FIR - Sekhon, Harman
IR  - Senbabaoglu Y
FIR - Senbabaoglu, Yasin
IR  - Setdikova G
FIR - Setdikova, Galiya
IR  - Shelton C
FIR - Shelton, Candace
IR  - Shelton T
FIR - Shelton, Troy
IR  - Shen R
FIR - Shen, Ronglai
IR  - Shi Y
FIR - Shi, Yan
IR  - Shih J
FIR - Shih, Juliann
IR  - Shmulevich I
FIR - Shmulevich, Ilya
IR  - Sica GL
FIR - Sica, Gabriel L
IR  - Simons JV
FIR - Simons, Janae V
IR  - Singer S
FIR - Singer, Samuel
IR  - Sipahimalani P
FIR - Sipahimalani, Payal
IR  - Skelly T
FIR - Skelly, Tara
IR  - Socci N
FIR - Socci, Nicholas
IR  - Sofia HJ
FIR - Sofia, Heidi J
IR  - Soloway MG
FIR - Soloway, Matthew G
IR  - Spellman P
FIR - Spellman, Paul
IR  - Sun Q
FIR - Sun, Qiang
IR  - Swanson P
FIR - Swanson, Patricia
IR  - Tam A
FIR - Tam, Angela
IR  - Tan D
FIR - Tan, Donghui
IR  - Tarnuzzer R
FIR - Tarnuzzer, Roy
IR  - Thiessen N
FIR - Thiessen, Nina
IR  - Thompson E
FIR - Thompson, Eric
IR  - Thorne LB
FIR - Thorne, Leigh B
IR  - Tong P
FIR - Tong, Pan
IR  - Torres KE
FIR - Torres, Keila E
IR  - van de Rijn M
FIR - van de Rijn, Matt
IR  - Van Den Berg DJ
FIR - Van Den Berg, David J
IR  - Van Tine BA
FIR - Van Tine, Brian A
IR  - Veluvolu U
FIR - Veluvolu, Umadevi
IR  - Verhaak R
FIR - Verhaak, Roel
IR  - Voet D
FIR - Voet, Doug
IR  - Voronina O
FIR - Voronina, Olga
IR  - Wan Y
FIR - Wan, Yunhu
IR  - Wang Z
FIR - Wang, Zhining
IR  - Wang J
FIR - Wang, Jing
IR  - Weinstein JN
FIR - Weinstein, John N
IR  - Weisenberger DJ
FIR - Weisenberger, Daniel J
IR  - Wilkerson MD
FIR - Wilkerson, Matthew D
IR  - Wilson RK
FIR - Wilson, Richard K
IR  - Wise L
FIR - Wise, Lisa
IR  - Wong T
FIR - Wong, Tina
IR  - Wong W
FIR - Wong, Winghing
IR  - Wrangle J
FIR - Wrangle, John
IR  - Wu Y
FIR - Wu, Ye
IR  - Wyczalkowski M
FIR - Wyczalkowski, Matthew
IR  - Yang L
FIR - Yang, Liming
IR  - Yau C
FIR - Yau, Christina
IR  - Yellapantula V
FIR - Yellapantula, Venkata
IR  - Zenklusen JC
FIR - Zenklusen, Jean C
IR  - Zhang JJ
FIR - Zhang, Jiashan Julia
IR  - Zhang H
FIR - Zhang, Hailei
IR  - Zhang H
FIR - Zhang, Hongxin
IR  - Zmuda E
FIR - Zmuda, Erik
EDAT- 2017/11/04 06:00
MHDA- 2017/11/29 06:00
CRDT- 2017/11/04 06:00
PMCR- 2018/11/02 00:00
PHST- 2017/03/17 00:00 [received]
PHST- 2017/07/07 00:00 [revised]
PHST- 2017/10/05 00:00 [accepted]
PHST- 2018/11/02 00:00 [pmc-release]
PHST- 2017/11/04 06:00 [entrez]
PHST- 2017/11/04 06:00 [pubmed]
PHST- 2017/11/29 06:00 [medline]
AID - S0092-8674(17)31203-5 [pii]
AID - 10.1016/j.cell.2017.10.014 [doi]
PST - ppublish
SO  - Cell. 2017 Nov 2;171(4):950-965.e28. doi: 10.1016/j.cell.2017.10.014.

PMID- 29133799
OWN - NLM
STAT- In-Data-Review
LR  - 20171219
IS  - 2041-1723 (Electronic)
IS  - 2041-1723 (Linking)
VI  - 8
IP  - 1
DP  - 2017 Nov 13
TI  - Hit-and-run epigenetic editing prevents senescence entry in primary breast cells 
      from healthy donors.
PG  - 1450
LID - 10.1038/s41467-017-01078-2 [doi]
AB  - Aberrant promoter DNA hypermethylation is a hallmark of cancer; however, whether 
      this is sufficient to drive cellular transformation is not clear. To investigate 
      this question, we use a CRISPR-dCas9 epigenetic editing tool, where an inactive
      form of Cas9 is fused to DNA methyltransferase effectors. Using this system, here
      we show simultaneous de novo DNA methylation of genes commonly methylated in
      cancer, CDKN2A, RASSF1, HIC1 and PTEN in primary breast cells isolated from
      healthy human breast tissue. We find that promoter methylation is maintained in
      this system, even in the absence of the fusion construct, and this prevents cells
      from engaging senescence arrest. Our data show that the key driver of this
      phenotype is repression of CDKN2A transcript p16 where myoepithelial cells
      harbour cancer-like gene expression but do not exhibit anchorage-independent
      growth. This work demonstrates that hit-and-run epigenetic events can prevent
      senescence entry, which may facilitate tumour initiation.
FAU - Saunderson, Emily A
AU  - Saunderson EA
AUID- ORCID: http://orcid.org/0000-0003-2132-7785
AD  - Barts Cancer Institute, John Vane Science Centre, Charterhouse Square, Queen Mary
      University of London, London, EC1M 6BQ, UK.
FAU - Stepper, Peter
AU  - Stepper P
AD  - Institute for Biochemistry and Technical Biochemistry, Department of
      Biochemistry, Faculty of Chemistry, University of Stuttgart, D-70569, Stuttgart, 
      Germany.
FAU - Gomm, Jennifer J
AU  - Gomm JJ
AD  - Barts Cancer Institute, John Vane Science Centre, Charterhouse Square, Queen Mary
      University of London, London, EC1M 6BQ, UK.
FAU - Hoa, Lily
AU  - Hoa L
AUID- ORCID: http://orcid.org/0000-0002-6336-2063
AD  - Barts Cancer Institute, John Vane Science Centre, Charterhouse Square, Queen Mary
      University of London, London, EC1M 6BQ, UK.
FAU - Morgan, Adrienne
AU  - Morgan A
AD  - Barts Cancer Institute, John Vane Science Centre, Charterhouse Square, Queen Mary
      University of London, London, EC1M 6BQ, UK.
FAU - Allen, Michael D
AU  - Allen MD
AUID- ORCID: http://orcid.org/0000-0003-2121-8087
AD  - Barts Cancer Institute, John Vane Science Centre, Charterhouse Square, Queen Mary
      University of London, London, EC1M 6BQ, UK.
FAU - Jones, J Louise
AU  - Jones JL
AD  - Barts Cancer Institute, John Vane Science Centre, Charterhouse Square, Queen Mary
      University of London, London, EC1M 6BQ, UK.
FAU - Gribben, John G
AU  - Gribben JG
AD  - Barts Cancer Institute, John Vane Science Centre, Charterhouse Square, Queen Mary
      University of London, London, EC1M 6BQ, UK.
FAU - Jurkowski, Tomasz P
AU  - Jurkowski TP
AUID- ORCID: http://orcid.org/0000-0002-2012-0240
AD  - Institute for Biochemistry and Technical Biochemistry, Department of
      Biochemistry, Faculty of Chemistry, University of Stuttgart, D-70569, Stuttgart, 
      Germany. tomasz.jurkowski@ibc.uni-stuttgart.de.
FAU - Ficz, Gabriella
AU  - Ficz G
AUID- ORCID: http://orcid.org/0000-0001-9313-9578
AD  - Barts Cancer Institute, John Vane Science Centre, Charterhouse Square, Queen Mary
      University of London, London, EC1M 6BQ, UK. g.ficz@qmul.ac.uk.
LA  - eng
PT  - Journal Article
DEP - 20171113
PL  - England
TA  - Nat Commun
JT  - Nature communications
JID - 101528555
PMC - PMC5684409
EDAT- 2017/11/15 06:00
MHDA- 2017/11/15 06:00
CRDT- 2017/11/15 06:00
PHST- 2016/12/23 00:00 [received]
PHST- 2017/08/16 00:00 [accepted]
PHST- 2017/11/15 06:00 [entrez]
PHST- 2017/11/15 06:00 [pubmed]
PHST- 2017/11/15 06:00 [medline]
AID - 10.1038/s41467-017-01078-2 [doi]
AID - 10.1038/s41467-017-01078-2 [pii]
PST - epublish
SO  - Nat Commun. 2017 Nov 13;8(1):1450. doi: 10.1038/s41467-017-01078-2.

PMID- 29180699
OWN - NLM
STAT- In-Data-Review
LR  - 20180117
IS  - 1546-1718 (Electronic)
IS  - 1061-4036 (Linking)
VI  - 50
IP  - 1
DP  - 2018 Jan
TI  - Mutant-IDH1-dependent chromatin state reprogramming, reversibility, and
      persistence.
PG  - 62-72
LID - 10.1038/s41588-017-0001-z [doi]
AB  - Mutations in IDH1 and IDH2 (encoding isocitrate dehydrogenase 1 and 2) drive the 
      development of gliomas and other human malignancies. Mutant IDH1 induces
      epigenetic changes that promote tumorigenesis, but the scale and reversibility of
      these changes are unknown. Here, using human astrocyte and glioma tumorsphere
      systems, we generate a large-scale atlas of mutant-IDH1-induced epigenomic
      reprogramming. We characterize the reversibility of the alterations in DNA
      methylation, the histone landscape, and transcriptional reprogramming that occur 
      following IDH1 mutation. We discover genome-wide coordinate changes in the
      localization and intensity of multiple histone marks and chromatin states. Mutant
      IDH1 establishes a CD24(+) population with a proliferative advantage and
      stem-like transcriptional features. Strikingly, prolonged exposure to mutant IDH1
      results in irreversible genomic and epigenetic alterations. Together, these
      observations provide unprecedented high-resolution molecular portraits of
      mutant-IDH1-dependent epigenomic reprogramming. These findings have substantial
      implications for understanding of mutant IDH function and for optimizing
      therapeutic approaches to targeting IDH-mutant tumors.
FAU - Turcan, Sevin
AU  - Turcan S
AD  - Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, 
      New York, NY, USA. sevin.turcan@med.uni-heidelberg.de.
AD  - Department of Neurology, University Hospital Heidelberg, Heidelberg, Germany.
      sevin.turcan@med.uni-heidelberg.de.
FAU - Makarov, Vladimir
AU  - Makarov V
AD  - Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, 
      New York, NY, USA.
FAU - Taranda, Julian
AU  - Taranda J
AD  - Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA.
FAU - Wang, Yuxiang
AU  - Wang Y
AD  - Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, 
      New York, NY, USA.
FAU - Fabius, Armida W M
AU  - Fabius AWM
AUID- ORCID: http://orcid.org/0000-0002-1220-1868
AD  - Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, 
      New York, NY, USA.
AD  - Department of Ophthalmology, VU Medical Center, Amsterdam, The Netherlands.
FAU - Wu, Wei
AU  - Wu W
AD  - Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, 
      New York, NY, USA.
FAU - Zheng, Yupeng
AU  - Zheng Y
AD  - Sanofi Genzyme, Waltham, MA, USA.
FAU - El-Amine, Nour
AU  - El-Amine N
AD  - Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA.
FAU - Haddock, Sara
AU  - Haddock S
AD  - Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, 
      New York, NY, USA.
AD  - Weill Cornell School of Medicine, New York, NY, USA.
FAU - Nanjangud, Gouri
AU  - Nanjangud G
AUID- ORCID: http://orcid.org/0000-0002-8547-1957
AD  - Molecular Cytogenetics Core Facility, Memorial Sloan Kettering Cancer Center, New
      York, NY, USA.
FAU - LeKaye, H Carl
AU  - LeKaye HC
AD  - Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, 
      NY, USA.
FAU - Brennan, Cameron
AU  - Brennan C
AD  - Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, NY,
      USA.
FAU - Cross, Justin
AU  - Cross J
AD  - Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan
      Kettering Cancer Center, New York, NY, USA.
FAU - Huse, Jason T
AU  - Huse JT
AD  - Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, 
      New York, NY, USA.
FAU - Kelleher, Neil L
AU  - Kelleher NL
AUID- ORCID: http://orcid.org/0000-0002-8815-3372
AD  - Department of Chemistry, Northwestern University, Evanston, IL, USA.
FAU - Osten, Pavel
AU  - Osten P
AD  - Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA.
FAU - Thompson, Craig B
AU  - Thompson CB
AD  - Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New 
      York, NY, USA.
FAU - Chan, Timothy A
AU  - Chan TA
AUID- ORCID: http://orcid.org/0000-0002-9265-0283
AD  - Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, 
      New York, NY, USA. chant@mskcc.org.
AD  - Weill Cornell School of Medicine, New York, NY, USA. chant@mskcc.org.
AD  - Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer
      Center, New York, NY, USA. chant@mskcc.org.
LA  - eng
GR  - T32 CA160001/CA/NCI NIH HHS/United States
GR  - R01 MH096946/MH/NIMH NIH HHS/United States
GR  - R01 CA177828/CA/NCI NIH HHS/United States
GR  - P41 GM108569/GM/NIGMS NIH HHS/United States
GR  - P30 CA008748/CA/NCI NIH HHS/United States
PT  - Journal Article
DEP - 20171127
PL  - United States
TA  - Nat Genet
JT  - Nature genetics
JID - 9216904
PMC - PMC5769471
MID - NIHMS926768
EDAT- 2017/11/29 06:00
MHDA- 2017/11/29 06:00
CRDT- 2017/11/29 06:00
PMCR- 2019/01/01 00:00
PHST- 2016/11/11 00:00 [received]
PHST- 2017/10/25 00:00 [accepted]
PHST- 2019/01/01 00:00 [pmc-release]
PHST- 2017/11/29 06:00 [pubmed]
PHST- 2017/11/29 06:00 [medline]
PHST- 2017/11/29 06:00 [entrez]
AID - 10.1038/s41588-017-0001-z [doi]
AID - 10.1038/s41588-017-0001-z [pii]
PST - ppublish
SO  - Nat Genet. 2018 Jan;50(1):62-72. doi: 10.1038/s41588-017-0001-z. Epub 2017 Nov
      27.

PMID- 29220667
OWN - NLM
STAT- In-Process
LR  - 20171208
IS  - 1875-9777 (Electronic)
IS  - 1875-9777 (Linking)
VI  - 21
IP  - 6
DP  - 2017 Dec 7
TI  - Transient and Permanent Reconfiguration of Chromatin and Transcription Factor
      Occupancy Drive Reprogramming.
PG  - 834-845.e6
LID - S1934-5909(17)30459-9 [pii]
LID - 10.1016/j.stem.2017.11.007 [doi]
AB  - Somatic cell reprogramming into induced pluripotent stem cells (iPSCs) induces
      changes in genome architecture reflective of the embryonic stem cell (ESC) state.
      However, only a small minority of cells typically transition to pluripotency,
      which has limited our understanding of the process. Here, we characterize the DNA
      regulatory landscape during reprogramming by time-course profiling of isolated
      sub-populations of intermediates poised to become iPSCs. Widespread
      reconfiguration of chromatin states and transcription factor (TF) occupancy
      occurs early during reprogramming, and cells that fail to reprogram partially
      retain their original chromatin states. A second wave of reconfiguration occurs
      just prior to pluripotency acquisition, where a majority of early changes revert 
      to the somatic cell state and many of the changes that define the pluripotent
      state become established. Our comprehensive characterization of
      reprogramming-associated molecular changes broadens our understanding of this
      process and sheds light on how TFs access and change the chromatin during
      cell-fate transitions.
CI  - Copyright (c) 2017 Elsevier Inc. All rights reserved.
FAU - Knaupp, Anja S
AU  - Knaupp AS
AD  - Department of Anatomy and Developmental Biology, Monash University, Wellington
      Road, Clayton, VIC 3800, Australia; Development and Stem Cells Program, Monash
      Biomedicine Discovery Institute, Wellington Road, Clayton, VIC 3800, Australia;
      Australian Regenerative Medicine Institute, Monash University, Wellington Road,
      Clayton, VIC 3800, Australia.
FAU - Buckberry, Sam
AU  - Buckberry S
AD  - Australian Research Council Centre of Excellence in Plant Energy Biology, School 
      of Molecular Sciences, The University of Western Australia, 35 Stirling Highway, 
      Crawley, WA 6009, Australia; Harry Perkins Institute of Medical Research, 6
      Verdun Street, Nedlands, WA 6009, Australia.
FAU - Pflueger, Jahnvi
AU  - Pflueger J
AD  - Australian Research Council Centre of Excellence in Plant Energy Biology, School 
      of Molecular Sciences, The University of Western Australia, 35 Stirling Highway, 
      Crawley, WA 6009, Australia; Harry Perkins Institute of Medical Research, 6
      Verdun Street, Nedlands, WA 6009, Australia.
FAU - Lim, Sue Mei
AU  - Lim SM
AD  - Department of Anatomy and Developmental Biology, Monash University, Wellington
      Road, Clayton, VIC 3800, Australia; Development and Stem Cells Program, Monash
      Biomedicine Discovery Institute, Wellington Road, Clayton, VIC 3800, Australia;
      Australian Regenerative Medicine Institute, Monash University, Wellington Road,
      Clayton, VIC 3800, Australia.
FAU - Ford, Ethan
AU  - Ford E
AD  - Australian Research Council Centre of Excellence in Plant Energy Biology, School 
      of Molecular Sciences, The University of Western Australia, 35 Stirling Highway, 
      Crawley, WA 6009, Australia; Harry Perkins Institute of Medical Research, 6
      Verdun Street, Nedlands, WA 6009, Australia.
FAU - Larcombe, Michael R
AU  - Larcombe MR
AD  - Department of Anatomy and Developmental Biology, Monash University, Wellington
      Road, Clayton, VIC 3800, Australia; Development and Stem Cells Program, Monash
      Biomedicine Discovery Institute, Wellington Road, Clayton, VIC 3800, Australia;
      Australian Regenerative Medicine Institute, Monash University, Wellington Road,
      Clayton, VIC 3800, Australia.
FAU - Rossello, Fernando J
AU  - Rossello FJ
AD  - Department of Anatomy and Developmental Biology, Monash University, Wellington
      Road, Clayton, VIC 3800, Australia; Development and Stem Cells Program, Monash
      Biomedicine Discovery Institute, Wellington Road, Clayton, VIC 3800, Australia;
      Australian Regenerative Medicine Institute, Monash University, Wellington Road,
      Clayton, VIC 3800, Australia.
FAU - de Mendoza, Alex
AU  - de Mendoza A
AD  - Australian Research Council Centre of Excellence in Plant Energy Biology, School 
      of Molecular Sciences, The University of Western Australia, 35 Stirling Highway, 
      Crawley, WA 6009, Australia; Harry Perkins Institute of Medical Research, 6
      Verdun Street, Nedlands, WA 6009, Australia.
FAU - Alaei, Sara
AU  - Alaei S
AD  - Department of Anatomy and Developmental Biology, Monash University, Wellington
      Road, Clayton, VIC 3800, Australia; Development and Stem Cells Program, Monash
      Biomedicine Discovery Institute, Wellington Road, Clayton, VIC 3800, Australia;
      Australian Regenerative Medicine Institute, Monash University, Wellington Road,
      Clayton, VIC 3800, Australia.
FAU - Firas, Jaber
AU  - Firas J
AD  - Department of Anatomy and Developmental Biology, Monash University, Wellington
      Road, Clayton, VIC 3800, Australia; Development and Stem Cells Program, Monash
      Biomedicine Discovery Institute, Wellington Road, Clayton, VIC 3800, Australia;
      Australian Regenerative Medicine Institute, Monash University, Wellington Road,
      Clayton, VIC 3800, Australia.
FAU - Holmes, Melissa L
AU  - Holmes ML
AD  - Department of Anatomy and Developmental Biology, Monash University, Wellington
      Road, Clayton, VIC 3800, Australia; Development and Stem Cells Program, Monash
      Biomedicine Discovery Institute, Wellington Road, Clayton, VIC 3800, Australia;
      Australian Regenerative Medicine Institute, Monash University, Wellington Road,
      Clayton, VIC 3800, Australia.
FAU - Nair, Shalima S
AU  - Nair SS
AD  - Epigenetics Research Laboratory, Genomics and Epigenetics Division, Garvan
      Institute of Medical Research, Sydney, NSW 2010, Australia; St Vincent's Clinical
      School, UNSW Australia, Sydney, NSW 2010, Australia.
FAU - Clark, Susan J
AU  - Clark SJ
AD  - Epigenetics Research Laboratory, Genomics and Epigenetics Division, Garvan
      Institute of Medical Research, Sydney, NSW 2010, Australia; St Vincent's Clinical
      School, UNSW Australia, Sydney, NSW 2010, Australia.
FAU - Nefzger, Christian M
AU  - Nefzger CM
AD  - Department of Anatomy and Developmental Biology, Monash University, Wellington
      Road, Clayton, VIC 3800, Australia; Development and Stem Cells Program, Monash
      Biomedicine Discovery Institute, Wellington Road, Clayton, VIC 3800, Australia;
      Australian Regenerative Medicine Institute, Monash University, Wellington Road,
      Clayton, VIC 3800, Australia.
FAU - Lister, Ryan
AU  - Lister R
AD  - Australian Research Council Centre of Excellence in Plant Energy Biology, School 
      of Molecular Sciences, The University of Western Australia, 35 Stirling Highway, 
      Crawley, WA 6009, Australia; Harry Perkins Institute of Medical Research, 6
      Verdun Street, Nedlands, WA 6009, Australia. Electronic address:
      ryan.lister@uwa.edu.au.
FAU - Polo, Jose M
AU  - Polo JM
AD  - Department of Anatomy and Developmental Biology, Monash University, Wellington
      Road, Clayton, VIC 3800, Australia; Development and Stem Cells Program, Monash
      Biomedicine Discovery Institute, Wellington Road, Clayton, VIC 3800, Australia;
      Australian Regenerative Medicine Institute, Monash University, Wellington Road,
      Clayton, VIC 3800, Australia. Electronic address: jose.polo@monash.edu.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Cell Stem Cell
JT  - Cell stem cell
JID - 101311472
OTO - NOTNLM
OT  - ATAC-sequencing
OT  - ChIP-sequencing
OT  - DNA methylation
OT  - Oct4
OT  - Sox2
OT  - chromatin remodeling
OT  - induced pluripotent stem cells
OT  - refractory cells
OT  - reprogramming intermediates
OT  - transcriptional waves
EDAT- 2017/12/09 06:00
MHDA- 2017/12/09 06:00
CRDT- 2017/12/09 06:00
PHST- 2017/07/11 00:00 [received]
PHST- 2017/09/26 00:00 [revised]
PHST- 2017/11/06 00:00 [accepted]
PHST- 2017/12/09 06:00 [entrez]
PHST- 2017/12/09 06:00 [pubmed]
PHST- 2017/12/09 06:00 [medline]
AID - S1934-5909(17)30459-9 [pii]
AID - 10.1016/j.stem.2017.11.007 [doi]
PST - ppublish
SO  - Cell Stem Cell. 2017 Dec 7;21(6):834-845.e6. doi: 10.1016/j.stem.2017.11.007.

PMID- 29141164
OWN - NLM
STAT- MEDLINE
DCOM- 20171201
LR  - 20171201
IS  - 1533-4406 (Electronic)
IS  - 0028-4793 (Linking)
VI  - 377
IP  - 20
DP  - 2017 Nov 16
TI  - Lomustine and Bevacizumab in Progressive Glioblastoma.
PG  - 1954-1963
LID - 10.1056/NEJMoa1707358 [doi]
AB  - BACKGROUND: Bevacizumab is approved for the treatment of patients with
      progressive glioblastoma on the basis of uncontrolled data. Data from a phase 2
      trial suggested that the addition of bevacizumab to lomustine might improve
      overall survival as compared with monotherapies. We sought to determine whether
      the combination would result in longer overall survival than lomustine alone
      among patients at first progression of glioblastoma. METHODS: We randomly
      assigned patients with progression after chemoradiation in a 2:1 ratio to receive
      lomustine plus bevacizumab (combination group, 288 patients) or lomustine alone
      (monotherapy group, 149 patients). The methylation status of the promoter of
      O(6)-methylguanine-DNA methyltransferase (MGMT) was assessed. Health-related
      quality of life and neurocognitive function were evaluated at baseline and every 
      12 weeks. The primary end point of the trial was overall survival. RESULTS: A
      total of 437 patients underwent randomization. The median number of 6-week
      treatment cycles was three in the combination group and one in the monotherapy
      group. With 329 overall survival events (75.3%), the combination therapy did not 
      provide a survival advantage; the median overall survival was 9.1 months (95%
      confidence interval [CI], 8.1 to 10.1) in the combination group and 8.6 months
      (95% CI, 7.6 to 10.4) in the monotherapy group (hazard ratio for death, 0.95; 95%
      CI, 0.74 to 1.21; P=0.65). Locally assessed progression-free survival was 2.7
      months longer in the combination group than in the monotherapy group: 4.2 months 
      versus 1.5 months (hazard ratio for disease progression or death, 0.49; 95% CI,
      0.39 to 0.61; P<0.001). Grade 3 to 5 adverse events occurred in 63.6% of the
      patients in the combination group and 38.1% of the patients in the monotherapy
      group. The addition of bevacizumab to lomustine affected neither health-related
      quality of life nor neurocognitive function. The MGMT status was prognostic.
      CONCLUSIONS: Despite somewhat prolonged progression-free survival, treatment with
      lomustine plus bevacizumab did not confer a survival advantage over treatment
      with lomustine alone in patients with progressive glioblastoma. (Funded by an
      unrestricted educational grant from F. Hoffmann-La Roche and by the EORTC Cancer 
      Research Fund; EORTC 26101 ClinicalTrials.gov number, NCT01290939 ; Eudra-CT
      number, 2010-023218-30 .).
FAU - Wick, Wolfgang
AU  - Wick W
AD  - From the University Medical Center and German Cancer Research Center, Heidelberg,
      Germany (W.W., M.B., F.S., I.H., A.D., M.P.); the European Organization for
      Research and Treatment of Cancer, Brussels (T.G., V.G.), and Leuven Cancer
      Institute-KU Leuven, Leuven (P.M.C.) - both in Belgium; Haaglanden Medical
      Center, The Hague (M.T.), Erasmus MC Cancer Institute, Rotterdam (W.T., J.C.B.,
      M.J.B.), and VU University Medical Center, Amsterdam (M.K.) - all in the
      Netherlands; the Medical Oncology Department, Azienda Unita Sanitaria Locale di
      Bologna-IRCCS Istituto delle Scienze Neurologiche, Bologna, Italy (A.A.B.);
      Institut Gustave Roussy, Villejuif (J.D.), Assistance Publique-Hopitaux de Paris,
      Hopitaux Universitaires La Pitie Salpetriere-Charles Foix, Service de Neurologie 
      2-Mazarin, INSERM Unite 1127, Centre National de la Recherche Scientifique Unite 
      Mixte de Recherche (UMR) 7225, Sorbonne Universites, University Pierre and Marie 
      Curie 06 UMR S1127, and Institut du Cerveau et de la Moelle Epiniere, Paris
      (A.I.), Institut de Cancerologie de l'Ouest-Centre Rene Gauducheau,
      Saint-Herblain (M.C.), Institut Regional du Cancer Montpellier, Montpellier
      (M.F.), and Centre Hospitalier Regional Universitaire de Lille, Lille (E.L.R.,
      F.D.) - all in France; and the Departments of Oncology and Neurology, University 
      Hospital and University of Zurich, Zurich, Switzerland (R.S., M.W.).
FAU - Gorlia, Thierry
AU  - Gorlia T
AD  - From the University Medical Center and German Cancer Research Center, Heidelberg,
      Germany (W.W., M.B., F.S., I.H., A.D., M.P.); the European Organization for
      Research and Treatment of Cancer, Brussels (T.G., V.G.), and Leuven Cancer
      Institute-KU Leuven, Leuven (P.M.C.) - both in Belgium; Haaglanden Medical
      Center, The Hague (M.T.), Erasmus MC Cancer Institute, Rotterdam (W.T., J.C.B.,
      M.J.B.), and VU University Medical Center, Amsterdam (M.K.) - all in the
      Netherlands; the Medical Oncology Department, Azienda Unita Sanitaria Locale di
      Bologna-IRCCS Istituto delle Scienze Neurologiche, Bologna, Italy (A.A.B.);
      Institut Gustave Roussy, Villejuif (J.D.), Assistance Publique-Hopitaux de Paris,
      Hopitaux Universitaires La Pitie Salpetriere-Charles Foix, Service de Neurologie 
      2-Mazarin, INSERM Unite 1127, Centre National de la Recherche Scientifique Unite 
      Mixte de Recherche (UMR) 7225, Sorbonne Universites, University Pierre and Marie 
      Curie 06 UMR S1127, and Institut du Cerveau et de la Moelle Epiniere, Paris
      (A.I.), Institut de Cancerologie de l'Ouest-Centre Rene Gauducheau,
      Saint-Herblain (M.C.), Institut Regional du Cancer Montpellier, Montpellier
      (M.F.), and Centre Hospitalier Regional Universitaire de Lille, Lille (E.L.R.,
      F.D.) - all in France; and the Departments of Oncology and Neurology, University 
      Hospital and University of Zurich, Zurich, Switzerland (R.S., M.W.).
FAU - Bendszus, Martin
AU  - Bendszus M
AD  - From the University Medical Center and German Cancer Research Center, Heidelberg,
      Germany (W.W., M.B., F.S., I.H., A.D., M.P.); the European Organization for
      Research and Treatment of Cancer, Brussels (T.G., V.G.), and Leuven Cancer
      Institute-KU Leuven, Leuven (P.M.C.) - both in Belgium; Haaglanden Medical
      Center, The Hague (M.T.), Erasmus MC Cancer Institute, Rotterdam (W.T., J.C.B.,
      M.J.B.), and VU University Medical Center, Amsterdam (M.K.) - all in the
      Netherlands; the Medical Oncology Department, Azienda Unita Sanitaria Locale di
      Bologna-IRCCS Istituto delle Scienze Neurologiche, Bologna, Italy (A.A.B.);
      Institut Gustave Roussy, Villejuif (J.D.), Assistance Publique-Hopitaux de Paris,
      Hopitaux Universitaires La Pitie Salpetriere-Charles Foix, Service de Neurologie 
      2-Mazarin, INSERM Unite 1127, Centre National de la Recherche Scientifique Unite 
      Mixte de Recherche (UMR) 7225, Sorbonne Universites, University Pierre and Marie 
      Curie 06 UMR S1127, and Institut du Cerveau et de la Moelle Epiniere, Paris
      (A.I.), Institut de Cancerologie de l'Ouest-Centre Rene Gauducheau,
      Saint-Herblain (M.C.), Institut Regional du Cancer Montpellier, Montpellier
      (M.F.), and Centre Hospitalier Regional Universitaire de Lille, Lille (E.L.R.,
      F.D.) - all in France; and the Departments of Oncology and Neurology, University 
      Hospital and University of Zurich, Zurich, Switzerland (R.S., M.W.).
FAU - Taphoorn, Martin
AU  - Taphoorn M
AD  - From the University Medical Center and German Cancer Research Center, Heidelberg,
      Germany (W.W., M.B., F.S., I.H., A.D., M.P.); the European Organization for
      Research and Treatment of Cancer, Brussels (T.G., V.G.), and Leuven Cancer
      Institute-KU Leuven, Leuven (P.M.C.) - both in Belgium; Haaglanden Medical
      Center, The Hague (M.T.), Erasmus MC Cancer Institute, Rotterdam (W.T., J.C.B.,
      M.J.B.), and VU University Medical Center, Amsterdam (M.K.) - all in the
      Netherlands; the Medical Oncology Department, Azienda Unita Sanitaria Locale di
      Bologna-IRCCS Istituto delle Scienze Neurologiche, Bologna, Italy (A.A.B.);
      Institut Gustave Roussy, Villejuif (J.D.), Assistance Publique-Hopitaux de Paris,
      Hopitaux Universitaires La Pitie Salpetriere-Charles Foix, Service de Neurologie 
      2-Mazarin, INSERM Unite 1127, Centre National de la Recherche Scientifique Unite 
      Mixte de Recherche (UMR) 7225, Sorbonne Universites, University Pierre and Marie 
      Curie 06 UMR S1127, and Institut du Cerveau et de la Moelle Epiniere, Paris
      (A.I.), Institut de Cancerologie de l'Ouest-Centre Rene Gauducheau,
      Saint-Herblain (M.C.), Institut Regional du Cancer Montpellier, Montpellier
      (M.F.), and Centre Hospitalier Regional Universitaire de Lille, Lille (E.L.R.,
      F.D.) - all in France; and the Departments of Oncology and Neurology, University 
      Hospital and University of Zurich, Zurich, Switzerland (R.S., M.W.).
FAU - Sahm, Felix
AU  - Sahm F
AD  - From the University Medical Center and German Cancer Research Center, Heidelberg,
      Germany (W.W., M.B., F.S., I.H., A.D., M.P.); the European Organization for
      Research and Treatment of Cancer, Brussels (T.G., V.G.), and Leuven Cancer
      Institute-KU Leuven, Leuven (P.M.C.) - both in Belgium; Haaglanden Medical
      Center, The Hague (M.T.), Erasmus MC Cancer Institute, Rotterdam (W.T., J.C.B.,
      M.J.B.), and VU University Medical Center, Amsterdam (M.K.) - all in the
      Netherlands; the Medical Oncology Department, Azienda Unita Sanitaria Locale di
      Bologna-IRCCS Istituto delle Scienze Neurologiche, Bologna, Italy (A.A.B.);
      Institut Gustave Roussy, Villejuif (J.D.), Assistance Publique-Hopitaux de Paris,
      Hopitaux Universitaires La Pitie Salpetriere-Charles Foix, Service de Neurologie 
      2-Mazarin, INSERM Unite 1127, Centre National de la Recherche Scientifique Unite 
      Mixte de Recherche (UMR) 7225, Sorbonne Universites, University Pierre and Marie 
      Curie 06 UMR S1127, and Institut du Cerveau et de la Moelle Epiniere, Paris
      (A.I.), Institut de Cancerologie de l'Ouest-Centre Rene Gauducheau,
      Saint-Herblain (M.C.), Institut Regional du Cancer Montpellier, Montpellier
      (M.F.), and Centre Hospitalier Regional Universitaire de Lille, Lille (E.L.R.,
      F.D.) - all in France; and the Departments of Oncology and Neurology, University 
      Hospital and University of Zurich, Zurich, Switzerland (R.S., M.W.).
FAU - Harting, Inga
AU  - Harting I
AD  - From the University Medical Center and German Cancer Research Center, Heidelberg,
      Germany (W.W., M.B., F.S., I.H., A.D., M.P.); the European Organization for
      Research and Treatment of Cancer, Brussels (T.G., V.G.), and Leuven Cancer
      Institute-KU Leuven, Leuven (P.M.C.) - both in Belgium; Haaglanden Medical
      Center, The Hague (M.T.), Erasmus MC Cancer Institute, Rotterdam (W.T., J.C.B.,
      M.J.B.), and VU University Medical Center, Amsterdam (M.K.) - all in the
      Netherlands; the Medical Oncology Department, Azienda Unita Sanitaria Locale di
      Bologna-IRCCS Istituto delle Scienze Neurologiche, Bologna, Italy (A.A.B.);
      Institut Gustave Roussy, Villejuif (J.D.), Assistance Publique-Hopitaux de Paris,
      Hopitaux Universitaires La Pitie Salpetriere-Charles Foix, Service de Neurologie 
      2-Mazarin, INSERM Unite 1127, Centre National de la Recherche Scientifique Unite 
      Mixte de Recherche (UMR) 7225, Sorbonne Universites, University Pierre and Marie 
      Curie 06 UMR S1127, and Institut du Cerveau et de la Moelle Epiniere, Paris
      (A.I.), Institut de Cancerologie de l'Ouest-Centre Rene Gauducheau,
      Saint-Herblain (M.C.), Institut Regional du Cancer Montpellier, Montpellier
      (M.F.), and Centre Hospitalier Regional Universitaire de Lille, Lille (E.L.R.,
      F.D.) - all in France; and the Departments of Oncology and Neurology, University 
      Hospital and University of Zurich, Zurich, Switzerland (R.S., M.W.).
FAU - Brandes, Alba A
AU  - Brandes AA
AD  - From the University Medical Center and German Cancer Research Center, Heidelberg,
      Germany (W.W., M.B., F.S., I.H., A.D., M.P.); the European Organization for
      Research and Treatment of Cancer, Brussels (T.G., V.G.), and Leuven Cancer
      Institute-KU Leuven, Leuven (P.M.C.) - both in Belgium; Haaglanden Medical
      Center, The Hague (M.T.), Erasmus MC Cancer Institute, Rotterdam (W.T., J.C.B.,
      M.J.B.), and VU University Medical Center, Amsterdam (M.K.) - all in the
      Netherlands; the Medical Oncology Department, Azienda Unita Sanitaria Locale di
      Bologna-IRCCS Istituto delle Scienze Neurologiche, Bologna, Italy (A.A.B.);
      Institut Gustave Roussy, Villejuif (J.D.), Assistance Publique-Hopitaux de Paris,
      Hopitaux Universitaires La Pitie Salpetriere-Charles Foix, Service de Neurologie 
      2-Mazarin, INSERM Unite 1127, Centre National de la Recherche Scientifique Unite 
      Mixte de Recherche (UMR) 7225, Sorbonne Universites, University Pierre and Marie 
      Curie 06 UMR S1127, and Institut du Cerveau et de la Moelle Epiniere, Paris
      (A.I.), Institut de Cancerologie de l'Ouest-Centre Rene Gauducheau,
      Saint-Herblain (M.C.), Institut Regional du Cancer Montpellier, Montpellier
      (M.F.), and Centre Hospitalier Regional Universitaire de Lille, Lille (E.L.R.,
      F.D.) - all in France; and the Departments of Oncology and Neurology, University 
      Hospital and University of Zurich, Zurich, Switzerland (R.S., M.W.).
FAU - Taal, Walter
AU  - Taal W
AD  - From the University Medical Center and German Cancer Research Center, Heidelberg,
      Germany (W.W., M.B., F.S., I.H., A.D., M.P.); the European Organization for
      Research and Treatment of Cancer, Brussels (T.G., V.G.), and Leuven Cancer
      Institute-KU Leuven, Leuven (P.M.C.) - both in Belgium; Haaglanden Medical
      Center, The Hague (M.T.), Erasmus MC Cancer Institute, Rotterdam (W.T., J.C.B.,
      M.J.B.), and VU University Medical Center, Amsterdam (M.K.) - all in the
      Netherlands; the Medical Oncology Department, Azienda Unita Sanitaria Locale di
      Bologna-IRCCS Istituto delle Scienze Neurologiche, Bologna, Italy (A.A.B.);
      Institut Gustave Roussy, Villejuif (J.D.), Assistance Publique-Hopitaux de Paris,
      Hopitaux Universitaires La Pitie Salpetriere-Charles Foix, Service de Neurologie 
      2-Mazarin, INSERM Unite 1127, Centre National de la Recherche Scientifique Unite 
      Mixte de Recherche (UMR) 7225, Sorbonne Universites, University Pierre and Marie 
      Curie 06 UMR S1127, and Institut du Cerveau et de la Moelle Epiniere, Paris
      (A.I.), Institut de Cancerologie de l'Ouest-Centre Rene Gauducheau,
      Saint-Herblain (M.C.), Institut Regional du Cancer Montpellier, Montpellier
      (M.F.), and Centre Hospitalier Regional Universitaire de Lille, Lille (E.L.R.,
      F.D.) - all in France; and the Departments of Oncology and Neurology, University 
      Hospital and University of Zurich, Zurich, Switzerland (R.S., M.W.).
FAU - Domont, Julien
AU  - Domont J
AD  - From the University Medical Center and German Cancer Research Center, Heidelberg,
      Germany (W.W., M.B., F.S., I.H., A.D., M.P.); the European Organization for
      Research and Treatment of Cancer, Brussels (T.G., V.G.), and Leuven Cancer
      Institute-KU Leuven, Leuven (P.M.C.) - both in Belgium; Haaglanden Medical
      Center, The Hague (M.T.), Erasmus MC Cancer Institute, Rotterdam (W.T., J.C.B.,
      M.J.B.), and VU University Medical Center, Amsterdam (M.K.) - all in the
      Netherlands; the Medical Oncology Department, Azienda Unita Sanitaria Locale di
      Bologna-IRCCS Istituto delle Scienze Neurologiche, Bologna, Italy (A.A.B.);
      Institut Gustave Roussy, Villejuif (J.D.), Assistance Publique-Hopitaux de Paris,
      Hopitaux Universitaires La Pitie Salpetriere-Charles Foix, Service de Neurologie 
      2-Mazarin, INSERM Unite 1127, Centre National de la Recherche Scientifique Unite 
      Mixte de Recherche (UMR) 7225, Sorbonne Universites, University Pierre and Marie 
      Curie 06 UMR S1127, and Institut du Cerveau et de la Moelle Epiniere, Paris
      (A.I.), Institut de Cancerologie de l'Ouest-Centre Rene Gauducheau,
      Saint-Herblain (M.C.), Institut Regional du Cancer Montpellier, Montpellier
      (M.F.), and Centre Hospitalier Regional Universitaire de Lille, Lille (E.L.R.,
      F.D.) - all in France; and the Departments of Oncology and Neurology, University 
      Hospital and University of Zurich, Zurich, Switzerland (R.S., M.W.).
FAU - Idbaih, Ahmed
AU  - Idbaih A
AD  - From the University Medical Center and German Cancer Research Center, Heidelberg,
      Germany (W.W., M.B., F.S., I.H., A.D., M.P.); the European Organization for
      Research and Treatment of Cancer, Brussels (T.G., V.G.), and Leuven Cancer
      Institute-KU Leuven, Leuven (P.M.C.) - both in Belgium; Haaglanden Medical
      Center, The Hague (M.T.), Erasmus MC Cancer Institute, Rotterdam (W.T., J.C.B.,
      M.J.B.), and VU University Medical Center, Amsterdam (M.K.) - all in the
      Netherlands; the Medical Oncology Department, Azienda Unita Sanitaria Locale di
      Bologna-IRCCS Istituto delle Scienze Neurologiche, Bologna, Italy (A.A.B.);
      Institut Gustave Roussy, Villejuif (J.D.), Assistance Publique-Hopitaux de Paris,
      Hopitaux Universitaires La Pitie Salpetriere-Charles Foix, Service de Neurologie 
      2-Mazarin, INSERM Unite 1127, Centre National de la Recherche Scientifique Unite 
      Mixte de Recherche (UMR) 7225, Sorbonne Universites, University Pierre and Marie 
      Curie 06 UMR S1127, and Institut du Cerveau et de la Moelle Epiniere, Paris
      (A.I.), Institut de Cancerologie de l'Ouest-Centre Rene Gauducheau,
      Saint-Herblain (M.C.), Institut Regional du Cancer Montpellier, Montpellier
      (M.F.), and Centre Hospitalier Regional Universitaire de Lille, Lille (E.L.R.,
      F.D.) - all in France; and the Departments of Oncology and Neurology, University 
      Hospital and University of Zurich, Zurich, Switzerland (R.S., M.W.).
FAU - Campone, Mario
AU  - Campone M
AD  - From the University Medical Center and German Cancer Research Center, Heidelberg,
      Germany (W.W., M.B., F.S., I.H., A.D., M.P.); the European Organization for
      Research and Treatment of Cancer, Brussels (T.G., V.G.), and Leuven Cancer
      Institute-KU Leuven, Leuven (P.M.C.) - both in Belgium; Haaglanden Medical
      Center, The Hague (M.T.), Erasmus MC Cancer Institute, Rotterdam (W.T., J.C.B.,
      M.J.B.), and VU University Medical Center, Amsterdam (M.K.) - all in the
      Netherlands; the Medical Oncology Department, Azienda Unita Sanitaria Locale di
      Bologna-IRCCS Istituto delle Scienze Neurologiche, Bologna, Italy (A.A.B.);
      Institut Gustave Roussy, Villejuif (J.D.), Assistance Publique-Hopitaux de Paris,
      Hopitaux Universitaires La Pitie Salpetriere-Charles Foix, Service de Neurologie 
      2-Mazarin, INSERM Unite 1127, Centre National de la Recherche Scientifique Unite 
      Mixte de Recherche (UMR) 7225, Sorbonne Universites, University Pierre and Marie 
      Curie 06 UMR S1127, and Institut du Cerveau et de la Moelle Epiniere, Paris
      (A.I.), Institut de Cancerologie de l'Ouest-Centre Rene Gauducheau,
      Saint-Herblain (M.C.), Institut Regional du Cancer Montpellier, Montpellier
      (M.F.), and Centre Hospitalier Regional Universitaire de Lille, Lille (E.L.R.,
      F.D.) - all in France; and the Departments of Oncology and Neurology, University 
      Hospital and University of Zurich, Zurich, Switzerland (R.S., M.W.).
FAU - Clement, Paul M
AU  - Clement PM
AD  - From the University Medical Center and German Cancer Research Center, Heidelberg,
      Germany (W.W., M.B., F.S., I.H., A.D., M.P.); the European Organization for
      Research and Treatment of Cancer, Brussels (T.G., V.G.), and Leuven Cancer
      Institute-KU Leuven, Leuven (P.M.C.) - both in Belgium; Haaglanden Medical
      Center, The Hague (M.T.), Erasmus MC Cancer Institute, Rotterdam (W.T., J.C.B.,
      M.J.B.), and VU University Medical Center, Amsterdam (M.K.) - all in the
      Netherlands; the Medical Oncology Department, Azienda Unita Sanitaria Locale di
      Bologna-IRCCS Istituto delle Scienze Neurologiche, Bologna, Italy (A.A.B.);
      Institut Gustave Roussy, Villejuif (J.D.), Assistance Publique-Hopitaux de Paris,
      Hopitaux Universitaires La Pitie Salpetriere-Charles Foix, Service de Neurologie 
      2-Mazarin, INSERM Unite 1127, Centre National de la Recherche Scientifique Unite 
      Mixte de Recherche (UMR) 7225, Sorbonne Universites, University Pierre and Marie 
      Curie 06 UMR S1127, and Institut du Cerveau et de la Moelle Epiniere, Paris
      (A.I.), Institut de Cancerologie de l'Ouest-Centre Rene Gauducheau,
      Saint-Herblain (M.C.), Institut Regional du Cancer Montpellier, Montpellier
      (M.F.), and Centre Hospitalier Regional Universitaire de Lille, Lille (E.L.R.,
      F.D.) - all in France; and the Departments of Oncology and Neurology, University 
      Hospital and University of Zurich, Zurich, Switzerland (R.S., M.W.).
FAU - Stupp, Roger
AU  - Stupp R
AD  - From the University Medical Center and German Cancer Research Center, Heidelberg,
      Germany (W.W., M.B., F.S., I.H., A.D., M.P.); the European Organization for
      Research and Treatment of Cancer, Brussels (T.G., V.G.), and Leuven Cancer
      Institute-KU Leuven, Leuven (P.M.C.) - both in Belgium; Haaglanden Medical
      Center, The Hague (M.T.), Erasmus MC Cancer Institute, Rotterdam (W.T., J.C.B.,
      M.J.B.), and VU University Medical Center, Amsterdam (M.K.) - all in the
      Netherlands; the Medical Oncology Department, Azienda Unita Sanitaria Locale di
      Bologna-IRCCS Istituto delle Scienze Neurologiche, Bologna, Italy (A.A.B.);
      Institut Gustave Roussy, Villejuif (J.D.), Assistance Publique-Hopitaux de Paris,
      Hopitaux Universitaires La Pitie Salpetriere-Charles Foix, Service de Neurologie 
      2-Mazarin, INSERM Unite 1127, Centre National de la Recherche Scientifique Unite 
      Mixte de Recherche (UMR) 7225, Sorbonne Universites, University Pierre and Marie 
      Curie 06 UMR S1127, and Institut du Cerveau et de la Moelle Epiniere, Paris
      (A.I.), Institut de Cancerologie de l'Ouest-Centre Rene Gauducheau,
      Saint-Herblain (M.C.), Institut Regional du Cancer Montpellier, Montpellier
      (M.F.), and Centre Hospitalier Regional Universitaire de Lille, Lille (E.L.R.,
      F.D.) - all in France; and the Departments of Oncology and Neurology, University 
      Hospital and University of Zurich, Zurich, Switzerland (R.S., M.W.).
FAU - Fabbro, Michel
AU  - Fabbro M
AD  - From the University Medical Center and German Cancer Research Center, Heidelberg,
      Germany (W.W., M.B., F.S., I.H., A.D., M.P.); the European Organization for
      Research and Treatment of Cancer, Brussels (T.G., V.G.), and Leuven Cancer
      Institute-KU Leuven, Leuven (P.M.C.) - both in Belgium; Haaglanden Medical
      Center, The Hague (M.T.), Erasmus MC Cancer Institute, Rotterdam (W.T., J.C.B.,
      M.J.B.), and VU University Medical Center, Amsterdam (M.K.) - all in the
      Netherlands; the Medical Oncology Department, Azienda Unita Sanitaria Locale di
      Bologna-IRCCS Istituto delle Scienze Neurologiche, Bologna, Italy (A.A.B.);
      Institut Gustave Roussy, Villejuif (J.D.), Assistance Publique-Hopitaux de Paris,
      Hopitaux Universitaires La Pitie Salpetriere-Charles Foix, Service de Neurologie 
      2-Mazarin, INSERM Unite 1127, Centre National de la Recherche Scientifique Unite 
      Mixte de Recherche (UMR) 7225, Sorbonne Universites, University Pierre and Marie 
      Curie 06 UMR S1127, and Institut du Cerveau et de la Moelle Epiniere, Paris
      (A.I.), Institut de Cancerologie de l'Ouest-Centre Rene Gauducheau,
      Saint-Herblain (M.C.), Institut Regional du Cancer Montpellier, Montpellier
      (M.F.), and Centre Hospitalier Regional Universitaire de Lille, Lille (E.L.R.,
      F.D.) - all in France; and the Departments of Oncology and Neurology, University 
      Hospital and University of Zurich, Zurich, Switzerland (R.S., M.W.).
FAU - Le Rhun, Emilie
AU  - Le Rhun E
AD  - From the University Medical Center and German Cancer Research Center, Heidelberg,
      Germany (W.W., M.B., F.S., I.H., A.D., M.P.); the European Organization for
      Research and Treatment of Cancer, Brussels (T.G., V.G.), and Leuven Cancer
      Institute-KU Leuven, Leuven (P.M.C.) - both in Belgium; Haaglanden Medical
      Center, The Hague (M.T.), Erasmus MC Cancer Institute, Rotterdam (W.T., J.C.B.,
      M.J.B.), and VU University Medical Center, Amsterdam (M.K.) - all in the
      Netherlands; the Medical Oncology Department, Azienda Unita Sanitaria Locale di
      Bologna-IRCCS Istituto delle Scienze Neurologiche, Bologna, Italy (A.A.B.);
      Institut Gustave Roussy, Villejuif (J.D.), Assistance Publique-Hopitaux de Paris,
      Hopitaux Universitaires La Pitie Salpetriere-Charles Foix, Service de Neurologie 
      2-Mazarin, INSERM Unite 1127, Centre National de la Recherche Scientifique Unite 
      Mixte de Recherche (UMR) 7225, Sorbonne Universites, University Pierre and Marie 
      Curie 06 UMR S1127, and Institut du Cerveau et de la Moelle Epiniere, Paris
      (A.I.), Institut de Cancerologie de l'Ouest-Centre Rene Gauducheau,
      Saint-Herblain (M.C.), Institut Regional du Cancer Montpellier, Montpellier
      (M.F.), and Centre Hospitalier Regional Universitaire de Lille, Lille (E.L.R.,
      F.D.) - all in France; and the Departments of Oncology and Neurology, University 
      Hospital and University of Zurich, Zurich, Switzerland (R.S., M.W.).
FAU - Dubois, Francois
AU  - Dubois F
AD  - From the University Medical Center and German Cancer Research Center, Heidelberg,
      Germany (W.W., M.B., F.S., I.H., A.D., M.P.); the European Organization for
      Research and Treatment of Cancer, Brussels (T.G., V.G.), and Leuven Cancer
      Institute-KU Leuven, Leuven (P.M.C.) - both in Belgium; Haaglanden Medical
      Center, The Hague (M.T.), Erasmus MC Cancer Institute, Rotterdam (W.T., J.C.B.,
      M.J.B.), and VU University Medical Center, Amsterdam (M.K.) - all in the
      Netherlands; the Medical Oncology Department, Azienda Unita Sanitaria Locale di
      Bologna-IRCCS Istituto delle Scienze Neurologiche, Bologna, Italy (A.A.B.);
      Institut Gustave Roussy, Villejuif (J.D.), Assistance Publique-Hopitaux de Paris,
      Hopitaux Universitaires La Pitie Salpetriere-Charles Foix, Service de Neurologie 
      2-Mazarin, INSERM Unite 1127, Centre National de la Recherche Scientifique Unite 
      Mixte de Recherche (UMR) 7225, Sorbonne Universites, University Pierre and Marie 
      Curie 06 UMR S1127, and Institut du Cerveau et de la Moelle Epiniere, Paris
      (A.I.), Institut de Cancerologie de l'Ouest-Centre Rene Gauducheau,
      Saint-Herblain (M.C.), Institut Regional du Cancer Montpellier, Montpellier
      (M.F.), and Centre Hospitalier Regional Universitaire de Lille, Lille (E.L.R.,
      F.D.) - all in France; and the Departments of Oncology and Neurology, University 
      Hospital and University of Zurich, Zurich, Switzerland (R.S., M.W.).
FAU - Weller, Michael
AU  - Weller M
AD  - From the University Medical Center and German Cancer Research Center, Heidelberg,
      Germany (W.W., M.B., F.S., I.H., A.D., M.P.); the European Organization for
      Research and Treatment of Cancer, Brussels (T.G., V.G.), and Leuven Cancer
      Institute-KU Leuven, Leuven (P.M.C.) - both in Belgium; Haaglanden Medical
      Center, The Hague (M.T.), Erasmus MC Cancer Institute, Rotterdam (W.T., J.C.B.,
      M.J.B.), and VU University Medical Center, Amsterdam (M.K.) - all in the
      Netherlands; the Medical Oncology Department, Azienda Unita Sanitaria Locale di
      Bologna-IRCCS Istituto delle Scienze Neurologiche, Bologna, Italy (A.A.B.);
      Institut Gustave Roussy, Villejuif (J.D.), Assistance Publique-Hopitaux de Paris,
      Hopitaux Universitaires La Pitie Salpetriere-Charles Foix, Service de Neurologie 
      2-Mazarin, INSERM Unite 1127, Centre National de la Recherche Scientifique Unite 
      Mixte de Recherche (UMR) 7225, Sorbonne Universites, University Pierre and Marie 
      Curie 06 UMR S1127, and Institut du Cerveau et de la Moelle Epiniere, Paris
      (A.I.), Institut de Cancerologie de l'Ouest-Centre Rene Gauducheau,
      Saint-Herblain (M.C.), Institut Regional du Cancer Montpellier, Montpellier
      (M.F.), and Centre Hospitalier Regional Universitaire de Lille, Lille (E.L.R.,
      F.D.) - all in France; and the Departments of Oncology and Neurology, University 
      Hospital and University of Zurich, Zurich, Switzerland (R.S., M.W.).
FAU - von Deimling, Andreas
AU  - von Deimling A
AD  - From the University Medical Center and German Cancer Research Center, Heidelberg,
      Germany (W.W., M.B., F.S., I.H., A.D., M.P.); the European Organization for
      Research and Treatment of Cancer, Brussels (T.G., V.G.), and Leuven Cancer
      Institute-KU Leuven, Leuven (P.M.C.) - both in Belgium; Haaglanden Medical
      Center, The Hague (M.T.), Erasmus MC Cancer Institute, Rotterdam (W.T., J.C.B.,
      M.J.B.), and VU University Medical Center, Amsterdam (M.K.) - all in the
      Netherlands; the Medical Oncology Department, Azienda Unita Sanitaria Locale di
      Bologna-IRCCS Istituto delle Scienze Neurologiche, Bologna, Italy (A.A.B.);
      Institut Gustave Roussy, Villejuif (J.D.), Assistance Publique-Hopitaux de Paris,
      Hopitaux Universitaires La Pitie Salpetriere-Charles Foix, Service de Neurologie 
      2-Mazarin, INSERM Unite 1127, Centre National de la Recherche Scientifique Unite 
      Mixte de Recherche (UMR) 7225, Sorbonne Universites, University Pierre and Marie 
      Curie 06 UMR S1127, and Institut du Cerveau et de la Moelle Epiniere, Paris
      (A.I.), Institut de Cancerologie de l'Ouest-Centre Rene Gauducheau,
      Saint-Herblain (M.C.), Institut Regional du Cancer Montpellier, Montpellier
      (M.F.), and Centre Hospitalier Regional Universitaire de Lille, Lille (E.L.R.,
      F.D.) - all in France; and the Departments of Oncology and Neurology, University 
      Hospital and University of Zurich, Zurich, Switzerland (R.S., M.W.).
FAU - Golfinopoulos, Vassilis
AU  - Golfinopoulos V
AD  - From the University Medical Center and German Cancer Research Center, Heidelberg,
      Germany (W.W., M.B., F.S., I.H., A.D., M.P.); the European Organization for
      Research and Treatment of Cancer, Brussels (T.G., V.G.), and Leuven Cancer
      Institute-KU Leuven, Leuven (P.M.C.) - both in Belgium; Haaglanden Medical
      Center, The Hague (M.T.), Erasmus MC Cancer Institute, Rotterdam (W.T., J.C.B.,
      M.J.B.), and VU University Medical Center, Amsterdam (M.K.) - all in the
      Netherlands; the Medical Oncology Department, Azienda Unita Sanitaria Locale di
      Bologna-IRCCS Istituto delle Scienze Neurologiche, Bologna, Italy (A.A.B.);
      Institut Gustave Roussy, Villejuif (J.D.), Assistance Publique-Hopitaux de Paris,
      Hopitaux Universitaires La Pitie Salpetriere-Charles Foix, Service de Neurologie 
      2-Mazarin, INSERM Unite 1127, Centre National de la Recherche Scientifique Unite 
      Mixte de Recherche (UMR) 7225, Sorbonne Universites, University Pierre and Marie 
      Curie 06 UMR S1127, and Institut du Cerveau et de la Moelle Epiniere, Paris
      (A.I.), Institut de Cancerologie de l'Ouest-Centre Rene Gauducheau,
      Saint-Herblain (M.C.), Institut Regional du Cancer Montpellier, Montpellier
      (M.F.), and Centre Hospitalier Regional Universitaire de Lille, Lille (E.L.R.,
      F.D.) - all in France; and the Departments of Oncology and Neurology, University 
      Hospital and University of Zurich, Zurich, Switzerland (R.S., M.W.).
FAU - Bromberg, Jacoline C
AU  - Bromberg JC
AD  - From the University Medical Center and German Cancer Research Center, Heidelberg,
      Germany (W.W., M.B., F.S., I.H., A.D., M.P.); the European Organization for
      Research and Treatment of Cancer, Brussels (T.G., V.G.), and Leuven Cancer
      Institute-KU Leuven, Leuven (P.M.C.) - both in Belgium; Haaglanden Medical
      Center, The Hague (M.T.), Erasmus MC Cancer Institute, Rotterdam (W.T., J.C.B.,
      M.J.B.), and VU University Medical Center, Amsterdam (M.K.) - all in the
      Netherlands; the Medical Oncology Department, Azienda Unita Sanitaria Locale di
      Bologna-IRCCS Istituto delle Scienze Neurologiche, Bologna, Italy (A.A.B.);
      Institut Gustave Roussy, Villejuif (J.D.), Assistance Publique-Hopitaux de Paris,
      Hopitaux Universitaires La Pitie Salpetriere-Charles Foix, Service de Neurologie 
      2-Mazarin, INSERM Unite 1127, Centre National de la Recherche Scientifique Unite 
      Mixte de Recherche (UMR) 7225, Sorbonne Universites, University Pierre and Marie 
      Curie 06 UMR S1127, and Institut du Cerveau et de la Moelle Epiniere, Paris
      (A.I.), Institut de Cancerologie de l'Ouest-Centre Rene Gauducheau,
      Saint-Herblain (M.C.), Institut Regional du Cancer Montpellier, Montpellier
      (M.F.), and Centre Hospitalier Regional Universitaire de Lille, Lille (E.L.R.,
      F.D.) - all in France; and the Departments of Oncology and Neurology, University 
      Hospital and University of Zurich, Zurich, Switzerland (R.S., M.W.).
FAU - Platten, Michael
AU  - Platten M
AD  - From the University Medical Center and German Cancer Research Center, Heidelberg,
      Germany (W.W., M.B., F.S., I.H., A.D., M.P.); the European Organization for
      Research and Treatment of Cancer, Brussels (T.G., V.G.), and Leuven Cancer
      Institute-KU Leuven, Leuven (P.M.C.) - both in Belgium; Haaglanden Medical
      Center, The Hague (M.T.), Erasmus MC Cancer Institute, Rotterdam (W.T., J.C.B.,
      M.J.B.), and VU University Medical Center, Amsterdam (M.K.) - all in the
      Netherlands; the Medical Oncology Department, Azienda Unita Sanitaria Locale di
      Bologna-IRCCS Istituto delle Scienze Neurologiche, Bologna, Italy (A.A.B.);
      Institut Gustave Roussy, Villejuif (J.D.), Assistance Publique-Hopitaux de Paris,
      Hopitaux Universitaires La Pitie Salpetriere-Charles Foix, Service de Neurologie 
      2-Mazarin, INSERM Unite 1127, Centre National de la Recherche Scientifique Unite 
      Mixte de Recherche (UMR) 7225, Sorbonne Universites, University Pierre and Marie 
      Curie 06 UMR S1127, and Institut du Cerveau et de la Moelle Epiniere, Paris
      (A.I.), Institut de Cancerologie de l'Ouest-Centre Rene Gauducheau,
      Saint-Herblain (M.C.), Institut Regional du Cancer Montpellier, Montpellier
      (M.F.), and Centre Hospitalier Regional Universitaire de Lille, Lille (E.L.R.,
      F.D.) - all in France; and the Departments of Oncology and Neurology, University 
      Hospital and University of Zurich, Zurich, Switzerland (R.S., M.W.).
FAU - Klein, Martin
AU  - Klein M
AD  - From the University Medical Center and German Cancer Research Center, Heidelberg,
      Germany (W.W., M.B., F.S., I.H., A.D., M.P.); the European Organization for
      Research and Treatment of Cancer, Brussels (T.G., V.G.), and Leuven Cancer
      Institute-KU Leuven, Leuven (P.M.C.) - both in Belgium; Haaglanden Medical
      Center, The Hague (M.T.), Erasmus MC Cancer Institute, Rotterdam (W.T., J.C.B.,
      M.J.B.), and VU University Medical Center, Amsterdam (M.K.) - all in the
      Netherlands; the Medical Oncology Department, Azienda Unita Sanitaria Locale di
      Bologna-IRCCS Istituto delle Scienze Neurologiche, Bologna, Italy (A.A.B.);
      Institut Gustave Roussy, Villejuif (J.D.), Assistance Publique-Hopitaux de Paris,
      Hopitaux Universitaires La Pitie Salpetriere-Charles Foix, Service de Neurologie 
      2-Mazarin, INSERM Unite 1127, Centre National de la Recherche Scientifique Unite 
      Mixte de Recherche (UMR) 7225, Sorbonne Universites, University Pierre and Marie 
      Curie 06 UMR S1127, and Institut du Cerveau et de la Moelle Epiniere, Paris
      (A.I.), Institut de Cancerologie de l'Ouest-Centre Rene Gauducheau,
      Saint-Herblain (M.C.), Institut Regional du Cancer Montpellier, Montpellier
      (M.F.), and Centre Hospitalier Regional Universitaire de Lille, Lille (E.L.R.,
      F.D.) - all in France; and the Departments of Oncology and Neurology, University 
      Hospital and University of Zurich, Zurich, Switzerland (R.S., M.W.).
FAU - van den Bent, Martin J
AU  - van den Bent MJ
AD  - From the University Medical Center and German Cancer Research Center, Heidelberg,
      Germany (W.W., M.B., F.S., I.H., A.D., M.P.); the European Organization for
      Research and Treatment of Cancer, Brussels (T.G., V.G.), and Leuven Cancer
      Institute-KU Leuven, Leuven (P.M.C.) - both in Belgium; Haaglanden Medical
      Center, The Hague (M.T.), Erasmus MC Cancer Institute, Rotterdam (W.T., J.C.B.,
      M.J.B.), and VU University Medical Center, Amsterdam (M.K.) - all in the
      Netherlands; the Medical Oncology Department, Azienda Unita Sanitaria Locale di
      Bologna-IRCCS Istituto delle Scienze Neurologiche, Bologna, Italy (A.A.B.);
      Institut Gustave Roussy, Villejuif (J.D.), Assistance Publique-Hopitaux de Paris,
      Hopitaux Universitaires La Pitie Salpetriere-Charles Foix, Service de Neurologie 
      2-Mazarin, INSERM Unite 1127, Centre National de la Recherche Scientifique Unite 
      Mixte de Recherche (UMR) 7225, Sorbonne Universites, University Pierre and Marie 
      Curie 06 UMR S1127, and Institut du Cerveau et de la Moelle Epiniere, Paris
      (A.I.), Institut de Cancerologie de l'Ouest-Centre Rene Gauducheau,
      Saint-Herblain (M.C.), Institut Regional du Cancer Montpellier, Montpellier
      (M.F.), and Centre Hospitalier Regional Universitaire de Lille, Lille (E.L.R.,
      F.D.) - all in France; and the Departments of Oncology and Neurology, University 
      Hospital and University of Zurich, Zurich, Switzerland (R.S., M.W.).
LA  - eng
SI  - ClinicalTrials.gov/NCT01290939
SI  - EudraCT/2010-023218-30
PT  - Clinical Trial, Phase III
PT  - Comparative Study
PT  - Journal Article
PT  - Randomized Controlled Trial
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - N Engl J Med
JT  - The New England journal of medicine
JID - 0255562
RN  - 0 (Antineoplastic Agents, Alkylating)
RN  - 2S9ZZM9Q9V (Bevacizumab)
RN  - 7BRF0Z81KG (Lomustine)
SB  - AIM
SB  - IM
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Antineoplastic Agents, Alkylating/*administration & dosage/adverse effects
MH  - Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
MH  - Bevacizumab/*administration & dosage/adverse effects
MH  - Brain Neoplasms/*drug therapy/mortality/radiotherapy
MH  - Chemoradiotherapy
MH  - Disease-Free Survival
MH  - Female
MH  - Glioblastoma/*drug therapy/mortality/radiotherapy
MH  - Humans
MH  - Intention to Treat Analysis
MH  - Kaplan-Meier Estimate
MH  - Lomustine/*administration & dosage/adverse effects
MH  - Male
MH  - Middle Aged
EDAT- 2017/11/16 06:00
MHDA- 2017/12/02 06:00
CRDT- 2017/11/16 06:00
PHST- 2017/11/16 06:00 [entrez]
PHST- 2017/11/16 06:00 [pubmed]
PHST- 2017/12/02 06:00 [medline]
AID - 10.1056/NEJMoa1707358 [doi]
PST - ppublish
SO  - N Engl J Med. 2017 Nov 16;377(20):1954-1963. doi: 10.1056/NEJMoa1707358.

PMID- 29348366
OWN - NLM
STAT- Publisher
LR  - 20180119
IS  - 1095-9203 (Electronic)
IS  - 0036-8075 (Linking)
DP  - 2018 Jan 18
TI  - Structures of human PRC2 with its cofactors AEBP2 and JARID2.
LID - eaar5700 [pii]
LID - 10.1126/science.aar5700 [doi]
AB  - Transcriptionally repressive histone H3K27 methylation by PRC2 (Polycomb
      repressive complex 2) is essential for cellular differentiation and development. 
      Here we report cryo-EM structures of human PRC2 in two distinct, active states,
      while in complex with its cofactors JARID2 and AEBP2. Both cofactors mimic the
      binding of histone H3 tails. JARID2, methylated by PRC2, mimics a methylated H3
      tail to stimulate PRC2 activity, while AEBP2 interacts with the RBAP48 subunit
      mimicking an unmodified H3 tail. SUZ12 interacts with all other subunits within
      the assembly and thus contributes to the stability of the complex. Our analysis
      defines the complete architecture of a functionally relevant PRC2 and provides a 
      structural framework to understand its regulation by cofactors, histone tails and
      RNA.
CI  - Copyright (c) 2018, American Association for the Advancement of Science.
FAU - Kasinath, Vignesh
AU  - Kasinath V
AUID- ORCID: http://orcid.org/0000-0003-2686-0546
AD  - QB3 Institute, Department of Molecular and Cell Biology, University of
      California, Berkeley, CA 94720, USA.
AD  - Molecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley
      National Laboratory, Berkeley, CA, USA.
FAU - Faini, Marco
AU  - Faini M
AUID- ORCID: http://orcid.org/0000-0001-8131-7648
AD  - Department of Biology, Institute of Molecular Systems Biology, ETH Zurich, 8093
      Zurich, Switzerland.
FAU - Poepsel, Simon
AU  - Poepsel S
AUID- ORCID: http://orcid.org/0000-0002-8304-4062
AD  - QB3 Institute, Department of Molecular and Cell Biology, University of
      California, Berkeley, CA 94720, USA.
AD  - Molecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley
      National Laboratory, Berkeley, CA, USA.
FAU - Reif, Dvir
AU  - Reif D
AUID- ORCID: http://orcid.org/0000-0001-7054-2751
AD  - QB3 Institute, Department of Molecular and Cell Biology, University of
      California, Berkeley, CA 94720, USA.
FAU - Feng, Xinyu Ashlee
AU  - Feng XA
AUID- ORCID: http://orcid.org/0000-0001-5862-1983
AD  - Department of Chemistry, University of California, Berkeley, CA, USA.
FAU - Stjepanovic, Goran
AU  - Stjepanovic G
AUID- ORCID: http://orcid.org/0000-0002-4841-9949
AD  - QB3 Institute, Department of Molecular and Cell Biology, University of
      California, Berkeley, CA 94720, USA.
AD  - Molecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley
      National Laboratory, Berkeley, CA, USA.
FAU - Aebersold, Ruedi
AU  - Aebersold R
AD  - Department of Biology, Institute of Molecular Systems Biology, ETH Zurich, 8093
      Zurich, Switzerland.
AD  - Faculty of Science, University of Zurich, Zurich, Switzerland.
FAU - Nogales, Eva
AU  - Nogales E
AUID- ORCID: http://orcid.org/0000-0001-9816-3681
AD  - QB3 Institute, Department of Molecular and Cell Biology, University of
      California, Berkeley, CA 94720, USA. enogales@lbl.gov.
AD  - Molecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley
      National Laboratory, Berkeley, CA, USA.
AD  - Howard Hughes Medical Institute, University of California, Berkeley, CA 94720,
      USA.
LA  - eng
PT  - Journal Article
DEP - 20180118
PL  - United States
TA  - Science
JT  - Science (New York, N.Y.)
JID - 0404511
EDAT- 2018/01/20 06:00
MHDA- 2018/01/20 06:00
CRDT- 2018/01/20 06:00
PHST- 2017/11/22 00:00 [received]
PHST- 2018/01/09 00:00 [accepted]
PHST- 2018/01/20 06:00 [entrez]
PHST- 2018/01/20 06:00 [pubmed]
PHST- 2018/01/20 06:00 [medline]
AID - science.aar5700 [pii]
AID - 10.1126/science.aar5700 [doi]
PST - aheadofprint
SO  - Science. 2018 Jan 18. pii: science.aar5700. doi: 10.1126/science.aar5700.

PMID- 29374233
OWN - NLM
STAT- In-Data-Review
LR  - 20180130
IS  - 2041-1723 (Electronic)
IS  - 2041-1723 (Linking)
VI  - 9
IP  - 1
DP  - 2018 Jan 26
TI  - GWAS of epigenetic aging rates in blood reveals a critical role for TERT.
PG  - 387
LID - 10.1038/s41467-017-02697-5 [doi]
AB  - DNA methylation age is an accurate biomarker of chronological age and predicts
      lifespan, but its underlying molecular mechanisms are unknown. In this
      genome-wide association study of 9907 individuals, we find gene variants mapping 
      to five loci associated with intrinsic epigenetic age acceleration (IEAA) and
      gene variants in three loci associated with extrinsic epigenetic age acceleration
      (EEAA). Mendelian randomization analysis suggests causal influences of menarche
      and menopause on IEAA and lipoproteins on IEAA and EEAA. Variants associated with
      longer leukocyte telomere length (LTL) in the telomerase reverse transcriptase
      gene (TERT) paradoxically confer higher IEAA (P < 2.7 x 10(-11)). Causal modeling
      indicates TERT-specific and independent effects on LTL and IEAA. Experimental
      hTERT-expression in primary human fibroblasts engenders a linear increase in DNA 
      methylation age with cell population doubling number. Together, these findings
      indicate a critical role for hTERT in regulating the epigenetic clock, in
      addition to its established role of compensating for cell replication-dependent
      telomere shortening.
FAU - Lu, Ake T
AU  - Lu AT
AD  - Human Genetics, David Geffen School of Medicine, University of California, Los
      Angeles, Los Angeles, CA, 90095, USA.
FAU - Xue, Luting
AU  - Xue L
AUID- ORCID: http://orcid.org/0000-0001-6159-1885
AD  - Department of Biostatistics, Boston University School of Public Health, Boston,
      MA, 02118, USA.
FAU - Salfati, Elias L
AU  - Salfati EL
AD  - Department of Medicine, Stanford University School of Medicine, Stanford, CA,
      94305, USA.
FAU - Chen, Brian H
AU  - Chen BH
AUID- ORCID: http://orcid.org/0000-0001-9065-3301
AD  - Intramural Research Program, National Institute on Aging, National Institutes of 
      Health, Baltimore, MD, 21224, USA.
AD  - National Heart, Lung and Blood Institute, Bethesda, MD, 20824-0105, USA.
FAU - Ferrucci, Luigi
AU  - Ferrucci L
AD  - Intramural Research Program, National Institute on Aging, National Institutes of 
      Health, Baltimore, MD, 21224, USA.
FAU - Levy, Daniel
AU  - Levy D
AD  - National Heart, Lung and Blood Institute, Bethesda, MD, 20824-0105, USA.
FAU - Joehanes, Roby
AU  - Joehanes R
AUID- ORCID: http://orcid.org/0000-0001-5549-9054
AD  - National Heart, Lung and Blood Institute, Bethesda, MD, 20824-0105, USA.
FAU - Murabito, Joanne M
AU  - Murabito JM
AD  - Department of Medicine, Section of General Medicine, Boston University School of 
      Medicine, Boston, MA, 02118, USA.
FAU - Kiel, Douglas P
AU  - Kiel DP
AD  - Institute for Aging Research, Hebrew SeniorLife, Beth Israel Deaconess Medical
      Centre, Harvard Medical School, Boston, MA, 02215, USA.
FAU - Tsai, Pei-Chien
AU  - Tsai PC
AD  - Department of Twin Research and Genetic Epidemiology, Kings College London,
      London, SE1 7EH, UK.
FAU - Yet, Idil
AU  - Yet I
AD  - Department of Twin Research and Genetic Epidemiology, Kings College London,
      London, SE1 7EH, UK.
FAU - Bell, Jordana T
AU  - Bell JT
AD  - Department of Twin Research and Genetic Epidemiology, Kings College London,
      London, SE1 7EH, UK.
FAU - Mangino, Massimo
AU  - Mangino M
AUID- ORCID: http://orcid.org/0000-0002-2167-7470
AD  - Department of Twin Research and Genetic Epidemiology, Kings College London,
      London, SE1 7EH, UK.
FAU - Tanaka, Toshiko
AU  - Tanaka T
AD  - Intramural Research Program, National Institute on Aging, National Institutes of 
      Health, Baltimore, MD, 21224, USA.
FAU - McRae, Allan F
AU  - McRae AF
AUID- ORCID: http://orcid.org/0000-0001-5286-5485
AD  - Institute for Molecular Bioscience, The University of Queensland, Brisbane, 4072,
      QLD, Australia.
AD  - Queensland Brain Institute, The University of Queensland, Brisbane, 4072, QLD,
      Australia.
FAU - Marioni, Riccardo E
AU  - Marioni RE
AD  - Institute for Molecular Bioscience, The University of Queensland, Brisbane, 4072,
      QLD, Australia.
AD  - Centre for Cognitive Aging and Cognitive Epidemiology, Department of Psychology, 
      University of Edinburgh, 7 George Square, Edinburgh, EH8 9JZ, UK.
AD  - Medical Genetics Section, Centre for Genomic and Experimental Medicine, Institute
      of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, EH4 2XU, 
      UK.
FAU - Visscher, Peter M
AU  - Visscher PM
AUID- ORCID: http://orcid.org/0000-0002-2143-8760
AD  - Institute for Molecular Bioscience, The University of Queensland, Brisbane, 4072,
      QLD, Australia.
AD  - Queensland Brain Institute, The University of Queensland, Brisbane, 4072, QLD,
      Australia.
FAU - Wray, Naomi R
AU  - Wray NR
AUID- ORCID: http://orcid.org/0000-0001-7421-3357
AD  - Institute for Molecular Bioscience, The University of Queensland, Brisbane, 4072,
      QLD, Australia.
AD  - Queensland Brain Institute, The University of Queensland, Brisbane, 4072, QLD,
      Australia.
FAU - Deary, Ian J
AU  - Deary IJ
AD  - Centre for Cognitive Aging and Cognitive Epidemiology, Department of Psychology, 
      University of Edinburgh, 7 George Square, Edinburgh, EH8 9JZ, UK.
FAU - Levine, Morgan E
AU  - Levine ME
AD  - Human Genetics, David Geffen School of Medicine, University of California, Los
      Angeles, Los Angeles, CA, 90095, USA.
FAU - Quach, Austin
AU  - Quach A
AD  - Human Genetics, David Geffen School of Medicine, University of California, Los
      Angeles, Los Angeles, CA, 90095, USA.
FAU - Assimes, Themistocles
AU  - Assimes T
AD  - Department of Medicine, Stanford University School of Medicine, Stanford, CA,
      94305, USA.
FAU - Tsao, Philip S
AU  - Tsao PS
AD  - Department of Medicine, Stanford University School of Medicine, Stanford, CA,
      94305, USA.
AD  - VA Palo Alto Health Care System, Palo Alto, CA, 94304, USA.
FAU - Absher, Devin
AU  - Absher D
AD  - HudsonAlpha Institute for Biotechnology, Huntsville, AL, 35806, USA.
FAU - Stewart, James D
AU  - Stewart JD
AD  - Department of Epidemiology, Gillings School of Global Public Health, University
      of North Carolina, Chapel Hill, NC, 27599, USA.
FAU - Li, Yun
AU  - Li Y
AD  - Department of Genetics, School of Medicine, University of North Carolina, Chapel 
      Hill, NC, 27599, USA.
AD  - Department of Biostatistics, Gillings School of Global Public Health, University 
      of North Carolina, Chapel Hill, NC, 27599, USA.
FAU - Reiner, Alex P
AU  - Reiner AP
AD  - Fred Hutchinson Cancer Research Center Box 358080, WHI Clinical Coordinating
      Ctr/Public Health Sciences M3-A4, Seattle, WA, 98109, USA.
FAU - Hou, Lifang
AU  - Hou L
AD  - Department of Preventive Medicine, Feinberg School of Medicine, Northwestern
      University Chicago, Evanston, IL, 60611, USA.
AD  - Center for Population Epigenetics, Robert H. Lurie Comprehensive Cancer Center,
      Feinberg School of Medicine, Northwestern University Chicago, Evanston, IL,
      60611, USA.
FAU - Baccarelli, Andrea A
AU  - Baccarelli AA
AD  - Laboratory of Environmental Epigenetics, Departments of Environmental Health
      Sciences Epidemiology, Columbia University Mailman School of Public Health, New
      York, NY, 10032, USA.
FAU - Whitsel, Eric A
AU  - Whitsel EA
AUID- ORCID: http://orcid.org/0000-0003-4843-3641
AD  - Department of Epidemiology, Gillings School of Global Public Health, University
      of North Carolina, Chapel Hill, NC, 27599, USA.
AD  - Department of Medicine, School of Medicine, University of North Carolina, Chapel 
      Hill, NC, 27516, USA.
FAU - Aviv, Abraham
AU  - Aviv A
AD  - The Center for Human Development and Aging, University of Medicine and Dentistry,
      New Jersey Medical School, Rutgers, Newark, NJ, 07103, USA.
FAU - Cardona, Alexia
AU  - Cardona A
AD  - Medical Research Council (MRC) Epidemiology Unit, University of Cambridge School 
      of Clinical Medicine, Institute of Metabolic Science, Cambridge Biomedical
      Campus, Cambridge, CB2 0SL, UK.
FAU - Day, Felix R
AU  - Day FR
AUID- ORCID: http://orcid.org/0000-0003-3789-7651
AD  - Medical Research Council (MRC) Epidemiology Unit, University of Cambridge School 
      of Clinical Medicine, Institute of Metabolic Science, Cambridge Biomedical
      Campus, Cambridge, CB2 0SL, UK.
FAU - Wareham, Nicholas J
AU  - Wareham NJ
AD  - Medical Research Council (MRC) Epidemiology Unit, University of Cambridge School 
      of Clinical Medicine, Institute of Metabolic Science, Cambridge Biomedical
      Campus, Cambridge, CB2 0SL, UK.
FAU - Perry, John R B
AU  - Perry JRB
AD  - Medical Research Council (MRC) Epidemiology Unit, University of Cambridge School 
      of Clinical Medicine, Institute of Metabolic Science, Cambridge Biomedical
      Campus, Cambridge, CB2 0SL, UK.
FAU - Ong, Ken K
AU  - Ong KK
AD  - Medical Research Council (MRC) Epidemiology Unit, University of Cambridge School 
      of Clinical Medicine, Institute of Metabolic Science, Cambridge Biomedical
      Campus, Cambridge, CB2 0SL, UK.
AD  - Department of Paediatrics, University of Cambridge School of Clinical Medicine,
      Cambridge Biomedical Campus, Cambridge, CB2 0SP, UK.
FAU - Raj, Kenneth
AU  - Raj K
AD  - Radiation Effects Department, Centre for Radiation, Chemical and Environmental
      Hazards, Public Health England, Chilton, Didcot, Oxfordshire, OX11 0RQ, UK.
FAU - Lunetta, Kathryn L
AU  - Lunetta KL
AD  - Department of Biostatistics, Boston University School of Public Health, Boston,
      MA, 02118, USA.
FAU - Horvath, Steve
AU  - Horvath S
AD  - Human Genetics, David Geffen School of Medicine, University of California, Los
      Angeles, Los Angeles, CA, 90095, USA. shorvath@mednet.ucla.edu.
AD  - Biostatistics, School of Public Health, University of California, Los Angeles,
      Los Angeles, CA, 90095, USA. shorvath@mednet.ucla.edu.
LA  - eng
PT  - Journal Article
DEP - 20180126
PL  - England
TA  - Nat Commun
JT  - Nature communications
JID - 101528555
PMC - PMC5786029
EDAT- 2018/01/28 06:00
MHDA- 2018/01/28 06:00
CRDT- 2018/01/28 06:00
PHST- 2017/07/12 00:00 [received]
PHST- 2017/12/19 00:00 [accepted]
PHST- 2018/01/28 06:00 [entrez]
PHST- 2018/01/28 06:00 [pubmed]
PHST- 2018/01/28 06:00 [medline]
AID - 10.1038/s41467-017-02697-5 [doi]
AID - 10.1038/s41467-017-02697-5 [pii]
PST - epublish
SO  - Nat Commun. 2018 Jan 26;9(1):387. doi: 10.1038/s41467-017-02697-5.

PMID- 29364877
OWN - NLM
STAT- Publisher
LR  - 20180124
IS  - 1476-4687 (Electronic)
IS  - 0028-0836 (Linking)
DP  - 2018 Jan 24
TI  - Tet2 promotes pathogen infection-induced myelopoiesis through mRNA oxidation.
LID - 10.1038/nature25434 [doi]
AB  - Varieties of RNA modification form the epitranscriptome for post-transcriptional 
      regulation. 5-Methylcytosine (5-mC) is a sparse RNA modification in messenger RNA
      (mRNA) under physiological conditions. The function of RNA
      5-hydroxymethylcytosine (5-hmC) oxidized by ten-eleven translocation (Tet)
      proteins in Drosophila has been revealed more recently. However, the turnover and
      function of 5-mC in mammalian mRNA have been largely unknown. Tet2 suppresses
      myeloid malignancies mostly in an enzymatic activity-dependent manner, and is
      important in resolving inflammatory response in an enzymatic activity-independent
      way. Myelopoiesis is a common host immune response in acute and chronic
      infections; however, its epigenetic mechanism needs to be identified. Here we
      demonstrate that Tet2 promotes infection-induced myelopoiesis in an mRNA
      oxidation-dependent manner through Adar1-mediated repression of Socs3 expression 
      at the post-transcription level. Tet2 promotes both abdominal sepsis-induced
      emergency myelopoiesis and parasite-induced mast cell expansion through
      decreasing mRNA levels of Socs3, a key negative regulator of the JAK-STAT pathway
      that is critical for cytokine-induced myelopoiesis. Tet2 represses Socs3
      expression through Adar1, which binds and destabilizes Socs3 mRNA in a RNA
      editing-independent manner. For the underlying mechanism of Tet2 regulation at
      the mRNA level, Tet2 mediates oxidation of 5-mC in mRNA. Tet2 deficiency leads to
      the transcriptome-wide appearance of methylated cytosines, including ones in the 
      3' untranslated region of Socs3, which influences double-stranded RNA formation
      for Adar1 binding, probably through cytosine methylation-specific readers, such
      as RNA helicases. Our study reveals a previously unknown regulatory role of Tet2 
      at the epitranscriptomic level, promoting myelopoiesis during infection in the
      mammalian system by decreasing 5-mCs in mRNAs. Moreover, the inhibitory function 
      of cytosine methylation on double-stranded RNA formation and Adar1 binding in
      mRNA reveals its new physiological role in the mammalian system.
FAU - Shen, Qicong
AU  - Shen Q
AD  - National Key Laboratory of Medical Immunology & Institute of Immunology, Second
      Military Medical University, Shanghai 200433, China.
FAU - Zhang, Qian
AU  - Zhang Q
AD  - National Key Laboratory of Medical Immunology & Institute of Immunology, Second
      Military Medical University, Shanghai 200433, China.
AD  - Department of Immunology & Center for Immunotherapy, Institute of Basic Medical
      Sciences, Peking Union Medical College, Chinese Academy of Medical Sciences,
      Beijing 100005, China.
FAU - Shi, Yang
AU  - Shi Y
AD  - Institute of Immunology, Zhejiang University School of Medicine, Hangzhou 310058,
      China.
FAU - Shi, Qingzhu
AU  - Shi Q
AD  - Institute of Immunology, Zhejiang University School of Medicine, Hangzhou 310058,
      China.
FAU - Jiang, Yanyan
AU  - Jiang Y
AD  - National Key Laboratory of Medical Immunology & Institute of Immunology, Second
      Military Medical University, Shanghai 200433, China.
FAU - Gu, Yan
AU  - Gu Y
AD  - National Key Laboratory of Medical Immunology & Institute of Immunology, Second
      Military Medical University, Shanghai 200433, China.
FAU - Li, Zhiqing
AU  - Li Z
AD  - Institute of Immunology, Zhejiang University School of Medicine, Hangzhou 310058,
      China.
FAU - Li, Xia
AU  - Li X
AD  - Department of Immunology & Center for Immunotherapy, Institute of Basic Medical
      Sciences, Peking Union Medical College, Chinese Academy of Medical Sciences,
      Beijing 100005, China.
FAU - Zhao, Kai
AU  - Zhao K
AD  - Department of Immunology & Center for Immunotherapy, Institute of Basic Medical
      Sciences, Peking Union Medical College, Chinese Academy of Medical Sciences,
      Beijing 100005, China.
FAU - Wang, Chunmei
AU  - Wang C
AD  - Department of Immunology & Center for Immunotherapy, Institute of Basic Medical
      Sciences, Peking Union Medical College, Chinese Academy of Medical Sciences,
      Beijing 100005, China.
FAU - Li, Nan
AU  - Li N
AD  - National Key Laboratory of Medical Immunology & Institute of Immunology, Second
      Military Medical University, Shanghai 200433, China.
FAU - Cao, Xuetao
AU  - Cao X
AD  - National Key Laboratory of Medical Immunology & Institute of Immunology, Second
      Military Medical University, Shanghai 200433, China.
AD  - Department of Immunology & Center for Immunotherapy, Institute of Basic Medical
      Sciences, Peking Union Medical College, Chinese Academy of Medical Sciences,
      Beijing 100005, China.
LA  - eng
PT  - Journal Article
DEP - 20180124
PL  - England
TA  - Nature
JT  - Nature
JID - 0410462
EDAT- 2018/01/25 06:00
MHDA- 2018/01/25 06:00
CRDT- 2018/01/25 06:00
PHST- 2016/11/22 00:00 [received]
PHST- 2017/12/05 00:00 [accepted]
PHST- 2018/01/25 06:00 [entrez]
PHST- 2018/01/25 06:00 [pubmed]
PHST- 2018/01/25 06:00 [medline]
AID - nature25434 [pii]
AID - 10.1038/nature25434 [doi]
PST - aheadofprint
SO  - Nature. 2018 Jan 24. pii: nature25434. doi: 10.1038/nature25434.

PMID- 29346752
OWN - NLM
STAT- In-Data-Review
LR  - 20180125
IS  - 1097-4199 (Electronic)
IS  - 0896-6273 (Linking)
VI  - 97
IP  - 2
DP  - 2018 Jan 17
TI  - Epitranscriptomic m(6)A Regulation of Axon Regeneration in the Adult Mammalian
      Nervous System.
PG  - 313-325.e6
LID - S0896-6273(17)31184-4 [pii]
LID - 10.1016/j.neuron.2017.12.036 [doi]
AB  - N(6)-methyladenosine (m(6)A) affects multiple aspects of mRNA metabolism and
      regulates developmental transitions by promoting mRNA decay. Little is known
      about the role of m(6)A in the adult mammalian nervous system. Here we report
      that sciatic nerve lesion elevates levels of m(6)A-tagged transcripts encoding
      many regeneration-associated genes and protein translation machinery components
      in the adult mouse dorsal root ganglion (DRG). Single-base resolution m(6)A-CLIP 
      mapping further reveals a dynamic m(6)A landscape in the adult DRG upon injury.
      Loss of either m(6)A methyltransferase complex component Mettl14 or m(6)A-binding
      protein Ythdf1 globally attenuates injury-induced protein translation in adult
      DRGs and reduces functional axon regeneration in the peripheral nervous system in
      vivo. Furthermore, Pten deletion-induced axon regeneration of retinal ganglion
      neurons in the adult central nervous system is attenuated upon Mettl14 knockdown.
      Our study reveals a critical epitranscriptomic mechanism in promoting
      injury-induced protein synthesis and axon regeneration in the adult mammalian
      nervous system.
CI  - Copyright (c) 2017 Elsevier Inc. All rights reserved.
FAU - Weng, Yi-Lan
AU  - Weng YL
AD  - Department of Neuroscience, Mahoney Institute for Neurosciences, Perelman School 
      of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Institute
      for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 
      21205, USA.
FAU - Wang, Xu
AU  - Wang X
AD  - Division of Life Science, State Key Laboratory of Molecular Neuroscience, Hong
      Kong University of Science and Technology, Hong Kong, China.
FAU - An, Ran
AU  - An R
AD  - Department of Neuroscience, Mahoney Institute for Neurosciences, Perelman School 
      of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Institute
      for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 
      21205, USA; Department of Neurology, State Key Laboratory of Medical
      Neurobiology, Huashan Hospital, Fudan University, Shanghai 200040, China.
FAU - Cassin, Jessica
AU  - Cassin J
AD  - Human Genetic Pre-graduate Program, Johns Hopkins University School of Medicine, 
      Baltimore, MD 21205, USA.
FAU - Vissers, Caroline
AU  - Vissers C
AD  - Biochemistry, Cellular, and Molecular Biology Graduate Program, Johns Hopkins
      University School of Medicine, Baltimore, MD 21205, USA.
FAU - Liu, Yuanyuan
AU  - Liu Y
AD  - State Key Laboratory of Reproductive Medicine, Department of Histology and
      Embryology, Nanjing Medical University, Nanjing 211166, China.
FAU - Liu, Yajing
AU  - Liu Y
AD  - School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, 
      China.
FAU - Xu, Tianlei
AU  - Xu T
AD  - Department of Biostatistics and Bioinformatics, Rollins School of Public Health, 
      Emory University, Atlanta, GA 30322, USA.
FAU - Wang, Xinyuan
AU  - Wang X
AD  - Department of Neuroscience, Mahoney Institute for Neurosciences, Perelman School 
      of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; School of
      Basic Medical Sciences, Fudan University, Shanghai 200040, China.
FAU - Wong, Samuel Zheng Hao
AU  - Wong SZH
AD  - Department of Neuroscience, Mahoney Institute for Neurosciences, Perelman School 
      of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Cellular
      and Molecular Medicine Graduate Program, Johns Hopkins University School of
      Medicine, Baltimore, MD 21205, USA.
FAU - Joseph, Jessica
AU  - Joseph J
AD  - Cellular and Molecular Medicine Graduate Program, Johns Hopkins University School
      of Medicine, Baltimore, MD 21205, USA.
FAU - Dore, Louis C
AU  - Dore LC
AD  - Department of Chemistry, University of Chicago, Chicago, IL 60637, USA; Institute
      for Biophysical Dynamics, University of Chicago, Chicago, IL 60637, USA; Howard
      Hughes Medical Institute, University of Chicago, Chicago, IL 60637, USA.
FAU - Dong, Qiang
AU  - Dong Q
AD  - Department of Neurology, State Key Laboratory of Medical Neurobiology, Huashan
      Hospital, Fudan University, Shanghai 200040, China.
FAU - Zheng, Wei
AU  - Zheng W
AD  - National Center for Advancing Translational Sciences, NIH, Bethesda, MD 20892,
      USA.
FAU - Jin, Peng
AU  - Jin P
AD  - Department of Human Genetics, School of Medicine, Emory University, Atlanta, GA
      30322, USA.
FAU - Wu, Hao
AU  - Wu H
AD  - Department of Biostatistics and Bioinformatics, Rollins School of Public Health, 
      Emory University, Atlanta, GA 30322, USA.
FAU - Shen, Bin
AU  - Shen B
AD  - State Key Laboratory of Reproductive Medicine, Department of Histology and
      Embryology, Nanjing Medical University, Nanjing 211166, China.
FAU - Zhuang, Xiaoxi
AU  - Zhuang X
AD  - Department of Neurobiology, University of Chicago, Chicago, IL 60637, USA.
FAU - He, Chuan
AU  - He C
AD  - Department of Chemistry, University of Chicago, Chicago, IL 60637, USA; Institute
      for Biophysical Dynamics, University of Chicago, Chicago, IL 60637, USA; Howard
      Hughes Medical Institute, University of Chicago, Chicago, IL 60637, USA.
FAU - Liu, Kai
AU  - Liu K
AD  - Division of Life Science, State Key Laboratory of Molecular Neuroscience, Hong
      Kong University of Science and Technology, Hong Kong, China.
FAU - Song, Hongjun
AU  - Song H
AD  - Department of Neuroscience, Mahoney Institute for Neurosciences, Perelman School 
      of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Human
      Genetic Pre-graduate Program, Johns Hopkins University School of Medicine,
      Baltimore, MD 21205, USA; Biochemistry, Cellular, and Molecular Biology Graduate 
      Program, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA;
      Cellular and Molecular Medicine Graduate Program, Johns Hopkins University School
      of Medicine, Baltimore, MD 21205, USA; Department of Cell and Developmental
      Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia,
      PA 19104, USA; The Epigenetics Institute, Perelman School of Medicine, University
      of Pennsylvania, Philadelphia, PA 19104, USA; Institute for Regenerative
      Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, 
      PA 19104, USA.
FAU - Ming, Guo-Li
AU  - Ming GL
AD  - Department of Neuroscience, Mahoney Institute for Neurosciences, Perelman School 
      of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA;
      Biochemistry, Cellular, and Molecular Biology Graduate Program, Johns Hopkins
      University School of Medicine, Baltimore, MD 21205, USA; Cellular and Molecular
      Medicine Graduate Program, Johns Hopkins University School of Medicine,
      Baltimore, MD 21205, USA; Department of Cell and Developmental Biology, Perelman 
      School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA;
      Institute for Regenerative Medicine, Perelman School of Medicine, University of
      Pennsylvania, Philadelphia, PA 19104, USA. Electronic address:
      gming@pennmedicine.upenn.edu.
LA  - eng
GR  - P01 NS097206/NS/NINDS NIH HHS/United States
GR  - R35 NS097370/NS/NINDS NIH HHS/United States
GR  - RM1 HG008935/HG/NHGRI NIH HHS/United States
PT  - Journal Article
PL  - United States
TA  - Neuron
JT  - Neuron
JID - 8809320
PMC - PMC5777326
MID - NIHMS931061
OTO - NOTNLM
OT  - CNS axon regeneration
OT  - DRG
OT  - Mettl14
OT  - PNS axon regeneration
OT  - RGC
OT  - YTHDF1
OT  - epitranscriptomics
OT  - mRNA methylation
OT  - protein synthesis
EDAT- 2018/01/19 06:00
MHDA- 2018/01/19 06:00
CRDT- 2018/01/19 06:00
PMCR- 2019/01/17 00:00
PHST- 2017/06/23 00:00 [received]
PHST- 2017/11/05 00:00 [revised]
PHST- 2017/12/22 00:00 [accepted]
PHST- 2019/01/17 00:00 [pmc-release]
PHST- 2018/01/19 06:00 [entrez]
PHST- 2018/01/19 06:00 [pubmed]
PHST- 2018/01/19 06:00 [medline]
AID - S0896-6273(17)31184-4 [pii]
AID - 10.1016/j.neuron.2017.12.036 [doi]
PST - ppublish
SO  - Neuron. 2018 Jan 17;97(2):313-325.e6. doi: 10.1016/j.neuron.2017.12.036.

PMID- 29290541
OWN - NLM
STAT- In-Data-Review
LR  - 20180109
IS  - 1878-3686 (Electronic)
IS  - 1535-6108 (Linking)
VI  - 33
IP  - 1
DP  - 2018 Jan 8
TI  - Genomic and Epigenomic Profiling of High-Risk Intestinal Metaplasia Reveals
      Molecular Determinants of Progression to Gastric Cancer.
PG  - 137-150.e5
LID - S1535-6108(17)30521-4 [pii]
LID - 10.1016/j.ccell.2017.11.018 [doi]
AB  - Intestinal metaplasia (IM) is a pre-malignant condition of the gastric mucosa
      associated with increased gastric cancer (GC) risk. We performed (epi)genomic
      profiling of 138 IMs from 148 cancer-free patients, recruited through a 10-year
      prospective study. Compared with GCs, IMs exhibit low mutational burdens,
      recurrent mutations in certain tumor suppressors (FBXW7) but not others (TP53,
      ARID1A), chromosome 8q amplification, and shortened telomeres. Sequencing
      identified more IM patients with active Helicobacter pylori infection compared
      with histopathology (11%-27%). Several IMs exhibited hypermethylation at DNA
      methylation valleys; however, IMs generally lack intragenic hypomethylation
      signatures of advanced malignancy. IM patients with shortened telomeres and
      chromosomal alterations were associated with subsequent dysplasia or GC;
      conversely patients exhibiting normal-like epigenomic patterns were associated
      with regression.
CI  - Copyright (c) 2017 Elsevier Inc. All rights reserved.
FAU - Huang, Kie Kyon
AU  - Huang KK
AD  - Program in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore
      169857, Singapore.
FAU - Ramnarayanan, Kalpana
AU  - Ramnarayanan K
AD  - Program in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore
      169857, Singapore.
FAU - Zhu, Feng
AU  - Zhu F
AD  - Department of Medicine, Yong Loo Lin School of Medicine, National University of
      Singapore, Singapore 119228, Singapore.
FAU - Srivastava, Supriya
AU  - Srivastava S
AD  - Department of Medicine, Yong Loo Lin School of Medicine, National University of
      Singapore, Singapore 119228, Singapore; Department of Pathology, National
      University of Singapore, Singapore 119228, Singapore.
FAU - Xu, Chang
AU  - Xu C
AD  - Program in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore
      169857, Singapore; Cancer Science Institute of Singapore, National University of 
      Singapore, Singapore 117599, Singapore.
FAU - Tan, Angie Lay Keng
AU  - Tan ALK
AD  - Program in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore
      169857, Singapore.
FAU - Lee, Minghui
AU  - Lee M
AD  - Program in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore
      169857, Singapore.
FAU - Tay, Suting
AU  - Tay S
AD  - Program in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore
      169857, Singapore.
FAU - Das, Kakoli
AU  - Das K
AD  - Program in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore
      169857, Singapore.
FAU - Xing, Manjie
AU  - Xing M
AD  - Program in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore
      169857, Singapore; NUS Graduate School for Integrative Sciences and Engineering, 
      Singapore 117456, Singapore; Cancer Therapeutics and Stratified Oncology, Genome 
      Institute of Singapore, Singapore 138672, Singapore.
FAU - Fatehullah, Aliya
AU  - Fatehullah A
AD  - Institute of Medical Biology, A-STAR, Singapore 138648, Singapore.
FAU - Alkaff, Syed Muhammad Fahmy
AU  - Alkaff SMF
AD  - Department of Anatomical Pathology, Singapore General Hospital, Singapore 169608,
      Singapore.
FAU - Lim, Tony Kiat Hon
AU  - Lim TKH
AD  - Department of Anatomical Pathology, Singapore General Hospital, Singapore 169608,
      Singapore.
FAU - Lee, Jonathan
AU  - Lee J
AD  - Department of Gastroenterology and Hepatology, National University Health System,
      Singapore 119074, Singapore.
FAU - Ho, Khek Yu
AU  - Ho KY
AD  - Department of Medicine, Yong Loo Lin School of Medicine, National University of
      Singapore, Singapore 119228, Singapore; Department of Gastroenterology and
      Hepatology, National University Health System, Singapore 119074, Singapore.
FAU - Rozen, Steven George
AU  - Rozen SG
AD  - Program in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore
      169857, Singapore.
FAU - Teh, Bin Tean
AU  - Teh BT
AD  - Program in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore
      169857, Singapore.
FAU - Barker, Nick
AU  - Barker N
AD  - Institute of Medical Biology, A-STAR, Singapore 138648, Singapore; Centre for
      Regenerative Medicine, Edinburgh EH16 4UU, UK.
FAU - Chia, Chung King
AU  - Chia CK
AD  - Department of Gastroenterology and Hepatology, Tan Tock Seng Hospital, Singapore 
      308433, Singapore.
FAU - Khor, Christopher
AU  - Khor C
AD  - Department of Gastroenterology and Hepatology, Singapore General Hospital,
      Singapore 169854, Singapore.
FAU - Ooi, Choon Jin
AU  - Ooi CJ
AD  - Department of Gastroenterology and Hepatology, Singapore General Hospital,
      Singapore 169854, Singapore.
FAU - Fock, Kwong Ming
AU  - Fock KM
AD  - Department of Gastroenterology and Hepatology, Changi General Hospital, Singapore
      529889, Singapore.
FAU - So, Jimmy
AU  - So J
AD  - Department of Surgery, National University of Singapore, Singapore 119228,
      Singapore.
FAU - Lim, Wee Chian
AU  - Lim WC
AD  - Department of Gastroenterology and Hepatology, Tan Tock Seng Hospital, Singapore 
      308433, Singapore.
FAU - Ling, Khoon Lin
AU  - Ling KL
AD  - Department of Gastroenterology and Hepatology, Singapore General Hospital,
      Singapore 169854, Singapore.
FAU - Ang, Tiing Leong
AU  - Ang TL
AD  - Department of Gastroenterology and Hepatology, Changi General Hospital, Singapore
      529889, Singapore.
FAU - Wong, Andrew
AU  - Wong A
AD  - Department of Surgery, Changi General Hospital, Singapore 529889, Singapore.
FAU - Rao, Jaideepraj
AU  - Rao J
AD  - Department of Surgery, Tan Tock Seng Hospital, Singapore 308433, Singapore.
FAU - Rajnakova, Andrea
AU  - Rajnakova A
AD  - Mt. Elizabeth Medical Centre, Singapore 228510, Singapore.
FAU - Lim, Lee Guan
AU  - Lim LG
AD  - Raffles Hospital, Singapore 188770, Singapore.
FAU - Yap, Wai Ming
AU  - Yap WM
AD  - Department of Pathology, Tan Tock Seng Hospital, Singapore 308433, Singapore.
FAU - Teh, Ming
AU  - Teh M
AD  - Department of Pathology, National University of Singapore, Singapore 119228,
      Singapore. Electronic address: pattehm@nus.edu.sg.
FAU - Yeoh, Khay Guan
AU  - Yeoh KG
AD  - Department of Medicine, Yong Loo Lin School of Medicine, National University of
      Singapore, Singapore 119228, Singapore; Department of Gastroenterology and
      Hepatology, National University Health System, Singapore 119074, Singapore;
      Singapore Gastric Cancer Consortium, Singapore 119074, Singapore. Electronic
      address: mdcykg@nus.edu.sg.
FAU - Tan, Patrick
AU  - Tan P
AD  - Program in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore
      169857, Singapore; Cancer Science Institute of Singapore, National University of 
      Singapore, Singapore 117599, Singapore; Cancer Therapeutics and Stratified
      Oncology, Genome Institute of Singapore, Singapore 138672, Singapore;
      SingHealth/Duke-NUS Institute of Precision Medicine, National Heart Centre
      Singapore, Singapore 169856, Singapore; Cellular and Molecular Research, National
      Cancer Centre, Singapore 169610, Singapore; Singapore Gastric Cancer Consortium, 
      Singapore 119074, Singapore. Electronic address: gmstanp@duke-nus.edu.sg.
LA  - eng
PT  - Journal Article
DEP - 20171228
PL  - United States
TA  - Cancer Cell
JT  - Cancer cell
JID - 101130617
OTO - NOTNLM
OT  - Helicobacter pylori
OT  - cancer genomics
OT  - gastric cancer
OT  - intestinal metaplasia
OT  - risk stratification
EDAT- 2018/01/02 06:00
MHDA- 2018/01/02 06:00
CRDT- 2018/01/02 06:00
PHST- 2017/06/09 00:00 [received]
PHST- 2017/10/02 00:00 [revised]
PHST- 2017/11/28 00:00 [accepted]
PHST- 2018/01/02 06:00 [pubmed]
PHST- 2018/01/02 06:00 [medline]
PHST- 2018/01/02 06:00 [entrez]
AID - S1535-6108(17)30521-4 [pii]
AID - 10.1016/j.ccell.2017.11.018 [doi]
PST - ppublish
SO  - Cancer Cell. 2018 Jan 8;33(1):137-150.e5. doi: 10.1016/j.ccell.2017.11.018. Epub 
      2017 Dec 28.

PMID- 29351847
OWN - NLM
STAT- In-Data-Review
LR  - 20180125
IS  - 1097-4164 (Electronic)
IS  - 1097-2765 (Linking)
VI  - 69
IP  - 2
DP  - 2018 Jan 18
TI  - Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and
      Oncogenic Function.
PG  - 279-291.e5
LID - S1097-2765(17)30981-4 [pii]
LID - 10.1016/j.molcel.2017.12.024 [doi]
AB  - Sustained energy starvation leads to activation of AMP-activated protein kinase
      (AMPK), which coordinates energy status with numerous cellular processes
      including metabolism, protein synthesis, and autophagy. Here, we report that AMPK
      phosphorylates the histone methyltransferase EZH2 at T311 to disrupt the
      interaction between EZH2 and SUZ12, another core component of the polycomb
      repressive complex 2 (PRC2), leading to attenuated PRC2-dependent methylation of 
      histone H3 at Lys27. As such, PRC2 target genes, many of which are known tumor
      suppressors, were upregulated upon T311-EZH2 phosphorylation, which suppressed
      tumor cell growth both in cell culture and mouse xenografts. Pathologically,
      immunohistochemical analyses uncovered a positive correlation between AMPK
      activity and pT311-EZH2, and higher pT311-EZH2 correlates with better survival in
      both ovarian and breast cancer patients. Our finding suggests that AMPK agonists 
      might be promising sensitizers for EZH2-targeting cancer therapies.
CI  - Copyright (c) 2018 Elsevier Inc. All rights reserved.
FAU - Wan, Lixin
AU  - Wan L
AD  - Department of Molecular Oncology, H. Lee Moffitt Cancer Center and Research
      Institute, Tampa, FL 33612, USA; Department of Pathology, Beth Israel Deaconess
      Medical Center, Harvard Medical School, Boston, MA 02215, USA. Electronic
      address: lixin.wan@moffitt.org.
FAU - Xu, Kexin
AU  - Xu K
AD  - Department of Molecular Medicine, University of Texas Health Science Center at
      San Antonio, San Antonio, TX 78229, USA; Department of Medical Oncology and
      Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston,
      MA 02215, USA.
FAU - Wei, Yongkun
AU  - Wei Y
AD  - Department of Molecular and Cellular Oncology, University of Texas MD Anderson
      Cancer Center, Houston, TX 77030, USA.
FAU - Zhang, Jinfang
AU  - Zhang J
AD  - Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical
      School, Boston, MA 02215, USA.
FAU - Han, Tao
AU  - Han T
AD  - Department of Molecular Oncology, H. Lee Moffitt Cancer Center and Research
      Institute, Tampa, FL 33612, USA.
FAU - Fry, Christopher
AU  - Fry C
AD  - Cell Signaling Technology, Danvers, MA 01923, USA.
FAU - Zhang, Zhao
AU  - Zhang Z
AD  - Department of Molecular Medicine, University of Texas Health Science Center at
      San Antonio, San Antonio, TX 78229, USA.
FAU - Wang, Yao Vickie
AU  - Wang YV
AD  - Department of Molecular Medicine, University of Texas Health Science Center at
      San Antonio, San Antonio, TX 78229, USA.
FAU - Huang, Liyu
AU  - Huang L
AD  - Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical
      School, Boston, MA 02215, USA; Chinese National Human Genome Center at Shanghai, 
      Shanghai 201203, PRC.
FAU - Yuan, Min
AU  - Yuan M
AD  - Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215,
      USA.
FAU - Xia, Weiya
AU  - Xia W
AD  - Department of Molecular and Cellular Oncology, University of Texas MD Anderson
      Cancer Center, Houston, TX 77030, USA.
FAU - Chang, Wei-Chao
AU  - Chang WC
AD  - Graduate Institute of Biomedical Sciences and Center for Molecular Medicine,
      China Medical University, Taichung 404, Taiwan.
FAU - Huang, Wen-Chien
AU  - Huang WC
AD  - Department of Surgery, Mackay Memorial Hospital, Taipei, Taiwan.
FAU - Liu, Chien-Liang
AU  - Liu CL
AD  - Department of Surgery, Mackay Memorial Hospital, Taipei, Taiwan.
FAU - Chang, Yuan-Ching
AU  - Chang YC
AD  - Department of Surgery, Mackay Memorial Hospital, Taipei, Taiwan.
FAU - Liu, Jinsong
AU  - Liu J
AD  - Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, 
      TX, USA.
FAU - Wu, Yun
AU  - Wu Y
AD  - Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, 
      TX, USA.
FAU - Jin, Victor X
AU  - Jin VX
AD  - Department of Molecular Medicine, University of Texas Health Science Center at
      San Antonio, San Antonio, TX 78229, USA.
FAU - Dai, Xiangpeng
AU  - Dai X
AD  - Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical
      School, Boston, MA 02215, USA.
FAU - Guo, Jianfeng
AU  - Guo J
AD  - Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical
      School, Boston, MA 02215, USA; Department of Obstetrics and Gynecology, Union
      Hospital, Tongji Medical College, Huazhong University of Science and Technology, 
      Wuhan 430022, PRC.
FAU - Liu, Jia
AU  - Liu J
AD  - Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical
      School, Boston, MA 02215, USA; Cardiovascular Research Center, Xi'an Jiaotong
      University School of Medicine, Xi'an 710061, PRC.
FAU - Jiang, Shulong
AU  - Jiang S
AD  - Department of Molecular Oncology, H. Lee Moffitt Cancer Center and Research
      Institute, Tampa, FL 33612, USA; Department of Oncology, Jining First People's
      Hospital, Jining, Shandong 272111, PRC; Department of Oncology, Guang'anmen
      Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, PRC.
FAU - Li, Jin
AU  - Li J
AD  - Department of Molecular Oncology, H. Lee Moffitt Cancer Center and Research
      Institute, Tampa, FL 33612, USA; Department of Urology, 254th Hospital of PLA,
      Tianjin 300142, PRC.
FAU - Asara, John M
AU  - Asara JM
AD  - Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215,
      USA.
FAU - Brown, Myles
AU  - Brown M
AD  - Department of Medical Oncology and Center for Functional Cancer Epigenetics,
      Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine,
      Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
      Electronic address: myles_brown@dfci.harvard.edu.
FAU - Hung, Mien-Chie
AU  - Hung MC
AD  - Department of Molecular and Cellular Oncology, University of Texas MD Anderson
      Cancer Center, Houston, TX 77030, USA; Graduate Institute of Biomedical Sciences 
      and Center for Molecular Medicine, China Medical University, Taichung 404,
      Taiwan. Electronic address: mhung@mdanderson.org.
FAU - Wei, Wenyi
AU  - Wei W
AD  - Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical
      School, Boston, MA 02215, USA. Electronic address: wwei2@bidmc.harvard.edu.
LA  - eng
GR  - R00 CA178199/CA/NCI NIH HHS/United States
GR  - R00 CA183914/CA/NCI NIH HHS/United States
GR  - R01 GM114142/GM/NIGMS NIH HHS/United States
GR  - R01 GM094777/GM/NIGMS NIH HHS/United States
GR  - K99 CA183914/CA/NCI NIH HHS/United States
GR  - K99 CA212292/CA/NCI NIH HHS/United States
GR  - R01 CA211615/CA/NCI NIH HHS/United States
GR  - R01 CA177910/CA/NCI NIH HHS/United States
GR  - R01 GM089763/GM/NIGMS NIH HHS/United States
PT  - Journal Article
PL  - United States
TA  - Mol Cell
JT  - Molecular cell
JID - 9802571
PMC - PMC5777296
MID - NIHMS930815
OTO - NOTNLM
OT  - AMPK
OT  - EZH2
OT  - metformin
OT  - ovarian cancer
OT  - phosphorylation
OT  - polycomb repressive complex 2
EDAT- 2018/01/21 06:00
MHDA- 2018/01/21 06:00
CRDT- 2018/01/21 06:00
PMCR- 2019/01/18 00:00
PHST- 2017/07/24 00:00 [received]
PHST- 2017/11/11 00:00 [revised]
PHST- 2017/12/22 00:00 [accepted]
PHST- 2019/01/18 00:00 [pmc-release]
PHST- 2018/01/21 06:00 [entrez]
PHST- 2018/01/21 06:00 [pubmed]
PHST- 2018/01/21 06:00 [medline]
AID - S1097-2765(17)30981-4 [pii]
AID - 10.1016/j.molcel.2017.12.024 [doi]
PST - ppublish
SO  - Mol Cell. 2018 Jan 18;69(2):279-291.e5. doi: 10.1016/j.molcel.2017.12.024.
